
<html lang="en"     class="pb-page"  data-request-id="d4e94050-670c-4c8d-b967-087eaa976c6c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2011.54.issue-21;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm201115f;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="4-Nitrobenzyloxycarbonyl Derivatives of O6-Benzylguanine as Hypoxia-Activated Prodrug Inhibitors of O6-Alkylguanine-DNA Alkyltransferase (AGT), Which Produces Resistance to Agents Targeting the O-6 Position of DNA Guanine" /></meta><meta name="dc.Creator" content="Rui  Zhu" /></meta><meta name="dc.Creator" content="Mao-Chin  Liu" /></meta><meta name="dc.Creator" content="Mei-Zhen  Luo" /></meta><meta name="dc.Creator" content="Philip G.  Penketh" /></meta><meta name="dc.Creator" content="Raymond P.  Baumann" /></meta><meta name="dc.Creator" content="Krishnamurthy  Shyam" /></meta><meta name="dc.Creator" content="Alan C.  Sartorelli" /></meta><meta name="dc.Description" content="A series of 4-nitrobenzyloxycarbonyl prodrug derivatives of O6-benzylguanine (O6-BG), conceived as prodrugs of O6-BG, an inhibitor of the resistance protein O6-alkylguanine-DNA alkyltransferase (AG..." /></meta><meta name="Description" content="A series of 4-nitrobenzyloxycarbonyl prodrug derivatives of O6-benzylguanine (O6-BG), conceived as prodrugs of O6-BG, an inhibitor of the resistance protein O6-alkylguanine-DNA alkyltransferase (AG..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 17, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201115f" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201115f" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201115f" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201115f" /></link>
        
    
    

<title>4-Nitrobenzyloxycarbonyl Derivatives of O6-Benzylguanine as Hypoxia-Activated Prodrug Inhibitors of O6-Alkylguanine-DNA Alkyltransferase (AGT), Which Produces Resistance to Agents Targeting the O-6 Position of DNA Guanine | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201115f" /></meta><meta property="og:title" content="4-Nitrobenzyloxycarbonyl Derivatives of O6-Benzylguanine as Hypoxia-Activated Prodrug Inhibitors of O6-Alkylguanine-DNA Alkyltransferase (AGT), Which Produces Resistance to Agents Targeting the O-6 Position of DNA Guanine" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0006.jpeg" /></meta><meta property="og:description" content="A series of 4-nitrobenzyloxycarbonyl prodrug derivatives of O6-benzylguanine (O6-BG), conceived as prodrugs of O6-BG, an inhibitor of the resistance protein O6-alkylguanine-DNA alkyltransferase (AGT), were synthesized and evaluated for their ability to undergo bioreductive activation by reductase enzymes under oxygen deficiency. Three agents of this class, 4-nitrobenzyl (6-(benzyloxy)-9H-purin-2-yl)carbamate (1) and its monomethyl (2) and gem-dimethyl analogues (3), were tested for activation by reductase enzyme systems under oxygen deficient conditions. Compound 3, the most water-soluble of these agents, gave the highest yield of O6-BG following reduction of the nitro group trigger. Compound 3 was also evaluated for its ability to sensitize 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (laromustine)-resistant DU145 human prostate carcinoma cells, which express high levels of AGT, to the cytotoxic effects of this agent under normoxic and oxygen deficient conditions. While 3 had little or no effect on laromustine cytotoxicity under aerobic conditions, significant enhancement occurred under oxygen deficiency, providing evidence for the preferential release of the AGT inhibitor O6-BG under hypoxia." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201115f"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201115f">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201115f&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201115f&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201115f&amp;href=/doi/10.1021/jm201115f" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 7720-7728</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201108k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200976s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">4-Nitrobenzyloxycarbonyl Derivatives of <i>O</i><sup>6</sup>-Benzylguanine as Hypoxia-Activated Prodrug Inhibitors of <i>O</i><sup>6</sup>-Alkylguanine-DNA Alkyltransferase (AGT), Which Produces Resistance to Agents Targeting the <i>O</i>-6 Position of DNA Guanine</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rui++Zhu">Rui Zhu</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mao-Chin++Liu">Mao-Chin Liu</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mei-Zhen++Luo">Mei-Zhen Luo</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+G.++Penketh">Philip G. Penketh</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raymond+P.++Baumann">Raymond P. Baumann</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Krishnamurthy++Shyam">Krishnamurthy Shyam</a></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+C.++Sartorelli">Alan C. Sartorelli</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520-8066, United States</span></div><div class="corresp-info">Telephone: (203) 785-4524. Fax: (203) 737-2045. E-mail: <a href="/cdn-cgi/l/email-protection#80f0e8e9ece9f0aef0e5eeebe5f4e8c0e7ede1e9ecaee3efed"><span class="__cf_email__" data-cfemail="c8b8a0a1a4a1b8e6b8ada6a3adbca088afa5a9a1a4e6aba7a5">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201115f&amp;href=/doi/10.1021%2Fjm201115f" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 7720â7728</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 28, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 August 2011</li><li><span class="item_label"><b>Published</b> online</span>17 October 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 November 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201115f" title="DOI URL">https://doi.org/10.1021/jm201115f</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7720%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRui%2BZhu%252C%2BMao-Chin%2BLiu%252C%2BMei-Zhen%2BLuo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D21%26contentID%3Djm201115f%26title%3D4-Nitrobenzyloxycarbonyl%2BDerivatives%2Bof%2BO6-Benzylguanine%2Bas%2BHypoxia-Activated%2BProdrug%2BInhibitors%2Bof%2BO6-Alkylguanine-DNA%2BAlkyltransferase%2B%2528AGT%2529%252C%2BWhich%2BProduces%2BResistance%2Bto%2BAgents%2BTargeting%2Bthe%2BO-6%2BPosition%2Bof%2BDNA%2BGuanine%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7728%26publicationDate%3DNovember%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201115f"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1398</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201115f" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;4-Nitrobenzyloxycarbonyl Derivatives of O6-Benzylguanine as Hypoxia-Activated Prodrug Inhibitors of O6-Alkylguanine-DNA Alkyltransferase (AGT), Which Produces Resistance to Agents Targeting the O-6 Position of DNA Guanine&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Rui&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Mao-Chin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Mei-Zhen&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;G. Penketh&quot;},{&quot;first_name&quot;:&quot;Raymond&quot;,&quot;last_name&quot;:&quot;P. Baumann&quot;},{&quot;first_name&quot;:&quot;Krishnamurthy&quot;,&quot;last_name&quot;:&quot;Shyam&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;C. Sartorelli&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;7720-7728&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201115f&quot;},&quot;abstract&quot;:&quot;A series of 4-nitrobenzyloxycarbonyl prodrug derivatives of O6-benzylguanine (O6-BG), conceived as prodrugs of O6-BG, an inhibitor of the resistance protein O6-alkylguanine-DNA alkyltransferase (AGT), were synthesized and evaluated for their ability to undergo bioreductive activation by reductase enzymes under oxygen deficiency. Three agents of this class, 4-nitrobenzyl (6-(benzyloxy)-9H-purin-2-yl)carbamate (1) and its monomethyl (2) and gem-dimethyl analogues (3), were tested for activation by reductase enzyme systems under oxygen deficient conditions. Compound 3, the most water-soluble of these agents, gave the highest yield of O6-BG following reduction of the nitro group trigger. Compound 3 was also evaluated for its ability to sensitize 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (laromustine)-resistant DU145 human prostate carcinoma cells, which express high levels of AGT, to the cytotoxic effects of this agent under normoxic and oxygen deficient conditions. While 3 had &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201115f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201115f" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201115f&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201115f" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201115f&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201115f" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201115f&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201115f&amp;href=/doi/10.1021/jm201115f" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201115f" /></input><a href="/doi/pdf/10.1021/jm201115f" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201115f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201115f%26sid%3Dliteratum%253Aachs%26pmid%3D21955333%26genre%3Darticle%26aulast%3DZhu%26date%3D2011%26atitle%3D4-Nitrobenzyloxycarbonyl%2BDerivatives%2Bof%2BO6-Benzylguanine%2Bas%2BHypoxia-Activated%2BProdrug%2BInhibitors%2Bof%2BO6-Alkylguanine-DNA%2BAlkyltransferase%2B%2528AGT%2529%252C%2BWhich%2BProduces%2BResistance%2Bto%2BAgents%2BTargeting%2Bthe%2BO-6%2BPosition%2Bof%2BDNA%2BGuanine%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D21%26spage%3D7720%26epage%3D7728%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292534" title="Oxygen">Oxygen</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jmcmar.2011.54.issue-21/production/jmcmar.2011.54.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of 4-nitrobenzyloxycarbonyl prodrug derivatives of <i>O</i><sup>6</sup>-benzylguanine (<i>O</i><sup>6</sup>-BG), conceived as prodrugs of <i>O</i><sup>6</sup>-BG, an inhibitor of the resistance protein <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase (AGT), were synthesized and evaluated for their ability to undergo bioreductive activation by reductase enzymes under oxygen deficiency. Three agents of this class, 4-nitrobenzyl (6-(benzyloxy)-9<i>H</i>-purin-2-yl)carbamate (<b>1</b>) and its monomethyl (<b>2</b>) and gem-dimethyl analogues (<b>3</b>), were tested for activation by reductase enzyme systems under oxygen deficient conditions. Compound <b>3</b>, the most water-soluble of these agents, gave the highest yield of <i>O</i><sup>6</sup>-BG following reduction of the nitro group trigger. Compound <b>3</b> was also evaluated for its ability to sensitize 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (laromustine)-resistant DU145 human prostate carcinoma cells, which express high levels of AGT, to the cytotoxic effects of this agent under normoxic and oxygen deficient conditions. While <b>3</b> had little or no effect on laromustine cytotoxicity under aerobic conditions, significant enhancement occurred under oxygen deficiency, providing evidence for the preferential release of the AGT inhibitor <i>O</i><sup>6</sup>-BG under hypoxia.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28518" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28518" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alkylating agents are among the most potent and widely used antineoplastic agents. A particularly important class of alkylating agents consists of compounds that methylate and chloroethylate the <i>O</i>-6 position of DNA guanine. This class includes as chloroethylating agents, the chloroethylnitrosoureas (e.g., carmustine or BCNU and lomustine or CCNU) and the sulfonylhydrazine prodrugs [e.g., 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (laromustine, onrigin, cloretazine, VNP40101M, 101M)<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1-6)</a> and 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119)]<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> synthesized in our laboratory, and the methylating agents temozolomide, procarbazine, dacarbazine, and streptozotocin. <i>O</i><sup>6</sup>-Alkylation of guanine residues in DNA is repaired by the protein <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase (AGT), which restores the <i>O</i>-6 position of guanine in DNA to its native state by transferring the <i>O</i><sup>6</sup>-methyl or <i>O</i><sup>6</sup>-(2-chloroethyl) group to a cysteine residue in the active site of the protein.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> There is no known biological acceptor that removes the alkyl moiety from this cysteine residue, so one AGT molecule can only repair a single alkyl lesion. The presence of increasing levels of AGT appears to correlate relatively well with elevated tumor and host tissue resistance to guanine <i>O</i><sup>6</sup>-methylating and chloroethylating agents.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a></div><div class="NLM_p"><i>O</i><sup>6</sup>-Benzylguanine (<i>O</i><sup>6</sup>-BG) is among the most effective known inhibitors of AGT;<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> this agent reacts with AGT to form <i>S</i>-benzylcysteine in the active site of the protein by acting as a substrate, depleting AGT and increasing the sensitivity of both tumor and host cells to agents that chloroethylate and methylate the <i>O</i>-6 position of guanine in DNA.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> Relatively nontoxic levels of <i>O</i><sup>6</sup>-BG have been shown experimentally in both cell and animal tumor systems, as well as in patients, to deplete the AGT content of tumors. This action sensitizes cell systems in vitro and experimental tumors in vivo to BCNU; however, since AGT levels are also depleted by <i>O</i><sup>6</sup>-BG in normal cells, a concomitant sensitization of host tissues occurs, requiring a considerable reduction in the dosage of BCNU. Thus, in cancer patients pretreated with <i>O</i><sup>6</sup>-BG, the resulting myelosuppression requires an 80% decrease in BCNU dosage, resulting in an ineffective therapeutic level of the nitrosourea.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> These findings imply that methodology producing a selective or preferential depletion of AGT in tumor tissue relative to normal tissue is required to circumvent AGT induced tumor resistance to guanine <i>O</i>-6 alkylating agents.</div><div class="NLM_p">The oxygen deficient tumor cell fractions present in solid tumors, which we believe are major sites of tumor vulnerability, can be used to selectively activate prodrugs susceptible to reductive fragmentation to generate a potent inhibitor of AGT (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> To this end, we have synthesized a series of agents containing a 4-nitrobenzyloxycarbonyl trigger/linker and have presented evidence to show selective/preferential activation under oxygen deficiency to generate the AGT inhibitor <i>O</i><sup>6</sup>-BG. These agents contain the nitrobenzyloxycarbonyl moiety in place of one of the protons in the 2-amino group of <i>O</i><sup>6</sup>-BG. Since a free amino group in <i>O</i><sup>6</sup>-BG is essential for potent AGT inhibitory activity, the proposed prodrug should be much less active than the parent compound (i.e., <i>O</i><sup>6</sup>-BG) until unmasking of the 2-amino group occurs following initial one electron nitro reduction in the oxygen deficient cellular fractions.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> In the past, we have used the Î±-methyl-4-nitrobenzyloxycarbonyl moiety as a masking group in KS119, a highly selective sulfonylhydrazine prodrug that displayed excellent activity against oxygen deficient EMT6 murine mammary carcinoma cells with little or no activity against their normoxic counterparts.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> The proposed activation mechanism is depicted in Scheme <a class="ref internalNav" href="#schI" aria-label="1">1</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Influence of oxygen concentration on nitro reduction. Shown is the chemical mechanism underlying the inverse oxygen concentration dependency of net prodrug reduction that leads to molecular fragmentation and the release of the AGT inhibitor <i>O</i><sup>6</sup>-BG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="schI" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0002.jpeg" id="_i2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=schI"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last"><i>O</i><sup>6</sup>-BG, once released, would be expected to enhance the kill of oxygen deficient tumor cells treated with agents such as laromustine, carmustine, and KS119; in addition, it is probable that the activated compounds will diffuse from the oxygen deficient fractions into adjacent oxygenated tumor cells. These phenomena should permit selective depletion of solid tumor AGT, thereby allowing a nearly full dosage of guanine <i>O</i><sup>6</sup>-methylating and chloroethylating agents to be used in the treatment of cancer patients, resulting in increases in the therapeutic efficacy of prodrugs containing agents targeting the <i>O</i>-6 position of DNA guanine in tumors that exhibit resistance to these compounds by virtue of the presence of relatively high levels of AGT.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have synthesized three 4-nitrobenzyloxycarbonyl derivatives of <i>O</i><sup>6</sup>-BG, i.e., the desmethyl (<b>1</b>), the monomethyl (<b>2</b>), and the gem-dimethyl (<b>3</b>) analogues, as shown in Scheme <a class="ref internalNav" href="#schII" aria-label="2">2</a>. These compounds differ structurally only in the degree of methylation of the benzylic carbon in the linker region. Thus, treatment of (2-amino-6-(benzyloxy)-9<i>H</i>-purin-9-yl)methyl pivalate (<b>4</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> with phosgene in the presence of pyridine in anhydrous dichloromethane gave the corresponding 2-isocyanatopurine (<b>5</b>) which, when reacted with the appropriate benzyl alcohol, gave the corresponding carbamate (<b>6</b>, <b>7</b>, or <b>8</b>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The reaction time and yield of the carbamate depended greatly upon the structure of the benzyl alcohol. Thus, intermediate <b>5</b>, when reacted with 4-nitrobenzyl alcohol, Î±-methyl-4-nitrobenzyl alcohol, or Î±,Î±-dimethyl-4-nitrobenzyl alcohol for 2 h, gave carbamate yields of 89% (<b>6</b>), 63% (<b>7</b>), and 14% (<b>8</b>), respectively. However, with prolonged reaction times, compounds <b>7</b> and <b>8</b> were produced in yields of 81% (6 h) and 68% (40 h), respectively. It is obvious that steric hindrance to nucleophilic addition produced by the Î±-methyl and the Î±,Î±-dimethyl groups on the benzylic carbon is responsible for the observed decrease in reaction rates, with the more hindered Î±,Î±-dimethyl alcohol being the least reactive. Two methods were employed for the deprotection of the pivaloyloxymethyl group in compounds <b>6</b>, <b>7</b>, and <b>8</b>. Treatment of <b>7</b> and <b>8</b> with ethanolic sodium hydroxide, followed by neutralization with 10% acetic acid, gave <b>2</b> and <b>3</b> in 60% and 63% yields, respectively; however, this procedure resulted in the cleavage of the carbamate linkage in <b>6</b> to give the original starting material <i>O</i><sup>6</sup>-BG. The greater stability of the carbamate linkage in <b>7</b> and <b>8</b> relative to <b>6</b> may be not only due to the steric protection afforded by the C-methyl groups in compounds <b>7</b> and <b>8</b> but also because the electron-releasing inductive effect of the C-methyl groups rendered the carbonyl carbon less prone to attack by the hydroxide ion. Therefore, a milder method was devised for the selective removal of the pivaloyloxymethyl group in compound <b>6</b>. Thus, not only did 0.1 M ammonia in methanol afford an excellent yield of <b>1</b> from compound <b>6</b> but a similar deprotection procedure employing 1 M ammonia in methanol gave better yields of <b>2</b> and <b>3</b> from compounds <b>7</b> and <b>8</b>, respectively.</div><figure id="schII" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0001.jpeg" id="_i4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=schII"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) phosgene CH<sub>2</sub>Cl<sub>2</sub>/pyridine, 0 Â°C to room temperature, 20 h; (ii) room temperature, 2â40 h; (iii) EtOH/1 M NaOH (6:1), 0 Â°C, 30 min, followed by neutralization with 10% acetic acid, or 0.1â1 M NH<sub>3</sub> in CH<sub>3</sub>OH, 20â40 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55636" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55636" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesized agents were evaluated for their ability to generate <i>O</i><sup>6</sup>-BG by chemical (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and enzymatic activation (Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), as well as by their ability to inhibit AGT (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The poor inhibition of AGT by the intact prodrugs <b>1</b>, <b>2</b>, and <b>3</b> compared to that by <i>O</i><sup>6</sup>-BG was essential for the success of this strategy. Therefore, we compared their relative abilities to inhibit AGT using a modification of previously described methodology.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This assay is based upon the ability of AGT to repair <i>O</i><sup>6</sup>-(2-chloroethyl)guanine and <i>N</i><sup>1</sup>,<i>O</i><sup>6</sup>-ethanoguanine adducts in DNA and thereby prevent the formation of 1-(<i>N</i><sup>3</sup>-deoxycytidinyl)-2-(<i>N</i><sup>1</sup>-deoxyguanosinyl)ethane cross-links. No significant inhibition of AGT was observed over a 30 min test period at 37 Â°C with <b>1</b>, <b>2</b>, and <b>3</b> up to the maximum concentration tested (50 Î¼M), while <i>O</i><sup>6</sup>-BG produced about a 50% inhibition at <sup>1</sup>/<sub>500</sub> of this concentration under the same conditions (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Yields of <i>O</i><sup>6</sup>-BG after Prodrug Reduction by Zn/EDTA<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">prodrug</th><th class="colsep0 rowsep0" align="center">% molar <i>O</i><sup>6</sup>-BG yield</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">4.0 Â± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">35.4 Â± 3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">54.8 Â± 3.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">A solution of each agent in 50 mM Tris-HCl, 10 mM EDTA, pH 7.0 buffer was shaken with â¼4 mg/mL Zn dust and allowed to settle. It was then centrifuged and the supernatant analyzed by HPLC for <i>O</i><sup>6</sup>-BG. The results represent the mean of three independent experiments Â± SEM.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Production of <i>O</i><sup>6</sup>-BG from <b>1</b>, <b>2</b>, and <b>3</b> by Xanthine (X)/Xanthine Oxidase (XO) under Oxygen Deficient and Normoxic Conditions<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">X/XO activation</th><th class="colsep0 rowsep0" align="center"><b>1</b>, normoxic</th><th class="colsep0 rowsep0" align="center"><b>1</b>, oxygen deficient</th><th class="colsep0 rowsep0" align="center"><b>2</b>, normoxic</th><th class="colsep0 rowsep0" align="center"><b>2</b>, oxygen deficient</th><th class="colsep0 rowsep0" align="center"><b>3</b>, normoxic</th><th class="colsep0 rowsep0" align="center"><b>3</b>, oxygen deficient</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[prodrug] Î¼M, <i>T</i> = 0</td><td class="colsep0 rowsep0" align="left">15.4 Â± 0.4</td><td class="colsep0 rowsep0" align="left">18.8 Â± 0.7</td><td class="colsep0 rowsep0" align="left">19.0 Â± 0.2</td><td class="colsep0 rowsep0" align="left">21.4 Â± 1.7</td><td class="colsep0 rowsep0" align="left">17.7 Â± 0.6</td><td class="colsep0 rowsep0" align="left">20.8 Â± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<i>O</i><sup>6</sup>-BG] Î¼M, <i>T</i> = 0</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[prodrug] Î¼M, <i>T</i> = 1</td><td class="colsep0 rowsep0" align="left">11.7 Â± 2.1</td><td class="colsep0 rowsep0" align="left">13.4 Â± 0.3</td><td class="colsep0 rowsep0" align="left">12.3 Â± 2.7</td><td class="colsep0 rowsep0" align="left">8.0 Â± 1.5</td><td class="colsep0 rowsep0" align="left">11.4 Â± 2.7</td><td class="colsep0 rowsep0" align="left">4.0 Â± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<i>O</i><sup>6</sup>-BG] Î¼M, <i>T</i> = 1</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">2.8 Â± 0.5</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">11.6 Â± 0.7</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">14.8 Â± 0.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Production of <i>O</i><sup>6</sup>-BG from â¼20 Î¼M <b>1</b>, <b>2</b>, and <b>3</b> by 1 mM xanthine (X) and 0.16 units/mL xanthine oxidase (XO) was determined under oxygen deficient and normoxic conditions over a 1 h incubation period at 37 Â°C. The concentrations are given with Â±SEM (<i>N</i> = 3) and were determined by HPLC. BLD = below the limit of detection (<0.05 Î¼M).</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Production of <i>O</i><sup>6</sup>-BG from <b>1</b>, <b>2</b>, and <b>3</b> by NADPH:Cytochrome P450 Reductase under Oxygen Deficient and Normoxic Conditions<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">P450 reductase activation</th><th class="colsep0 rowsep0" align="center"><b>1</b>, normoxic</th><th class="colsep0 rowsep0" align="center"><b>1</b>, oxygen deficient</th><th class="colsep0 rowsep0" align="center"><b>2</b>, normoxic</th><th class="colsep0 rowsep0" align="center"><b>2</b>, oxygen deficient</th><th class="colsep0 rowsep0" align="center"><b>3</b>, normoxic</th><th class="colsep0 rowsep0" align="center"><b>3</b>, oxygen deficient</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[prodrug] Î¼M, <i>T</i> = 0</td><td class="colsep0 rowsep0" align="left">18.2 Â± 0.9</td><td class="colsep0 rowsep0" align="left">17.6 Â± 0.5</td><td class="colsep0 rowsep0" align="left">19.8 Â± 2.1</td><td class="colsep0 rowsep0" align="left">18.0 Â± 1.1</td><td class="colsep0 rowsep0" align="left">20.3 Â± 1.2</td><td class="colsep0 rowsep0" align="left">19.3 Â± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<i>O</i><sup>6</sup>-BG] Î¼M, <i>T</i> = 0</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[prodrug] Î¼M, <i>T</i> = 1</td><td class="colsep0 rowsep0" align="left">15.5 Â± 2.8</td><td class="colsep0 rowsep0" align="left">13.8 Â± 2.6</td><td class="colsep0 rowsep0" align="left">18.8 Â± 2.0</td><td class="colsep0 rowsep0" align="left">17.3 Â± 1.6</td><td class="colsep0 rowsep0" align="left">18.2 Â± 2.8</td><td class="colsep0 rowsep0" align="left">4.2 Â± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<i>O</i><sup>6</sup>-BG] Î¼M, <i>T</i> = 1</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">BLD</td><td class="colsep0 rowsep0" align="left">0.1 Â± 0.1</td><td class="colsep0 rowsep0" align="left">0.1 Â± 0.1</td><td class="colsep0 rowsep0" align="left">13.9 Â± 0.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Production of <i>O</i><sup>6</sup>-BG from â¼20 Î¼M <b>1</b>, <b>2</b>, and <b>3</b> by 1 mM NADPH and 1.04 units/mL NADPH:cytochrome P450 reductase was determined under oxygen deficient and normoxic conditions over a 1 h incubation period at 37 Â°C. The concentrations are given with Â±SEM (<i>N</i> = 3) and were determined by HPLC. BLD = below the limit of detection (<0.05 Î¼M).</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. AGT Inactivation by Various Agents<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">agent</th><th class="colsep0 rowsep0" align="center">percent AGT inactivation</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>O</i><sup>6</sup>-BG</td><td class="colsep0 rowsep0" align="left">47 Â± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Comparison of the levels of purified recombinant human AGT inactivation by 50 Î¼M <b>1</b>, <b>2</b>, or <b>3</b> and 0.1 Î¼M <i>O</i><sup>6</sup>-BG after a 30 min incubation at 37 Â°C by assaying the ability of each agent to repair substrate DNA containing <i>O</i><sup>6</sup>-(2-chloroethyl)guanine and <i>N</i><sup>1</sup>,<i>O</i><sup>6</sup>-ethanoguanine lesions relative to AGT incubated in the absence of agent. Values are the mean of three determinations (Â±SEM where applicable).</p></div></div></div><div class="NLM_p">The ability of the chemical and enzyme systems to reduce the nitro group was also evaluated using nitrobenzene as a model nitroaromatic. <i>N</i>-Phenylhydroxylamine and aniline, which are commercially available, were used as standards for quantifying the product yields by HPLC under the various reducing conditions employed. The chemical reduction of nitrobenzene (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), as well as that of the three <i>O</i><sup>6</sup>-BG prodrugs, was carried out using zinc/EDTA. This methodology, which afforded the complete reduction of the nitro group in nitrobenzene to give aniline, resulted in the formation of <i>O</i><sup>6</sup>-BG from each of the three synthesized prodrugs, the rank order being <b>3</b> â¥ <b>2</b> > <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Enzymatic reduction of nitrobenzene with xanthine/xanthine oxidase, as well as with NADPH:cytochrome P450 reductase, gave a mixture of partially reduced (<i>N</i>-phenylhydroxylamine) and fully reduced (aniline) products. Xanthine/xanthine oxidase gave a much higher yield of aniline on a molar basis than NADPH:cytochrome P450 reductase, which gave <i>N</i>-phenylhydroxylamine as the main product of nitroreduction (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The relative yields of reduction products had a bearing on the yield of <i>O</i><sup>6</sup>-BG from each prodrug. Thus, enzymatic reduction with xanthine/xanthine oxidase resulted in the formation of <i>O</i><sup>6</sup>-BG in every case when the three <i>O</i><sup>6</sup>-BG prodrugs were employed as substrates. The rank order of <i>O</i><sup>6</sup>-BG formation was unchanged from the chemical reduction, i.e., <b>3</b> â¥ <b>2</b> > <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Enzymatic reduction by NADPH:cytochrome P450 reductase gave slightly different results. While all three parental prodrugs (â¼20 Î¼M) were reduced by this enzyme, only <b>3</b> gave a significant yield of <i>O</i><sup>6</sup>-BG (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In addition, a greater proportion of <b>3</b> was also reduced, implying that it was a better substrate than either <b>1</b> or <b>2</b> for NADPH:cytochrome P450 reductase (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). As observed earlier, nitroreduction by this enzyme gave the hydroxylamine as the principal product, as evidenced by the observation that approximately 8 times as much <i>N</i>-phenylhydroxylamine as aniline was formed when nitrobenzene was employed as the substrate (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Compound <b>3</b> also generated very small quantities of <i>O</i><sup>6</sup>-BG under aerobic conditions. From these results we can infer that (a) the amino derivatives of <b>1</b>, <b>2</b>, and <b>3</b> readily fragment to form <i>O</i><sup>6</sup>-BG, with <b>3</b> giving the best yield, (b) the hydroxylamino derivative of <b>3</b> generates <i>O</i><sup>6</sup>-BG, while the hydroxylamino derivatives of <b>1</b> and <b>2</b> do not readily fragment to give <i>O</i><sup>6</sup>-BG, and (c) <b>3</b> has a greater tendency to form <i>O</i><sup>6</sup>-BG under aerobic conditions than <b>1</b> and <b>2</b>, possibly because of a low level of reduction despite the presence of oxygen or because of the relief of steric strain or because of other possible routes of activation. However, this background rate was always relatively small when observed. Loss of initial material was observed with all three prodrugs under normoxic conditions with both enzyme systems, but this loss of parental agent was not associated with any significant <i>O</i><sup>6</sup>-BG production.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Nitrobenzene Reducing Agent Dependent Aniline:Phenylhydroxylamine Reduction Product Ratios<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" valign="top">Zn/EDTA</th><th class="colsep0 rowsep0" align="center" valign="top">xanthine/xanthine oxidase</th><th class="colsep0 rowsep0" align="center" valign="top">NADPH:P450 reductase</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1:0.0</td><td class="colsep0 rowsep0" align="left">1:0.7 Â± 0.2</td><td class="colsep0 rowsep0" align="left">1:7.8 Â± 1.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">The influence of different reducing agents on the nitrobenzene reduction product ratio of aniline:<i>N</i>-phenylhydroxylamine. Nitrobenzene was reduced with either Zn dust/EDTA, xanthine/xanthine oxidase, or NADPH:cytochrome P450 reductase as described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>, and the reduction products were analyzed by HPLC. The concentration ratios are the mean of three deteriminations Â± SEM.</p></div></div></div><div class="NLM_p">Reductive activation of the synthesized prodrugs was also studied using two tumor cell lines, the murine EMT6 mammary carcinoma and the human DU145 prostate carcinoma (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). While only <b>3</b> generated measurable quantities of <i>O</i><sup>6</sup>-BG in the case of the DU145 under conditions of oxygen deficiency, all three compounds generated <i>O</i><sup>6</sup>-BG in the rank order <b>3</b> > <b>2</b> > <b>1</b> in the case of the EMT6 carcinoma. Little or no aerobic activation was seen with these agents in both the enzymatic and cellular studies. As with the enzymatic studies, some loss of parental agent was observed with both of these cell lines under normoxic conditions. This normoxic loss was most marked with <b>1</b>; however, this loss did not result in the formation of <i>O</i><sup>6</sup>-BG. These findings collectively indicate that the linker used in <b>3</b> is superior to those employed in <b>1</b> and <b>2</b>. Furthermore, clonogenic assays using <b>3</b> at 40 Î¼M sensitized DU145 prostate carcinoma cells to various concentrations of laromustine (50â200 Î¼M) under conditions of oxygen deficiency but not under aerobic conditions (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Loss of parental prodrugs (<b>1</b>, upper row; <b>2</b>, middle row; <b>3</b>, lower row) and the subsequent generation of <i>O</i><sup>6</sup>-BG over a 3 h 37 Â°C incubation period in medium in the presence of either 10<sup>7</sup>/mL DU145 cells (left-hand column) or 10<sup>7</sup>/mL EMT6 cells (right-hand column). In all panels, â  represents the concentration of parental prodrug under normoxic conditions, â¼ represents the concentration of parental prodrug under oxygen deficient conditions, â² represents the concentration of generated <i>O</i><sup>6</sup>-BG under normoxic conditions, and â represents the concentration of generated <i>O</i><sup>6</sup>-BG under oxygen deficient conditions. The plotted values represent the mean of three separate experiments Â± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Sensitization of DU145 human prostate carcinoma cells to laromustine by <b>3</b> induced inhibition of AGT in clonogenic experiments. DU145 AGT containing cells in confluent monolayers were exposed to 40 Î¼M <b>3</b> for 6 h and then treated with graded concentrations of laromustine for a total of 24 h under conditions of normoxia (â ) or oxygen deficiency (â²). The cytotoxicity of laromustine alone under conditions of normoxia (â¼) or oxygen deficiency (â) is also displayed. After treatment, cells were detached by trypsinization and survival was quantified using clonogenicity. The <i>Y</i> axis indicates the percent survival and the <i>X</i> axis the concentration of laromustine employed. Oxygen was removed from test samples enzymatically in the presence of 2 units/mL glucose oxidase, 120 units/mL catalase, and 25 mM glucose during incubation and plating of cells to measure cloning efficiency. All points are the result of at least three independent experimental determinations Â± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The three factors that would be expected to have an impact on the activation of the synthesized <i>O</i><sup>6</sup>-BG prodrugs are (a) the ease and extent of reduction of the nitro group, (b) the relative position of the nitro group with respect to the side chain, and (c) the ease of fragmentation of the CâO bond, where C is the benzylic carbon, once the nitro group is converted to the hydroxylamino or amino function. Although all three prodrugs have similar half-wave reduction potentials, as measured by differential pulse polarography (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), <b>3</b> is a much better substrate for NADPH:cytochrome P450 reductase than <b>2</b> and <b>1</b>. The relative position of the nitro group with respect to the side chain is identical for all three prodrugs and therefore cannot explain the differences in the yields of <i>O</i><sup>6</sup>-BG generated from these agents. However, any factor that stabilizes the partial positive charge on the benzylic carbon in the transition state of the fragmentation step, following reduction of the nitro group to a hydroxylamino or amino function, will facilitate the release of <i>O</i><sup>6</sup>-BG. In the reduction product of <b>3</b> the charge is stabilized not only by the electron-releasing mesomeric (resonance) effect of the hydroxylamino or amino group in the para position but also by the electron-releasing inductive effect of not one but two methyl groups. However, in the absence of the benzylic methyl group(s), a complete reduction of the nitro group to the highly electron-releasing amino function, relative to the more weakly electron releasing hydroxylamino group, appears to be needed for the release of <i>O</i><sup>6</sup>-BG from the compounds under study. Thus, <b>3</b> is not only more easily reduced by a key nitroreductase, i.e., NADPH:cytochrome P450 reductase, than <b>2</b> and <b>1</b> but also has the structural features necessary for a more facile fragmentation once the nitro group is reduced.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Polarographic Half-Wave Reduction Potentials of Synthesized Prodrugs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">prodrug</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>3</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">polarographic half-wave reduction potential, pH 7.0</td><td class="colsep0 rowsep0" align="left">â463 mV<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">â447 mV<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">â449 mV<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">The supporting electrolyte contained 10% DMSO in all cases for consistency. The DMSO was required to aid in the dissolution of <b>1</b>. The presence of 10% DMSO resulted in the measured polarographic half-wave reduction potentials being shifted approximately 50 mV more negative than in its absence.</p></div></div></div><div class="NLM_p">Thomson et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> recently reported the evaluation of 4-nitrobenzyl and gem-dimethyl substituted 4-nitrobenzyl derivatives of 6-thioguanine as hypoxia-selective agents. While reduction of the nitro group did not result in the release of 6-thioguanine in the case of the desmethyl analogue, hypoxia-selective release of 6-thioguanine was indeed observed with the gem-disubstituted analogue. It is conceivable that factors similar to those described for the 6-thioguanine prodrugs are operative in this case.</div><div class="NLM_p">In the enzymatic and cellular studies, loss of parental prodrug was also seen to various degrees under normoxic conditions; this occurred without the concomitant generation of <i>O</i><sup>6</sup>-BG. This loss could be due to the reaction of the prodrugs with reactive oxygen species generated as a consequence of prodrug redox cycling under normoxic conditions and in the case of xanthine oxidase directly from the oxidation of xanthine with oxygen. In the presence of cells, additional metabolic routes not resulting in <i>O</i><sup>6</sup>-BG formation may contribute to this normoxic loss. The cellular sensitization studies which indicated pronounced potentiation of the toxicity of laromustine only under oxygen deficient conditions strongly support the lack of formation of AGT inhibitory agents of any type under normoxic conditions.</div><div class="NLM_p">Surprisingly, the rank order of water solubility for the three prodrugs is <b>3</b> > <b>2</b> > <b>1</b>. The absence of a chiral center also makes <b>3</b> a more attractive candidate for further possible development as a pharmaceutical than <b>2</b>. Thus, <b>3</b>, conceived as a hypoxia-activated prodrug of <i>O</i><sup>6</sup>-BG, appears to be a promising new agent with the following desirable properties:</div><ul class="NLM_list-list_type-label"><li><p class="inline">The intact <b>3</b> prodrug is >500-fold less effective as an AGT inhibitor than <i>O</i><sup>6</sup>-BG.</p></li><li><p class="inline">Reduction of <b>3</b> by common nitroreductases such as NADPH:cytochrome P450 reductase and xanthine/xanthine oxidase under oxygen-deficient conditions results in the generation of <i>O</i><sup>6</sup>-BG.</p></li><li><p class="inline">The activation rate for <b>3</b> under normoxic conditions is low or below the limit of detection under the conditions and incubation times examined to date.</p></li><li><p class="inline">Once <i>O</i><sup>6</sup>-BG is released in the oxygen deficient compartment, it is conceivable that the inhibitor will diffuse into the surrounding oxygenated tumor cells and sensitize them to the cytodestructive effects of guanine O-6 alkylating agents (i.e., will exert a bystander effect). However, very extensive release and equilibration around host tissues could be problematic, since it would attenuate the targeting effect.</p></li><li><p class="inline">The trigger/linker employed (i.e., the gem-dimethyl 4-nitrobenzyloxycarbonyl moiety) ensures that release of <i>O</i><sup>6</sup>-BG in normal tissues will be relatively low relative to oxygen deficient areas of solid tumors. This should minimize the undesirable effects that result from treatment with a guanine <i>O</i>-6 alkylating agent following nonselective (global) ablation of AGT.</p></li></ul></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All chemicals, solvents, reagents, and enzymes were purchased from Sigma-Aldrich (St. Louis, MO) and used without further purification with the exceptions of laromustine which was provided by Vion Pharmaceuticals Inc. (New Haven, CT), the fluorescent dye Hoechst 33258 which was purchased from Molecular Probes, Inc. (Eugene, OR.), and purified recombinant human AGT which was a kind gift from Dr. Joann Sweasy (Yale Medical School, New Haven, CT).</div><div class="NLM_p">Melting points were determined on a Thomas-Hoover Unimelt melting point apparatus and are uncorrected. NMR spectra were recorded on a Varian EM-390 (90 MHz) or Bruker Avance DRX-400 (400 MHz) NMR spectrometer with tetramethylsilane as an internal standard. Mass spectra were recorded on a VG-ZAB-SE mass spectrometer in the fast atom bombardment mode (glycerol matrix). Column chromatography was conducted with Merck silica gel 60, 230â400 mesh. Thin layer chromatography was performed on EM precoated silica gel sheets containing a fluorescent indicator. High resolution mass spectra were obtained at the W. M. Keck Foundation Biotechnology Resource Laboratory at Yale University. The purity of the tested compounds was determined by analytical HPLC, using a Beckman System Gold HPLC system, comprising a 168 UV/vis detector, a 502 autosampler, and a 127P solvent module monitoring at 280 nm with a 40 nm bandwidth. The purity of the tested compounds was >95% in each and every case.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (6-(Benzyloxy)-2-((((4-nitrobenzyl)oxy)carbonyl)amino)-9<i>H</i>-purin-9-yl)methyl Pivalate (<b>6</b>)</h3><div class="NLM_p">To a stirred solution of (2-amino-6-(benzyloxy)-9<i>H</i>-purin-9-yl)methyl pivalate (<b>4</b>) (1.06 g, 3 mmol) and dry pyridine (3 mL) in 70 mL of anhydrous dichloromethane was added a 20% solution of phosgene in toluene (1.5 mL, 3.4 mmol) dropwise at 0â5 Â°C. The mixture was stirred overnight, while the ice bath was allowed to warm to room temperature. A solution of 4-nitrobenzyl alcohol (0.46 g, 3 mmol) in anhydrous dichloromethane (10 mL) was added, and the reaction mixture was stirred at room temperature for 2 h. It was then evaporated with 5 g of silica gel to dryness in vacuo and the residue was purified by column chromatography (silica gel, dichloromethaneâethanol, 30:1) to give 1.42 g (89%) of the title compound as a white solid: mp 146â148 Â°C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 90 MHz) Î´ 10.20 (s, D<sub>2</sub>O exchangeable,1H), 8.24 (d, <i>J</i> = 8.5 Hz, 2H), 8.03 (s, 1H), 7.33â7.61 (m, 7H), 6.08 (s, 2H), 5.62 (s, 2H), 5.37 (s, 2H), 1.16 (s, 9H); MS <i>m</i>/<i>z</i> 535 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>7</b> and <b>8</b> were synthesized using procedures analogous to the one described above except that for compound <b>7</b>, after the addition of 1-(4-nitrophenyl)ethanol, the reaction mixture was stirred at room temperature for 6 h, and for compound <b>8</b>, the reaction mixture was stirred at room temperature for 40 h after the addition of 2-(4-nitrophenyl)propan-2-ol.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (6-(Benzyloxy)-2-(((1-(4-nitrophenyl)ethoxy)carbonyl)amino)-9<i>H</i>-purin-9-yl)methyl Pivalate (<b>7</b>)</h3><div class="NLM_p last">Compound <b>7</b> was obtained in an 81% yield as a white solid: mp 140â142 Â°C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 90 MHz) Î´ 10.34 (s, D<sub>2</sub>O exchangeable, 1H), 8.26 (d, <i>J</i> = 9 Hz, 2H), 8.04 (s, 1H), 7.54 (d, <i>J</i> = 9 Hz, 2H), 7.34â7.41 (m, 5H), 6.07 (s, 2 H), 6.06 (q, <i>J</i> = 6.6 Hz, 1H), 5.61 (s, 2H), 1.65 (d, <i>J</i> = 6.6 Hz, 3H), 1.15 (s, 9H); MS <i>m</i>/<i>z</i> 549 [M + H]<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (6-(Benzyloxy)-2-((((2-(4-nitrophenyl)propan-2-yl)oxy)carbonyl)amino)-9<i>H</i>-purin-9-yl)methyl Pivalate (<b>8</b>)</h3><div class="NLM_p last">Compound <b>8</b> was obtained in a 68% yield as a white solid: mp 92â94 Â°C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 90 MHz) Î´ 10.20 (s, D<sub>2</sub>O exchangeable, 1H), 8.19 (d, <i>J</i> = 9 Hz, 2H), 7.97 (s, 1H), 7.45 (d, <i>J</i> = 9 Hz, 2H), 7.29â7.45 (m, 5H), 6.02 (s, 2 H), 5.58 (s, 2H), 1.87 (s, 6H), 1.13 (s, 9H); MS <i>m</i>/<i>z</i> 563 [M + H]<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-Nitrobenzyl (6-(Benzyloxy)-9<i>H</i>-purin-2-yl)carbamate (<b>1</b>)</h3><div class="NLM_p last">A suspension of <b>6</b> (0.53 g, 1 mmol) in 0.1 M ammonia in methanol (40 mL) was stirred at room temperature until TLC showed a complete disappearance of the starting material (approximately 40 h). The white solid that was formed was collected by filtration after cooling the reaction mixture in an iceâwater bath for 1 h, washed with methanol and ether, and dried to give 0.36 g (85%) of the target molecule: mp 233â235 Â°C; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.24 (s, 1H), 10.51 (s, 1H), 8.29â8.21 (m, 3H), 7.74 (d, <i>J</i> = 8.7 Hz, 2H), 7.61â7.49 (m, 2H), 7.46â7.26 (m, 3H), 5.59 (s, 2H), 5.34 (s, 2H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 151.8, 151.7, 147.0, 144.7, 136.3, 128.9, 128.5, 128.3, 123.6, 67.5, 64.5. HRMS, calculated for C<sub>20</sub>H<sub>16</sub>N<sub>6</sub>O<sub>5</sub>, <i>m</i>/<i>z</i>, 421.1255 [(M + H)<sup>+</sup>]; found, 421.1257.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 1-(4-Nitrophenyl)ethyl (6-(Benzyloxy)-9<i>H</i>-purin-2-yl)carbamate (<b>2</b>)</h3><div class="NLM_p"><i>Method 1.</i> To an ice-cooled solution of <b>7</b> (1.2 g, 2.2 mmol) in ethanol (60 mL) was added an ice-cooled solution of 1 M sodium hydroxide (10 mL), and the mixture was stirred at 0 Â°C for 30 min. The reaction mixture was neutralized with 10% acetic acid and was evaporated with 5.8 g of silica gel to dryness in vacuo. The residue was chromatographed on a silica gel column (60 Ã, 70â230 mesh) and eluted with CH<sub>2</sub>Cl<sub>2</sub>/EtOH, 20:1 (v/v), to give 0.57 g (60%) of the title compound as a white solid.</div><div class="NLM_p last"><i>Method 2.</i> Compound <b>2</b> was also synthesized using a procedure analogous to the one described for <b>1</b> except that 1 M ammonia in methanol was used as a base in lieu of 0.1 M ammonia and was obtained as a white solid: yield, 79%; mp 134â135 Â°C (dec); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.22 (s, 1H), 10.44 (s, 1H), 8.42â8.12 (m, 3H), 7.76 (d, <i>J</i> = 8.7 Hz, 2H), 7.56 (dd, <i>J</i> = 7.9, 1.5 Hz, 2H), 7.46â7.26 (m, 3H), 5.96 (q, <i>J</i> = 6.6 Hz, 1H), 5.59 (s, 2H), 1.56 (d, <i>J</i> = 6.6 Hz, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 151.7, 151.3, 146.9, 136.3, 128.9, 128.5, 128.3, 126.9, 123.7, 71.2, 67.5, 22.5. HRMS, calculated for C<sub>21</sub>H<sub>18</sub>N<sub>6</sub>O<sub>5</sub>, <i>m</i>/<i>z</i>, 435.1411 [(M + H)<sup>+</sup>]; found, 435.1414.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-(4-Nitrophenyl)propan-2-yl (6-(Benzyloxy)-9<i>H</i>-purin-2-yl)carbamate (<b>3</b>)</h3><div class="NLM_p last">Compound <b>3</b> was synthesized using procedures analogous to the ones described for <b>2</b> and was obtained as a white solid: yield, 63% (method 1), 82% (method 2); mp 246 Â°C (dec); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.21 (s, 1H), 10.36 (s, 1H), 8.34â8.19 (m, 3H), 7.79 (dd, <i>J</i> = 9.2, 2.1 Hz, 2H), 7.57 (dd, <i>J</i> = 7.8, 1.4 Hz, 2H), 7.46â7.27 (m, 3H), 5.61 (s, 2H), 1.84 (s, 6H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 154.1, 151.8, 150.5, 146.3, 136.3, 128.9, 128.4, 128.3, 125.8, 123.5, 80.2, 67.5, 28.4. HRMS, calculated for C<sub>22</sub>H<sub>20</sub>N<sub>6</sub>O<sub>5</sub>, <i>m</i>/<i>z</i>, 449.1568 [(M + H)<sup>+</sup>]; found, 449.1571.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> AGT Inactivation Assay</h3><div class="NLM_p last">AGT substrate DNA was prepared by treating L1210 DNA (175 Î¼g/mL) in 10 mM Tris-HCl buffer (pH â¼7.4) with 0.2 mM 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine for 3 min at 37 Â°C. This substrate DNA was then stored at 0 Â°C until used. A 10 Î¼L aliquot of substrate DNA containing <i>O</i><sup>6</sup>-(2-chloroethyl)guanine and <i>N</i><sup>1</sup>,<i>O</i><sup>6</sup>-ethanoguanine lesions (â¼50 fmol) was incubated for 30 min at 37 Â°C with 40 fmol of purified recombinant human AGT which was pretreated (or not) with various inhibitors for 30 min at 37 Â°C. This assay gives a moderately linear decrease in these DNA lesions in proportion to the level of AGT activity until the lesions have been largely titrated. The level of remaining cross-link precursors in this mixture was then determined and the level of inhibition of AGT calculated from this value. The procedure is as follows. About 40 fmol of AGT in AGT stabilization buffer of the following composition was used: 20 mM Tris-HCl, 1 mM EDTA, 1 mg/mL of bovine serum albumin, 0.1 mM dithiothreitol, and 2 Î¼g/mL of L1210 DNA, pH 7.4 (the L1210 DNA greatly contributes to the AGT stability but does not add significantly to the total DNA in the final assay). This was mixed with an equal volume of 2Ã concentration of inhibitor in an equivalent amount of buffer to give a mixture of the desired inhibitor and AGT concentration. This mixture was then incubated for 30 min at 37 Â°C. Then an amount of 10 Î¼L was added to 10 Î¼L of substrate DNA, and the mixture was incubated for a further 30 min at 37 Â°C to allow the residual AGT activity to repair the DNA. This mixture was then diluted 10-fold with 5 mM Tris-HCl, 1 mM EDTA, and 1 mM NaN<sub>3</sub>, pH 8.0 buffer, then incubated at 50 Â°C for 2â3 h to allow the unrepaired cross-link precursors to progress to cross-links. The level of cross-linking was then measured using a previously described fluorescence methodology.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This involved dilution of the sample to a volume of 1.5 mL with 5 mM Tris-HCl, 1.0 mM EDTA, and 1.0 mM NaN<sub>3</sub> buffer, pH 8.0, containing 0.1 Î¼g/mL of Hoechst H33258 fluorescent dye, and measuring the fluorescence using a Hoefer Scientific Instruments TKO 100 fluorometer. The mixture was then heated in a 100 Â°C hot-block for 5 min and then plunged into a water bath at room temperature for 5 min, and the fluorescence measured again. The percentage of DNA molecules that were cross-linked (i.e., containing at least one cross-link per molecule) was then calculated from the change in fluorescence.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Polarographic Determination of Half-Wave Reduction Potentials</h3><div class="NLM_p last">Differential pulse polarography (DPP) voltagrams of the synthesized agents were obtained using a pH 7.0 buffer composed of 100 mM potassium chloride and 50 mM potassium phosphate as the supporting electrolyte containing 10% DMSO by volume. Compounds were added as 0.5% of a 10 mM solution in DMSO to give final concentrations of 50 Î¼M. The samples were purged with nitrogen to remove dissolved oxygen, and DPP voltammograms were obtained using a Princeton Applied Research electrochemical trace analyzer model 394, linked to a model 303A static mercury drop electrode (Princeton Applied Research, Oak Ridge, TN, U.S.). Scans were performed from 0 to â900 mV (2 mV/s) using a platinum counter electrode versus an Ag/AgCl reference electrode (saturated KCl/AgCl electolyte). A pulse amplitude of 50 mV was used, and the polarographic half-wave reduction potential <i>E</i><sub>1/2</sub> was calculated from the peak current potential (<i>E</i><sub>P</sub>) according to the following equation: <i>E</i><sub>1/2</sub> = <i>E</i><sub>P</sub> â pulse amplitude/2.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Determination by HPLC</h3><div class="NLM_p last">HPLC measurements of the concentrations of nitrobenzene, <i>N</i>-phenylhydroxylamine, aniline, <b>1</b>, <b>2</b>, and <b>3</b> were performed using a Beckman 127P solvent module and a Beckman 168 UV/vis detector (Beckman, Fullerton, CA, U.S.). A standard curve for estimation of total agent was established, and a linear relationship between concentration and the area under the curve was found in all cases. Samples in 50% v/v acetonitrile were separated on a 5 Î¼m, 220 mm Ã 4.6 mm Applied Biosystems RP-18 C-18 reverse phase column (Applied Biosystems, Carlsbad, CA, U.S.) by elution with 34% acetonitrile in buffer (0.03 M KH<sub>2</sub>PO<sub>4</sub>, 1.0 mM NaN<sub>3</sub>, pH 5.4) for 5 min followed by a 34â70% acetonitrile linear gradient in buffer, at a flow rate of 0.6 mL/min from 5 to 35 min. After this point the concentration of acetonitrile was maintained at this level for 5 min and then returned to the starting concentration over an additional 5 min. Absorbance was monitored at 280 nm using a Beckman 168 UV/vis detector.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Reduction of Nitrobenzene with Zn/EDTA</h3><div class="NLM_p last">A solution of nitrobenzene at 1 mM in 50 mM Tris-HCl, 10 mM EDTA, pH 7.0, was quickly shaken with approximately 4 mg/mL Zn dust and allowed to settle at room temperature, then centrifuged at 10000<i>g</i> for 4 min. The supernatant was then diluted 10-fold with 30 mM potassium phosphate buffer, pH 5.4, and analyzed by HPLC.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Reduction of Nitrobenzene with Xanthine/Xanthine Oxidase</h3><div class="NLM_p last">A solution of nitrobenzene at 100 Î¼M in 100 mM potassium phosphate buffer, pH 7.4, containing 2.5 mM xanthine added as 1% of a 250 mM solution in 1 M NaOH was purged with nitrogen and 0.16 units/mL xanthine oxidase (Sigma, bovine milk, X4500-5UN) added and the mixture incubated at 37 Â°C. Samples were taken at 2 h and analyzed by HPLC for aniline, nitrobenzene, and <i>N</i>-phenylhydroxylamine. Nitrobenzene, <i>N</i>-phenylhydroxylamine, and aniline eluted at approximately 20, 10, and 8 min, respectively.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Reduction of Nitrobenzene with NADPH:Cytochrome P450 Reductase</h3><div class="NLM_p last">A solution of nitrobenzene at 100 Î¼M in 100 mM potassium phosphate buffer, pH 7.85, the pH optimum for NADPH:cytochrome P450 reductase (Sigma, human recombinant C8113), containing 10 mM NADPH, 10 mM glucose, 2 units/mL glucose oxidase, 120 units/mL catalase, and 4 units/mL of NADPH:cytochrome P450 reductase, added after 5 min to allow the oxygen to be depleted, was incubated for 2 h in a sealed tube at 37 Â°C. Then the mixture was analyzed by HPLC for aniline, nitrobenzene, and <i>N</i>-phenylhydroxylamine.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Reduction of <b>1</b>, <b>2</b>, and <b>3</b> with Zn/EDTA</h3><div class="NLM_p last">A solution of each agent at 50 Î¼M in 50 mM Tris-HCl, 10 mM EDTA, pH 7.0, was quickly shaken with approximately 4 mg/mL Zn dust and allowed to settle at room temperature, then centrifuged at 10000<i>g</i> for 4 min. The supernatant was then analyzed by HPLC.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Reduction of <b>1</b>, <b>2</b>, and <b>3</b> by NADPH:Cytochrome P450 Reductase and Xanthine Oxidase</h3><div class="NLM_p last">In these experiments, oxygen deficiency was enzymatically generated as previously described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Briefly, glucose/glucose oxidase was used to rapidly consume the available free oxygen and catalase was employed to remove the generated hydrogen peroxide. In the absence of other components, this system itself does not measurably reduce <b>1</b>, <b>2</b>, and <b>3</b> in the time frames employed in these experiments. The reaction mixtures in a total volume of 0.5 mL were as follows: 100 mM potassium phosphate buffer, pH 7.4, containing 10 mM glucose, 5 Î¼L of a solution of 200 units/mL glucose oxidase and 12â000 units/mL catalase, 20 Î¼M test agent added as a 100Ã solution in DMSO plus either 5 Î¼L of 104 units/mL NADPH:cytochrome P450 reductase plus 1 mM NADPH or 0.16 units/mL xanthine oxidase plus 1 mM xanthine. The aerobic reaction was identical except that the glucose needed for the oxygen deficiency system to operate was omitted. Furthermore, the aerobic reaction volumes were scaled up 10-fold and the mixture was incubated as a shallow layer with shaking in sealed 25 cm<sup>2</sup> plastic culture flasks to ensure that full air saturation was maintained and evaporation prevented. The reaction mixtures were incubated at 37 Â°C, and samples were removed at 0 and 1 h after initiation, mixed with an equal volume of CH<sub>3</sub>CN, and centrifuged at 10000<i>g</i> for 10 min to sediment any precipitated protein. The supernatant was then analyzed as described above for the remaining agent and reduction products using HPLC.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Cellular Activation of <b>1</b>, <b>2</b>, and <b>3</b> under Normoxic and Oxygen Deficient Conditions</h3><div class="NLM_p last">Experiments, following the time course of prodrug loss and <i>O</i><sup>6</sup>-BG generation when â¼20 Î¼M <b>1</b>, <b>2</b>, or <b>3</b> was incubated with either EMT6 or DU145 cells, were conducted as follows. Cells at 10<sup>7</sup>/mL in Dulbeccoâs minimal essential medium (DMEM) supplemented with 10% fetal bovine serum (EMT6) or in Î±-minimum essential medium with 10% fetal bovine serum (DU145) containing 10 mM glucose were shaken as cell suspensions as shallow layers (5 mL) in 25 cm<sup>2</sup> plastic culture flasks for the normoxic incubations. For the oxygen deficient condition incubations, the cells were incubated in sealed microfuge tubes with an additional 10 mM glucose and 2 units/mL glucose oxidase plus 120 units/mL catalase as additional components. Samples were removed at 0, 1, 2, and 3 h after the start of the incubations and mixed with an equal volume of acetonitrile to lyze the cells, precipitate the macromolecules, and extract the remaining prodrug and generated <i>O</i><sup>6</sup>-BG. The mixture was allowed to stand for 15 min at room temperature, centrifuged at 10000<i>g</i> for 10 min and the supernatant analyzed by HPLC for parental prodrug and <i>O</i><sup>6</sup>-BG.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Cytotoxicity Studies</h3><div class="NLM_p last">Cell survival (clonogenic) assays were performed using a previously described method.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The 25 cm<sup>2</sup> plastic tissue culture flasks were seeded with 2.5 Ã 10<sup>5</sup> cells each and 3 days later cells were pretreated for 6 h in the presence of <b>3</b> prior to the addition of laromustine dissolved in 10 mL of medium for 24 h at 37 Â°C. All agents were initially dissolved in DMSO and then diluted to the required concentration. For oxygen-deficient conditions, cells were incubated with laromustine in the presence of 2 units/mL glucose oxidase (Sigma G6641), 120 units/mL catalase (Sigma, C1345) in high glucose DMEM (Invitrogen).<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> Flasks were flushed with nitrogen for 10 s and the caps screwed on tightly. This action facilitated oxygen depletion of the medium by glucose oxidase through removal of residual oxygen containing air and denial of the entry of additional air. After treatment, monolayers were rinsed with phosphate buffered saline, and cells were detached by trypsinization, suspended in culture medium, and counted and sequential cell dilutions were plated in duplicate into six-well plates at a density of 1 Ã 10<sup>2</sup>, 1 Ã 10<sup>3</sup>, and 1 Ã 10<sup>4</sup> cells per well. At 10â14 days later, colonies were fixed, stained with 0.25% crystal violet in 80% methanol, and quantified. DMSO concentrations were â¤0.05% and nontoxic. Cells under aerobic conditions were treated under similar conditions and cytotoxic agent concentrations but in unsealed flasks without glucose oxidase and catalase. Cells were then washed, harvested by trypsinization, and assayed for survival using a clonogenic assay described previously.<a onclick="showRef(event, 'ref3 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref3 ref30 ref31">(3, 30, 31)</a> In the absence of cells, no measurable direct metabolism of <b>3</b> or of laromustine was detected in the presence of the glucose oxidase and catalase enzyme components of the oxygen deficiency generating system.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71042" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71042" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip G. Penketh</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520-8066, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#72021a1b1e1b025c02171c1917061a32151f131b1e5c111d1f"><span class="__cf_email__" data-cfemail="3f4f575653564f114f5a51545a4b577f58525e5653115c5052">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rui Zhu</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520-8066, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mao-Chin Liu</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520-8066, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mei-Zhen Luo</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520-8066, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raymond P. Baumann</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520-8066, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Krishnamurthy Shyam</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520-8066, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan C. Sartorelli</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520-8066, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm201115f" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78503" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78503" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported in part by U.S. Public Health Service Grants CA090671, CA122112, and CA129186 from the National Cancer Institute and a grant from the National Foundation for Cancer Research.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i31" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i31"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32"> Abbreviations Used</h2><tr><td class="NLM_term"><i>O</i><sup>6</sup>-BG</td><td class="NLM_def"><p class="first last"><i>O</i><sup>6</sup>-benzylguanine</p></td></tr><tr><td class="NLM_term">AGT</td><td class="NLM_def"><p class="first last"><i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loomis, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">796</span><span class="NLM_x">â</span> <span class="NLM_lpage">801</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9505021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=796-801&author=K.+Shyamauthor=P.+G.+Penkethauthor=R.+H.+Loomisauthor=W.+C.+Roseauthor=A.+C.+Sartorelli&title=Antitumor+2-%28aminocarbonyl%29-1%2C2-bis%28methylsulfonyl%29-1-%282-chloroethyl%29hydrazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm9505021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9505021%26sid%3Dliteratum%253Aachs%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DLoomis%26aufirst%3DR.%2BH.%26aulast%3DRose%26aufirst%3DW.%2BC.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DAntitumor%25202-%2528aminocarbonyl%2529-1%252C2-bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529hydrazines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D796%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Finch, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3033</span><span class="NLM_x">â</span> <span class="NLM_lpage">3038</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=3033-3038&author=R.+A.+Finchauthor=K.+Shyamauthor=P.+G.+Penkethauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2-%28methylamino%29carbonylhydrazine+%28101M%29%3A+a+novel+sulfonylhydrazine+prodrug+with+broad-spectrum+antineoplastic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinch%26aufirst%3DR.%2BA.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2-%2528methylamino%2529carbonylhydrazine%2520%2528101M%2529%253A%2520a%2520novel%2520sulfonylhydrazine%2520prodrug%2520with%2520broad-spectrum%2520antineoplastic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D3033%26epage%3D3038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Baumann, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seow, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">The antineoplastic efficacy of the prodrug cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation</span> <span class="citation_source-journal">Oncol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">â</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=16408696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGns73L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=313-325&author=R.+P.+Baumannauthor=H.+A.+Seowauthor=K.+Shyamauthor=P.+G.+Penkethauthor=A.+C.+Sartorelli&title=The+antineoplastic+efficacy+of+the+prodrug+cloretazine+is+produced+by+the+synergistic+interaction+of+carbamoylating+and+alkylating+products+of+its+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation</span></div><div class="casAuthors">Baumann, Raymond P.; Seow, Helen A.; Shyam, Krishnamurthy; Penketh, Philip G.; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">313-325</span>CODEN:
                <span class="NLM_cas:coden">ONREE8</span>;
        ISSN:<span class="NLM_cas:issn">0965-0407</span>.
    
            (<span class="NLM_cas:orgname">Cognizant Communication Corp.</span>)
        </div><div class="casAbstract">Cloretazine {1,2-bis(methylsulfonyl)-1-[(2-chloroethyl)-2-(methylamino)carbonyl]hydrazine; VNP40101M; 101M} is a sulfonylhydrazine prodrug that possesses broad spectrum antitumor efficacy against transplanted murine and human tumor models and has shown activity in clin. trials against relapsed or refractory acute myeloid leukemia.  Base catalyzed activation of this prodrug generates two different reactive intermediates: chloroethylating species that covalently interact with DNA at the O6-position of guanine residues that progress to a G-C interstrand cross-link, and a carbamoylating agent, Me isocyanate.  Previous findings from this lab. have provided initial evidence that Me isocyanate can contribute to the efficacy of Cloretazine by enhancing the cytotoxicity of the generated chloroethylating species.  This action may be due in part to inhibition of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT); however, activity in cells devoid of AGT indicates that other actions are involved in the synergistic cytotoxicity.  Herein we demonstrate that O6-benzylguanine can also produce synergistic cell kill with the alkylating component of Cloretazine but differs from Me isocyanate in that the enhancement occurs in AGT-contg. cells, but not in cells devoid of AGT.  Me isocyanate generated by the decompn. of 1,2-bis(methylsulfonyl)-1-[methylaminocarbonyl]hydrazine also acts to enhance the activity of a variety of DNA crosslinking agents, while only producing additive cytotoxicity with methylating agents.  How cytometric studies using annexin as a marker for apoptosis indicate that in Chinese hamster ovary cells and in human leukemia cells Cloretazine-induced apoptosis is primarily caused by the generated Me isocyanate.  Comet assays designed to detect DNA cross-links in intact cells indicate that the chloroethylating species generated by the activation of Cloretazine produce DNA cross-links, with the co-generated Me isocyanate increasing the degree of crosslinking produced by the reactive chloroethylating species.  These findings provide further evidence that the Me isocyanate produced by the activation of Cloretazine can be a major contributor to the cytotoxicity produced by this antineoplastic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKSXgyHd6hYLVg90H21EOLACvtfcHk0lgpIitOnxI6QQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGns73L&md5=1906d7583ae64a43c7fc393f6dcbce4f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DSeow%26aufirst%3DH.%2BA.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DThe%2520antineoplastic%2520efficacy%2520of%2520the%2520prodrug%2520cloretazine%2520is%2520produced%2520by%2520the%2520synergistic%2520interaction%2520of%2520carbamoylating%2520and%2520alkylating%2520products%2520of%2520its%2520activation%26jtitle%3DOncol.%2520Res.%26date%3D2005%26volume%3D15%26spage%3D313%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Role of <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">â</span> <span class="NLM_lpage">1763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1158%2F1535-7163.MCT-05-0169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=16275997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyrtLjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=1755-1763&author=K.+Ishiguroauthor=K.+Shyamauthor=P.+G.+Penkethauthor=A.+C.+Sartorelli&title=Role+of+O6-alkylguanine-DNA+alkyltransferase+in+the+cytotoxic+activity+of+cloretazine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine</span></div><div class="casAuthors">Ishiguro, Kimiko; Shyam, Krishnamurthy; Penketh, Philip G.; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1755-1763</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cloretazine (VNP40101M; 101M; 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine) is a sulfonylhydrazine prodrug that generates both chloroethylating and carbamoylating species on activation.  To explore the mol. mechanisms underlying the broad anticancer activity obsd. in preclin. studies, cloretazine and chloroethylating-only [i.e., 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine] and carbamoylating-only (i.e., 1,2-bis(methylsulfonyl)-1-[(methylamino)carbonyl]hydrazine) analogs were evaluated in five murine hematopoietic cell lines.  These cell lines were separable into two groups by virtue of their sensitivity to 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine; the sensitive group included L1210, P388, and F-MEL leukemias (IC50s, 6-8 Î¼mol/L) and the resistant group consisted of Ba/F3 bone marrow and WEHI-3B leukemia cells (IC50s, 50-70 Î¼mol/L).  Resistant cells expressed O6-alkylguanine-DNA alkyltransferase (AGT), whereas sensitive cells did not.  A correlation existed between AGT expression and the functional status of p53; AGT- cells possessed defective p53, whereas AGT+ cells contained wild-type p53.  Based on recent findings on regulation of AGT gene expression by others, we suspect that silencing of the AGT gene by promoter hypermethylation frequently occurs during tumor progression involving p53 inactivation.  O6-Chloroethylguanine is the initial DNA lesion that progresses to lethal interstrand DNA cross-links.  Cloretazine exhibited a much higher preference toward the O6-chloroethylation of guanine, as measured by the difference in IC50s to wild-type and AGT-transfected L1210 cells, than 1,3-bis(2-chloroethyl)-1-nitrosourea, which targets the same site in DNA.  Preferential toxicity of cloretazine against AGT- tumor cells coupled with decreased toxicity to AGT+ cells in host tissues constitute the therapeutic basis for cloretazine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Gm7rc8wLOLVg90H21EOLACvtfcHk0lgpIitOnxI6QQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyrtLjI&md5=2b12a94dfcd41eb622cea51e1301c6dd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0169%26sid%3Dliteratum%253Aachs%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DRole%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%2520in%2520the%2520cytotoxic%2520activity%2520of%2520cloretazine%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D1755%26epage%3D1763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seow, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Mode of action of the chloroethylating and carbamoylating moiety of the prodrug cloretazine</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">â</span> <span class="NLM_lpage">976</span><div class="note"><p class="first last">. PMCID: PMC2680221</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1158%2F1535-7163.MCT-05-0532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=16648568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=969-976&author=K.+Ishiguroauthor=H.+A.+Seowauthor=P.+G.+Penkethauthor=A.+C.+Sartorelli&title=Mode+of+action+of+the+chloroethylating+and+carbamoylating+moiety+of+the+prodrug+cloretazine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mode of action of the chloroethylating and carbamoylating moieties of the prodrug cloretazine</span></div><div class="casAuthors">Ishiguro, Kimiko; Seow, Helen A.; Penketh, Philip G.; Shyam, Krishnamurthy; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">969-976</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cloretazine is an antitumor sulfonylhydrazine prodrug that generates both chloroethylating and carbamoylating species.  The cytotoxic potency of these species was analyzed in L1210 leukemia cells using analogs with chloroethylating or carbamoylating function only.  Clonogenic assays showed that the chloroethylating-only agent 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine (90CE) produced marked differential cytotoxicity against wild-type and O6-alkylguanine-DNA alkyltransferase-transfected L1210 cells (LC10, 1.4 vs. 31 Î¼mol/L), indicating that a large portion of the cytotoxicity was due to alkylation of DNA at the O-6 position of guanine.  Consistent with the concept that O-6 chloroethylation of DNA guanine progresses to interstrand cross-links, the comet assay, in which DNA cross-links were measured by a redn. in DNA migration induced by strand breaks, showed that cloretazine and 90CE, but not the carbamoylating-only agent 1,2-bis(methylsulfonyl)-1-[(methylamino)carbonyl]hydrazine (101MDCE), produced DNA cross-links and that cloretazine caused more DNA cross-links than 90CE at equimolar concns.  Cell cycle analyses showed that 90CE and 101MDCE at concns. of 5 and 80 Î¼mol/L, resp., produced similar degrees of G2-M arrest.  90CE produced selective inhibition of DNA synthesis after overnight incubation, whereas 101MDCE caused rapid and nonselective inhibition of RNA, DNA, and protein syntheses.  Both 90CE and 101MDCE induced phosphorylation of histone H2AX, albeit with distinct kinetics.  These results indicate that (a) differential expression of O6-alkylguanine-DNA alkyltransferase in tumor and host cells seems to be responsible for tumor selectivity exerted by cloretazine; (b) 101MDCE enhances DNA crosslinking activity; and (c) 90CE induces cell death at concns. lower than those causing alterations in the cell cycle and macromol. syntheses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk7NojajtpXLVg90H21EOLACvtfcHk0li8-4WmsySA9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7w%253D&md5=6961c6c4bb345a016c66494fb6d1250b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0532%26sid%3Dliteratum%253Aachs%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DSeow%26aufirst%3DH.%2BA.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DMode%2520of%2520action%2520of%2520the%2520chloroethylating%2520and%2520carbamoylating%2520moiety%2520of%2520the%2520prodrug%2520cloretazine%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D969%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seow, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Lethality to leukemia cell lines of DNA interstrand cross-links generated by cloretazine derived alkylating species</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1546</span><span class="NLM_x">â</span> <span class="NLM_lpage">1553</span><div class="note"><p class="first last">. PMCID: PMC2888535</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1016%2Fj.leukres.2008.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=18479747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlGgs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=1546-1553&author=P.+G.+Penkethauthor=R.+P.+Baumannauthor=K.+Ishiguroauthor=K.+Shyamauthor=H.+A.+Seowauthor=A.+C.+Sartorelli&title=Lethality+to+leukemia+cell+lines+of+DNA+interstrand+cross-links+generated+by+cloretazine+derived+alkylating+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating species</span></div><div class="casAuthors">Penketh, Philip G.; Baumann, Raymond P.; Ishiguro, Kimiko; Shyam, Krishnamurthy; Seow, Helen A.; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1546-1553</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cloretazine [1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine; VNP40101M; 101 M] is a relatively new prodrug with activity in elderly acute myelogenous leukemia (AML) patients.  Its therapeutic action is due largely to the prodn. of 1-(3-cytosinyl),2-(1-guanyl)ethane cross-links (G-C ethane cross-links) in DNA.  The nos. of cross-links produced in three exptl. leukemia lines (L1210, U937 and HL-60) were fewer than 10 per genome at their resp. LC50 concns.  Only 1 in approx. 20,000 90CE mols. produces a cross-link in the AGT (O 6-alkylguanine-DNA alkyltransferase) neg. L1210 and U937 cell lines and 1 in 400,000 in the AGT pos. HL-60 cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZlmxuj5gTfrVg90H21EOLACvtfcHk0li8-4WmsySA9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlGgs74%253D&md5=34e2216f8d6963bdad1bdaa747dcac69</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2008.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2008.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DSeow%26aufirst%3DH.%2BA.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DLethality%2520to%2520leukemia%2520cell%2520lines%2520of%2520DNA%2520interstrand%2520cross-links%2520generated%2520by%2520cloretazine%2520derived%2520alkylating%2520species%26jtitle%3DLeuk.%2520Res.%26date%3D2008%26volume%3D32%26spage%3D1546%26epage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belcourt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loomis, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Hypoxia-selective nitrobenzyloxycarbonyl derivatives of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">â</span> <span class="NLM_lpage">946</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9805891" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=941-946&author=K.+Shyamauthor=P.+G.+Penkethauthor=M.+Shapiroauthor=M.+F.+Belcourtauthor=R.+H.+Loomisauthor=S.+Rockwellauthor=A.+C.+Sartorelli&title=Hypoxia-selective+nitrobenzyloxycarbonyl+derivatives+of+1%2C2-bis%28methylsulfonyl%29-1-%282-chloroethyl%29hydrazine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm9805891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9805891%26sid%3Dliteratum%253Aachs%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DBelcourt%26aufirst%3DM.%2BF.%26aulast%3DLoomis%26aufirst%3DR.%2BH.%26aulast%3DRockwell%26aufirst%3DS.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DHypoxia-selective%2520nitrobenzyloxycarbonyl%2520derivatives%2520of%25201%252C2-bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529hydrazine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D941%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Seow, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): an anticancer agents targeting hypoxic cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">9282</span><span class="NLM_x">â</span> <span class="NLM_lpage">9287</span><div class="note"><p class="first last">. PMCID: PMC1166587</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=9282-9287&author=H.+A.+Seowauthor=P.+G.+Penkethauthor=K.+Shyamauthor=S.+Rockwellauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2%5B%5B1-%284-nitrophenyl%29ethoxy%5Dcarbonyl%5Dhydrazine+%28KS119%29%3A+an+anticancer+agents+targeting+hypoxic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeow%26aufirst%3DH.%2BA.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DRockwell%26aufirst%3DS.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2%255B%255B1-%25284-nitrophenyl%2529ethoxy%255Dcarbonyl%255Dhydrazine%2520%2528KS119%2529%253A%2520an%2520anticancer%2520agents%2520targeting%2520hypoxic%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D9282%26epage%3D9287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pegg, A. E.</span><span> </span><span class="NLM_article-title">Mammalian <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6119</span><span class="NLM_x">â</span> <span class="NLM_lpage">6129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=6119-6129&author=A.+E.+Pegg&title=Mammalian+O6-alkylguanine-DNA+alkyltransferase%3A+regulation+and+importance+in+response+to+alkylating+carcinogenic+and+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPegg%26aufirst%3DA.%2BE.%26atitle%3DMammalian%2520O6-alkylguanine-DNA%2520alkyltransferase%253A%2520regulation%2520and%2520importance%2520in%2520response%2520to%2520alkylating%2520carcinogenic%2520and%2520therapeutic%2520agents%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D6119%26epage%3D6129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Brent, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remack, J. S.</span><span> </span><span class="NLM_article-title">Formation of covalent complexes between human <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase and BCNU-treated defined length oligodeoxynucleotides</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6779</span><span class="NLM_x">â</span> <span class="NLM_lpage">6788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1988&pages=6779-6788&author=T.+P.+Brentauthor=J.+S.+Remack&title=Formation+of+covalent+complexes+between+human+O6-alkylguanine-DNA+alkyltransferase+and+BCNU-treated+defined+length+oligodeoxynucleotides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrent%26aufirst%3DT.%2BP.%26aulast%3DRemack%26aufirst%3DJ.%2BS.%26atitle%3DFormation%2520of%2520covalent%2520complexes%2520between%2520human%2520O6-alkylguanine-DNA%2520alkyltransferase%2520and%2520BCNU-treated%2520defined%2520length%2520oligodeoxynucleotides%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1988%26volume%3D16%26spage%3D6779%26epage%3D6788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Baumann, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brent, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2mac_hyphen;[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of <i>O</i><sup>6</sup>-alkylguanine DNA alkyltransferase in cytotoxicity</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">â</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1007%2Fs00280-003-0739-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=14685775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVWgsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=288-295&author=R.+P.+Baumannauthor=K.+Shyamauthor=P.+G.+Penkethauthor=J.+Remackauthor=T.+P.+Brentauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2mac_hyphen%3B%5B%28methylamino%29carbonyl%5Dhydrazine+%28VNP40101M%29%3A+II.+Role+of+O6-alkylguanine+DNA+alkyltransferase+in+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity</span></div><div class="casAuthors">Baumann, R. P.; Shyam, K.; Penketh, P. G.; Remack, J. S.; Brent, T. P.; Sartorelli, A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">288-295</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">VNP40101M (1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine) is a sulfonylhydrazine prodrug that possesses broad spectrum antitumor efficacy in murine models.  VNP40101M activation generates chloroethylating species that alkylate DNA at the O6-position of guanine, and a carbamoylating agent, Me isocyanate, which inhibits O6-alkylguanine-DNA alkyltransferase (AGT) in model systems.  We detd. whether expression of AGT in Chinese hamster ovary (CHO) cells decreased sensitivity to VNP40101M and explored the mechanism of VNP40101M cytotoxicity by employing analogs of VNP40101M that generate reactive intermediates with either carbamoylating or chloroethylating activity.  AGT was overexpressed in CHO cells by transfection with an expression vector contg. the human AGT gene.  Cell lines expressing AGT were employed in clonogenic assays to det. the cytotoxicity of VNP40101M and its analogs.  VNP40101M was more active against AGT-expressing CHO cells than 90CE (1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine), a chloroethylating generator devoid of carbamoylating activity.  Furthermore, the greater the degree of AGT expression the more resistance to VNP40101M cytotoxicity.  Combination chemotherapy expts. support the conclusions that Me isocyanate and the chloroethylating species generated from the activation of VNP40101M function synergistically to kill cells.  The findings support the concept that alkylation of the O6-position of guanine residues in DNA is the predominant lesion created by VNP40101M, and that Me isocyanate resulting from the base-catalyzed activation of VNP40101M inhibits AGT and presumably other enzymes involved in DNA repair, thereby enhancing the yield of the DNA G-C interstrand crosslinks responsible for the antitumor activity of this agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhaLV7N-CdBbVg90H21EOLACvtfcHk0ljrYuUJlTLkTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVWgsrg%253D&md5=f977fb4530185d2e1c098e051c78531f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00280-003-0739-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-003-0739-0%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DRemack%26aufirst%3DJ.%26aulast%3DBrent%26aufirst%3DT.%2BP.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2mac_hyphen%253B%255B%2528methylamino%2529carbonyl%255Dhydrazine%2520%2528VNP40101M%2529%253A%2520II.%2520Role%2520of%2520O6-alkylguanine%2520DNA%2520alkyltransferase%2520in%2520cytotoxicity%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2004%26volume%3D53%26spage%3D288%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Gerson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K.</span><span> </span><span class="NLM_article-title"><i>O</i><sup>6</sup>-Alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance</span> <span class="citation_source-journal">Hematol. Oncol. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">â</span> <span class="NLM_lpage">450</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=7642472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A280%3ADyaK2MzntVWjtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=431-450&author=S.+L.+Gersonauthor=J.+K.+Willson&title=O6-Alkylguanine-DNA+alkyltransferase.+A+target+for+the+modulation+of+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance</span></div><div class="casAuthors">Gerson S L; Willson J K</div><div class="citationInfo"><span class="NLM_cas:title">Hematology/oncology clinics of North America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">431-50</span>
        ISSN:<span class="NLM_cas:issn">0889-8588</span>.
    </div><div class="casAbstract">The DNA repair protein, O6-alkylguanine DNA alkyltransferase, is a major contributor to the resistance to the nitrosourea, triazine, and tetrazine class of alkylating agents.  Many tumor cells and primary tumor samples contain high levels of this protein, although a great deal of heterogeneity exists between and within tumors.  Inhibition of the alkyl-transferase by O6-benzylguanine results in significant potentiation of the cytotoxic effects of these chemotherapeutic agents, generating responses in human tumor xenografts that are completely resistant to nitrosoureas alone.  These studies may rekindle the interest in the nitrosourea class of alkylating agents and stimulate the search for inhibitors of other mechanisms of chemotherapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGEsUYPoRYj7ZpSb_XWfMrfW6udTcc2ebI2-kQ8zAaYrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2MzntVWjtA%253D%253D&md5=441b5a9977ab012a6f9913aa06f7e5cb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerson%26aufirst%3DS.%2BL.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%26atitle%3DO6-Alkylguanine-DNA%2520alkyltransferase.%2520A%2520target%2520for%2520the%2520modulation%2520of%2520drug%2520resistance%26jtitle%3DHematol.%2520Oncol.%2520Clin.%2520North%2520Am.%26date%3D1995%26volume%3D9%26spage%3D431%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Schold, S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brent, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Hofe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenberg, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleihues, P.</span><span> </span><span class="NLM_article-title"><i>O</i><sup>6</sup>-Alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts</span> <span class="citation_source-journal">J. Neurosurg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">â</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.3171%2Fjns.1989.70.4.0573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=2926498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A280%3ADyaL1M7nslGisA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1989&pages=573-577&author=S.+Scholdauthor=T.+P.+Brentauthor=E.+von+Hofeauthor=H.+S.+Friedmanauthor=S.+Mitraauthor=D.+D.+Bignerauthor=J.+A.+Swenbergauthor=P.+Kleihues&title=O6-Alkylguanine-DNA+alkyltransferase+and+sensitivity+to+procarbazine+in+human+brain-tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts</span></div><div class="casAuthors">Schold S C Jr; Brent T P; von Hofe E; Friedman H S; Mitra S; Bigner D D; Swenberg J A; Kleihues P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurosurgery</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">573-7</span>
        ISSN:<span class="NLM_cas:issn">0022-3085</span>.
    </div><div class="casAbstract">The level of O6-alkylguanine-deoxyribonucleic acid (DNA) alkyltransferase (AT) was determined in 15 human brain-tumor xenografts in athymic mice.  This enzyme is a primary intracellular repair mechanism for lesions produced at the O6 position of guanine by a wide range of alkylating agents, including nitrosoureas and procarbazine.  Its activity ranged from undetectable in five tumor lines to 2338 fmol/mg protein in N-1941, a human glioblastoma xenograft.  The sensitivity of 10 of these xenografts to procarbazine was determined and it was found that four of the five tumor lines with AT levels of more than 100 fmol/mg protein had growth delays after procarbazine treatment of less than 20 days, whereas all five lines with undetectable AT levels had growth delays of over 30 days.  The primary cytotoxic DNA adduct produced by procarbazine (namely, O6-methylguanine) was found to be significantly higher in two sensitive lines with low AT levels than in a highly resistant line with a high AT level.  These data suggest that the AT levels of individual brain tumors can be used as predictive indicators of their susceptibility to drugs that exert their antineoplastic effect primarily by O6-alkylation of guanine in nuclear DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAZRWUuW1YBsAKB7Fa-xrUfW6udTcc2ebI2-kQ8zAaYrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7nslGisA%253D%253D&md5=ec237fc7488007e7d7fb8a03a94eb459</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3171%2Fjns.1989.70.4.0573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3171%252Fjns.1989.70.4.0573%26sid%3Dliteratum%253Aachs%26aulast%3DSchold%26aufirst%3DS.%26aulast%3DBrent%26aufirst%3DT.%2BP.%26aulast%3Dvon%2BHofe%26aufirst%3DE.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DSwenberg%26aufirst%3DJ.%2BA.%26aulast%3DKleihues%26aufirst%3DP.%26atitle%3DO6-Alkylguanine-DNA%2520alkyltransferase%2520and%2520sensitivity%2520to%2520procarbazine%2520in%2520human%2520brain-tumor%2520xenografts%26jtitle%3DJ.%2520Neurosurg.%26date%3D1989%26volume%3D70%26spage%3D573%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span> </span><span class="NLM_article-title">Depletion of mammalian <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase activity by <i>O</i><sup>6</sup>-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">5368</span><span class="NLM_x">â</span> <span class="NLM_lpage">5372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=5368-5372&author=M.+E.+Dolanauthor=R.+C.+Moschelauthor=A.+E.+Pegg&title=Depletion+of+mammalian+O6-alkylguanine-DNA+alkyltransferase+activity+by+O6-benzylguanine+provides+a+means+to+evaluate+the+role+of+this+protein+in+protection+against+carcinogenic+and+therapeutic+alkylating+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26atitle%3DDepletion%2520of%2520mammalian%2520O6-alkylguanine-DNA%2520alkyltransferase%2520activity%2520by%2520O6-benzylguanine%2520provides%2520a%2520means%2520to%2520evaluate%2520the%2520role%2520of%2520this%2520protein%2520in%2520protection%2520against%2520carcinogenic%2520and%2520therapeutic%2520alkylating%2520agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1990%26volume%3D87%26spage%3D5368%26epage%3D5372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mummert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span> </span><span class="NLM_article-title">Effect of <i>O</i><sup>6</sup>-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3367</span><span class="NLM_x">â</span> <span class="NLM_lpage">3372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=3367-3372&author=M.+E.+Dolanauthor=R.+B.+Mitchellauthor=C.+Mummertauthor=R.+C.+Moschelauthor=A.+E.+Pegg&title=Effect+of+O6-benzylguanine+analogues+on+sensitivity+of+human+tumor+cells+to+the+cytotoxic+effects+of+alkylating+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DMitchell%26aufirst%3DR.%2BB.%26aulast%3DMummert%26aufirst%3DC.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26atitle%3DEffect%2520of%2520O6-benzylguanine%2520analogues%2520on%2520sensitivity%2520of%2520human%2520tumor%2520cells%2520to%2520the%2520cytotoxic%2520effects%2520of%2520alkylating%2520agents%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D3367%26epage%3D3372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Baer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlands, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafferty, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margison, G. P.</span><span> </span><span class="NLM_article-title">Depletion of <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumor cells</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1299</span><span class="NLM_x">â</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1038%2Fbjc.1993.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=8512814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFGht7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1993&pages=1299-1302&author=J.+C.+Baerauthor=A.+A.+Freemanauthor=E.+S.+Newlandsauthor=A.+J.+Watsonauthor=J.+A.+Raffertyauthor=G.+P.+Margison&title=Depletion+of+O6-alkylguanine-DNA+alkyltransferase+correlates+with+potentiation+of+temozolomide+and+CCNU+toxicity+in+human+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumor cells</span></div><div class="casAuthors">Baer, J. C.; Freeman, A. A.; Newlands, E. S.; Watson, A. J.; Rafferty, J. A.; Margison, G. P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1299-302</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Temozolomide (8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-triazin-4(3H)-one) has shown promising activity in Phase I trials against some brain (glioma) and skin (Melanoma, mycosis fungoides) cancers.  Temozolomide and lomustine (CCNU) showed parallel toxicity in seven human tumor cell lines and this generally correlated (correlation coeffs. 0.87 and 0.92 resp.) with the level of expression of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (ATase, EC 2.1.1.63).  Pretreating cells with the ATase inhibitor, O6-benzylguanine (BG), potentiated cytotoxicity to a similar degree with both drugs, but did not sensitize a cell line (ZR-75-1) expressing very low levels of this protein.  When BG pretreatment was combined with repeat doses of temozolomide a dramatic potentiation (300 fold) was seen in MAWI cells, which express high levels of ATase, but not in a cell line (U373) expressing lower levels of ATase.  [14C]-labeled temozolomide uptake was similar in sensitive and resistant lines.  Human ATase-cDNA transfected Xeroderma pigmentosum (XP) fibroblasts were more resistant than XP control cells to temozolomide and the related chloroethylating agent mitozolomide and although BG completely suppressed ATase activity in these cells, resistance was still greater than in control cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsxAlV44XaBbVg90H21EOLACvtfcHk0ljsHWS51MmjZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFGht7g%253D&md5=0b2862b808fe4d4ed2c92961bbc9067f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1993.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1993.241%26sid%3Dliteratum%253Aachs%26aulast%3DBaer%26aufirst%3DJ.%2BC.%26aulast%3DFreeman%26aufirst%3DA.%2BA.%26aulast%3DNewlands%26aufirst%3DE.%2BS.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26aulast%3DRafferty%26aufirst%3DJ.%2BA.%26aulast%3DMargison%26aufirst%3DG.%2BP.%26atitle%3DDepletion%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%2520correlates%2520with%2520potentiation%2520of%2520temozolomide%2520and%2520CCNU%2520toxicity%2520in%2520human%2520tumor%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1993%26volume%3D67%26spage%3D1299%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Magull-Seltenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeller, W. J.</span><span> </span><span class="NLM_article-title">Sensitization of human colon tumor cell lines to carmustine by depletion of <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase</span> <span class="citation_source-journal">J. Cancer Res. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">â</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1995&pages=225-229&author=A.+Magull-Seltenreichauthor=W.+J.+Zeller&title=Sensitization+of+human+colon+tumor+cell+lines+to+carmustine+by+depletion+of+O6-alkylguanine-DNA+alkyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMagull-Seltenreich%26aufirst%3DA.%26aulast%3DZeller%26aufirst%3DW.%2BJ.%26atitle%3DSensitization%2520of%2520human%2520colon%2520tumor%2520cell%2520lines%2520to%2520carmustine%2520by%2520depletion%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D1995%26volume%3D121%26spage%3D225%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Quinn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colvin, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haglund, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClendon, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Provenzale, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guruangan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourt-Uhlig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J. E.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidman, H. S.</span><span> </span><span class="NLM_article-title">Phase II trial of carmustine plus <i>O</i><sup>6</sup>-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2277</span><span class="NLM_x">â</span> <span class="NLM_lpage">2283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1200%2FJCO.2002.09.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=11980998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVKrs78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=2277-2283&author=J.+A.+Quinnauthor=J.+Pludaauthor=M.+E.+Dolanauthor=S.+Delaneyauthor=R.+Kaplanauthor=J.+N.+Richauthor=A.+H.+Friedmanauthor=D.+A.+Reardonauthor=J.+H.+Sampsonauthor=O.+M.+Colvinauthor=M.+M.+Haglundauthor=A.+E.+Peggauthor=R.+C.+Moschelauthor=R.+E.+McClendonauthor=J.+M.+Provenzaleauthor=S.+Guruanganauthor=S.+Tourt-Uhligauthor=J.+E.+Herndonauthor=D.+D.+Bignerauthor=H.+S.+Freidman&title=Phase+II+trial+of+carmustine+plus+O6-benzylguanine+for+patients+with+nitrosourea-resistant+recurrent+or+progressive+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of carmustine plus O6-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma</span></div><div class="casAuthors">Quinn, Jennifer A.; Pluda, James; Dolan, M. Eileen; Delaney, Shannon; Kaplan, Richard; Rich, Jeremy N.; Friedman, Allan H.; Reardon, David A.; Sampson, John H.; Colvin, O. Michael; Haglund, Michael M.; Pegg, Anthony E.; Moschel, Robert C.; McLendon, Roger E.; Provenzale, James M.; Gururangan, Sridharan; Tourt-Uhlig, Sandra; Herndon, James E., II; Bigner, Darell D.; Friedman, Henry S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2277-2283</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose: the authors conducted a phase II trial of carmustine (BCNU) plus the O6-alkylguanine-DNA alkyltransferase inhibitor O6-benzylguanine (O6-BG) to define the activity and toxicity of this regimen in the treatment of adults with progressive or recurrent malignant glioma resistant to nitrosoureas.  Patients and Methods: Patients were treated with O6-BG at an i.v. dose of 120 mg/M2 followed 1 h later by 40 mg/M2 of BCNU, with cycles repeated at 6-wk intervals.  Results: Eighteen patients were treated (15 with glioblastoma multiforme, two with anaplastic astrocytoma, and one with malignant glioma).  None of the 18 patients demonstrated a partial or complete response.  Two patients exhibited stable disease for 12 wk before their tumors progressed.  Three patients demonstrated stable disease for 6, 12, and 18 wk before discontinuing therapy because of hematopoietic toxicity.  Twelve patients experienced reversible â¥ grade 3 hematopoietic toxicity.  There was no difference in half-lives (0.56Â±0.21 h v 0.54Â±0.20 h) or area under the curve values (4.8Â±1.7 Î¼g/mL/h v 5.0Â±1.3 Î¼g/mL/h) of O6-BG for patients receiving phenytoin and those not treated with this drug.  Conclusion: These results indicate that O6-BG plus BCNU at the dose schedule used in this trial is unsuccessful in producing tumor regression in patients with nitrosourea-resistant malignant glioma, although stable disease was seen in five patients for 6, 12, 12, 12, and 18 wk.  Future use of this approach will require strategies to minimize dose-limiting toxicity of BCNU such as regional delivery or hematopoietic stem-cell protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCxLQ0k9A7ErVg90H21EOLACvtfcHk0ljsHWS51MmjZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVKrs78%253D&md5=60e1702ff9920f775d83e1f2ea08f60b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1200%2FJCO.2002.09.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2002.09.084%26sid%3Dliteratum%253Aachs%26aulast%3DQuinn%26aufirst%3DJ.%2BA.%26aulast%3DPluda%26aufirst%3DJ.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DDelaney%26aufirst%3DS.%26aulast%3DKaplan%26aufirst%3DR.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26aulast%3DFriedman%26aufirst%3DA.%2BH.%26aulast%3DReardon%26aufirst%3DD.%2BA.%26aulast%3DSampson%26aufirst%3DJ.%2BH.%26aulast%3DColvin%26aufirst%3DO.%2BM.%26aulast%3DHaglund%26aufirst%3DM.%2BM.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26aulast%3DMcClendon%26aufirst%3DR.%2BE.%26aulast%3DProvenzale%26aufirst%3DJ.%2BM.%26aulast%3DGuruangan%26aufirst%3DS.%26aulast%3DTourt-Uhlig%26aufirst%3DS.%26aulast%3DHerndon%26aufirst%3DJ.%2BE.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFreidman%26aufirst%3DH.%2BS.%26atitle%3DPhase%2520II%2520trial%2520of%2520carmustine%2520plus%2520O6-benzylguanine%2520for%2520patients%2520with%2520nitrosourea-resistant%2520recurrent%2520or%2520progressive%2520malignant%2520glioma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2002%26volume%3D20%26spage%3D2277%26epage%3D2283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Schilsky, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewesuedo, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelzang, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratain, M. J.</span><span> </span><span class="NLM_article-title">Phase I clinical and pharmacological study of <i>O</i><sup>6</sup>-benzylguanine followed by carmustine in patients with advanced cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3025</span><span class="NLM_x">â</span> <span class="NLM_lpage">3031</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=10955780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVOmsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=3025-3031&author=R.+L.+Schilskyauthor=M.+E.+Dolanauthor=D.+Bertucciauthor=R.+B.+Ewesuedoauthor=N.+J.+Vogelzangauthor=S.+Maniauthor=L.+R.+Wilsonauthor=M.+J.+Ratain&title=Phase+I+clinical+and+pharmacological+study+of+O6-benzylguanine+followed+by+carmustine+in+patients+with+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer</span></div><div class="casAuthors">Schilsky, Richard L.; Dolan, M. Eileen; Bertucci, Donna; Ewesuedo, Reginald B.; Vogelzang, Nicholas J.; Mani, Sridhar; Wilson, Lynette R.; Ratain, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3025-3031</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">O6-benzylguanine (BG) is a potent inactivator of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT) that enhances sensitivity to nitrosoureas in tumor cell lines and tumor-bearing animals.  The major objectives of this study were to define the optimal modulatory dose and assocd. toxicities of benzylguanine administered alone and in combination with carmustine; to define the maximally tolerated dose and assocd. toxicities of carmustine administered with benzylguanine and to describe the pharmacokinetics of BG in humans and its effects on AGT depletion and recovery in peripheral blood mononuclear cells.  Patients with histol. confirmed advanced solid tumors or lymphoma that had failed to respond to std. therapy or for which no std. therapy was available were eligible to participate in this study.  Patients initially received BG as a 1-h i.v. infusion without carmustine.  After a 14-day washout (i.e., without therapy) period, patients received BG as a 1-h i.v. infusion followed, 1 h later, by a 15-min i.v. infusion of carmustine.  Cycles of chemotherapy were repeated every 6 wk.  Cohorts of patients received BG doses ranging from 10 to 120 mg/m2 and carmustine doses ranging from 13 to 50 mg/m2.  Plasma and urine samples were collected and analyzed for BG, and O6-benzyl-8-oxoguanine concns. and AGT activity was detd. in peripheral blood mononuclear cells.  There was no toxicity attributable to BG alone at any dose tested.  Bone marrow suppression was the primary and dose-limiting toxicity of BG combined with carmustine and was cumulative in some patients.  The neutrophil nadir occurred at a median of day 27, with complete recovery in most patients by day 43.  Nonhematol. toxicity included fatigue, anorexia, increased bilirubin, and transaminase elevation.  Recommended doses for Phase II testing are 120 mg/m2 BG given with carmustine at 40 mg/m2.  BG rapidly disappeared from plasma and was converted to a major metabolite, O6-benzyl-8-oxoguanine, which has a 2.4-fold higher maximal concn. and 20-fold higher area under the concn. vs. time curve than BG.  AGT activity in peripheral blood mononuclear cells was rapidly and completely suppressed at all of the BG doses.  The rate of AGT regeneration was more rapid for patients treated with the lowest dose of BG but was similar for BG doses ranging from 20-120 mg/m2.  In conclusion, coadministration of BG and carmustine is feasible in cancer patients, but the maximal dose of carmustine that can be safely administered with BG is approx. one-third of the std. clin. dose.  Bone marrow suppression, which may be cumulative, is the dose-limiting toxicity of the combination.  Prolonged AGT suppression is likely attributable primarily to the effect of O6-benzyl-8-oxoguanine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcXhq5tQNd4rVg90H21EOLACvtfcHk0lhbArq_2Oxvww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVOmsb8%253D&md5=0a9215fd136d362e082a31551eecb927</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchilsky%26aufirst%3DR.%2BL.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DBertucci%26aufirst%3DD.%26aulast%3DEwesuedo%26aufirst%3DR.%2BB.%26aulast%3DVogelzang%26aufirst%3DN.%2BJ.%26aulast%3DMani%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DL.%2BR.%26aulast%3DRatain%26aufirst%3DM.%2BJ.%26atitle%3DPhase%2520I%2520clinical%2520and%2520pharmacological%2520study%2520of%2520O6-benzylguanine%2520followed%2520by%2520carmustine%2520in%2520patients%2520with%2520advanced%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D3025%26epage%3D3031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kennedy, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teicher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">The hypoxic tumor cell: a target for selective cancer chemotherapy</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1980&pages=1-8&author=K.+A.+Kennedyauthor=B.+A.+Teicherauthor=S.+Rockwellauthor=A.+C.+Sartorelli&title=The+hypoxic+tumor+cell%3A+a+target+for+selective+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DK.%2BA.%26aulast%3DTeicher%26aufirst%3DB.%2BA.%26aulast%3DRockwell%26aufirst%3DS.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DThe%2520hypoxic%2520tumor%2520cell%253A%2520a%2520target%2520for%2520selective%2520cancer%2520chemotherapy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1980%26volume%3D29%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Therapeutic attack of hypoxic cells of solid tumors: presidential address</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">â</span> <span class="NLM_lpage">778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1988&pages=775-778&author=A.+C.+Sartorelli&title=Therapeutic+attack+of+hypoxic+cells+of+solid+tumors%3A+presidential+address"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DTherapeutic%2520attack%2520of%2520hypoxic%2520cells%2520of%2520solid%2520tumors%253A%2520presidential%2520address%26jtitle%3DCancer%2520Res.%26date%3D1988%26volume%3D48%26spage%3D775%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Chae, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDougall, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span> </span><span class="NLM_article-title">Substituted <i>O</i><sup>6</sup>-benzylguanine derivatives and their inactivation of human <i>O</i><sup>6</sup>-alkylguanine DNA alkyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">â</span> <span class="NLM_lpage">347</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00029a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=342-347&author=M.-Y.+Chaeauthor=M.+G.+McDougallauthor=M.+E.+Dolanauthor=K.+Swennauthor=A.+E.+Peggauthor=R.+C.+Moschel&title=Substituted+O6-benzylguanine+derivatives+and+their+inactivation+of+human+O6-alkylguanine+DNA+alkyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm00029a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00029a005%26sid%3Dliteratum%253Aachs%26aulast%3DChae%26aufirst%3DM.-Y.%26aulast%3DMcDougall%26aufirst%3DM.%2BG.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DSwenn%26aufirst%3DK.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26atitle%3DSubstituted%2520O6-benzylguanine%2520derivatives%2520and%2520their%2520inactivation%2520of%2520human%2520O6-alkylguanine%2520DNA%2520alkyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D342%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Chae, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanugula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span> </span><span class="NLM_article-title">8-Substituted <i>O</i><sup>6</sup>-benzylguanine, substituted 6(4)-(benzyloxy)pyrimidine derivatives, and related compounds as inhibitors of human <i>O</i><sup>6</sup>-alkylguanine DNA alkyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">â</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00002a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=359-365&author=M.-Y.+Chaeauthor=K.+Swennauthor=S.+Kanugulaauthor=M.+E.+Dolanauthor=A.+E.+Peggauthor=R.+C.+Moschel&title=8-Substituted+O6-benzylguanine%2C+substituted+6%284%29-%28benzyloxy%29pyrimidine+derivatives%2C+and+related+compounds+as+inhibitors+of+human+O6-alkylguanine+DNA+alkyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm00002a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00002a018%26sid%3Dliteratum%253Aachs%26aulast%3DChae%26aufirst%3DM.-Y.%26aulast%3DSwenn%26aufirst%3DK.%26aulast%3DKanugula%26aufirst%3DS.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26atitle%3D8-Substituted%2520O6-benzylguanine%252C%2520substituted%25206%25284%2529-%2528benzyloxy%2529pyrimidine%2520derivatives%252C%2520and%2520related%2520compounds%2520as%2520inhibitors%2520of%2520human%2520O6-alkylguanine%2520DNA%2520alkyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D359%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loktionova, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span> </span><span class="NLM_article-title">Î²-Glucuronidase-cleavable prodrugs of <i>O</i><sup>6</sup>-benzylguanine and <i>O</i><sup>6</sup>-benzyl-2â²-deoxyguanine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">â</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493865" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=256-261&author=G.+Weiauthor=N.+A.+Loktionovaauthor=A.+E.+Peggauthor=R.+C.+Moschel&title=%CE%B2-Glucuronidase-cleavable+prodrugs+of+O6-benzylguanine+and+O6-benzyl-2%E2%80%B2-deoxyguanine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm0493865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493865%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DG.%26aulast%3DLoktionova%26aufirst%3DN.%2BA.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26atitle%3D%25CE%25B2-Glucuronidase-cleavable%2520prodrugs%2520of%2520O6-benzylguanine%2520and%2520O6-benzyl-2%25E2%2580%25B2-deoxyguanine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D256%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Penketh, P. G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, R. P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remack, J. S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brent, T. P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">â</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1007%2Fs00280-003-0740-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=14704831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVWgs7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=279-287&author=P.+G+Penkethauthor=K+Shyamauthor=R.+P+Baumannauthor=J.+S+Remackauthor=T.+P+Brentauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2-%5B%28methylamino%29carbonyl%5Dhydrazine+%28VNP40101M%29%3A+I.+Direct+inhibition+of+O6-alkylguanine-DNA+alkyltransferase+%28AGT%29+by+electrophilic+species+generated+by+decomposition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition</span></div><div class="casAuthors">Penketh, P. G.; Shyam, K.; Baumann, R. P.; Remack, J. S.; Brent, T. P.; Sartorelli, A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-287</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">To investigate the interaction of the electrophilic species generated by the decompn. of the antineoplastic prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M) on the ability of O6-alkylguanine-DNA alkyltransferase (AGT) to repair alkylated O6-chloroethylguanine and/or N1,O6-ethanoguanine DNA lesions.  The contributions of inhibitory electrophilic species generated from VNP40101M towards AGT was assessed using analogs that selectively generated either the chloroethylating or the carbamoylating components of VNP40101M.  The activity of AGT was detd. from the inhibition of crosslink formation from O6-chloroethylguanine and/or N1,O6-ethanoguanine lesions.  The half-lives of sulfonylhydrazine derivs. and isocyanates were measured using an acidification assay which gives a change in absorbance proportional to the release or consumption of small quantities of protons.  Both of the reactive components produced by VNP40101M directly inactivated cloned human AGT; the carbamoylating moiety (IC50 about 13 Î¼M) was approx. seven- to eight-fold more potent than the alkylating component(s) (IC50 about 100 Î¼M).  These inhibitory actions were moderated by the addn. of naked T5 bacteriophage DNA.  Thus, AGT bound to DNA was markedly more resistant than free AGT to these electrophilic species.  DNA also blocked the spontaneous loss of AGT activity which occurred upon incubation of this protein under mild conditions.  The reaction of AGT with the Me isocyanate generated from the decompn. of VNP40101M increased the net no. of crosslinks generated by VNP40101M compared to a sulfonylhydrazine prodrug that formed the equiv. alkylating species in the absence of the cogeneration of Me isocyanate.  These actions may be of significance to the antineoplastic activity of VNP40101M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbeymFLugB-7Vg90H21EOLACvtfcHk0lhbArq_2Oxvww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVWgs7o%253D&md5=432784614b47bc46aec031bc0c2e7a72</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00280-003-0740-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-003-0740-7%26sid%3Dliteratum%253Aachs%26aulast%3DPenketh%26aufirst%3DP.%2BG%26aulast%3DShyam%26aufirst%3DK%26aulast%3DBaumann%26aufirst%3DR.%2BP%26aulast%3DRemack%26aufirst%3DJ.%2BS%26aulast%3DBrent%26aufirst%3DT.%2BP%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2-%255B%2528methylamino%2529carbonyl%255Dhydrazine%2520%2528VNP40101M%2529%253A%2520I.%2520Direct%2520inhibition%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%2520%2528AGT%2529%2520by%2520electrophilic%2520species%2520generated%2520by%2520decomposition%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2004%26volume%3D53%26spage%3D279%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Thomson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, M. R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P. D.</span><span> </span><span class="NLM_article-title">Hypoxia-driven elimination of thiopurines from their nitrobenzyl prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4320</span><span class="NLM_x">â</span> <span class="NLM_lpage">4322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4320-4322&author=P.+Thomsonauthor=M.+A.+Naylorauthor=M.+R.+L.+Stratfordauthor=G.+Lewisauthor=S.+Hillauthor=K.+B.+Patelauthor=P.+Wardmanauthor=P.+D.+Davis&title=Hypoxia-driven+elimination+of+thiopurines+from+their+nitrobenzyl+prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DP.%26aulast%3DNaylor%26aufirst%3DM.%2BA.%26aulast%3DStratford%26aufirst%3DM.%2BR.%2BL.%26aulast%3DLewis%26aufirst%3DG.%26aulast%3DHill%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DK.%2BB.%26aulast%3DWardman%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DP.%2BD.%26atitle%3DHypoxia-driven%2520elimination%2520of%2520thiopurines%2520from%2520their%2520nitrobenzyl%2520prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4320%26epage%3D4322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bianco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haladjian, J.</span><span> </span><span class="NLM_article-title">Study of two forms of ferredoxin from <i>Desulfovibrio gigas</i> by differential pulse polarography</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">â</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1977&pages=323-327&author=P.+Biancoauthor=J.+Haladjian&title=Study+of+two+forms+of+ferredoxin+from+Desulfovibrio+gigas+by+differential+pulse+polarography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBianco%26aufirst%3DP.%26aulast%3DHaladjian%26aufirst%3DJ.%26atitle%3DStudy%2520of%2520two%2520forms%2520of%2520ferredoxin%2520from%2520Desulfovibrio%2520gigas%2520by%2520differential%2520pulse%2520polarography%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1977%26volume%3D78%26spage%3D323%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Baumann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A.</span><span> </span><span class="NLM_article-title">Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cells</span> <span class="citation_source-journal">Radiat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">â</span> <span class="NLM_lpage">660</span><div class="note"><p class="first last">. PMCID: PMC2667281</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1667%2FRR1431.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=18959466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlCnt73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=651-660&author=R.+Baumannauthor=P.+Penkethauthor=H.+Seowauthor=K.+Shyamauthor=A.+Sartorelli&title=Generation+of+oxygen+deficiency+in+cell+culture+using+a+two-enzyme+system+to+evaluate+agents+targeting+hypoxic+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cells</span></div><div class="casAuthors">Baumann, Raymond P.; Penketh, Philip G.; Seow, Helen A.; Shyam, Krishnamurthy; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Radiation Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">651-660</span>CODEN:
                <span class="NLM_cas:coden">RAREAE</span>;
        ISSN:<span class="NLM_cas:issn">0033-7587</span>.
    
            (<span class="NLM_cas:orgname">Radiation Research Society</span>)
        </div><div class="casAbstract">The poor and aberrant vascularization of solid tumors makes them susceptible to localized areas of oxygen deficiency that can be considered sites of tumor vulnerability to prodrugs that are preferentially activated to cytotoxic species under conditions of low oxygenation.  To readily facilitate the selection of agents targeted to oxygen-deficient cells in solid tumors, we have developed a simple and convenient two-enzyme system to generate oxygen deficiency in cell cultures.  Glucose oxidase is employed to deplete oxygen from the medium by selectively oxidizing glucose and reducing mol. oxygen to hydrogen peroxide; an excess of catalase is also used to scavenge the peroxide mols.  Rapid and sustained depletion of oxygen occurs in medium or buffer, even in the presence of oxygen at the liq./air interface.  Studies using CHO/AA8 Chinese hamster cells, EMT6 murine mammary carcinoma cells, and U251 human glioma cells indicate that this system generates an oxygen deficiency that produces activation of the hypoxia-targeted prodrug KS 119.  This method of generating oxygen deficiency in cell culture is inexpensive, does not require cumbersome equipment, permits longer incubation times to be used without the loss of sample vol., and should be adaptable for high-throughput screening in 96-well plates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQFARvu3M87Vg90H21EOLACvtfcHk0lj3cgT8M7-LcQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlCnt73M&md5=60e0e75caa5cf7e0257d4f30df2a4d2d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1667%2FRR1431.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1667%252FRR1431.1%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DR.%26aulast%3DPenketh%26aufirst%3DP.%26aulast%3DSeow%26aufirst%3DH.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DSartorelli%26aufirst%3DA.%26atitle%3DGeneration%2520of%2520oxygen%2520deficiency%2520in%2520cell%2520culture%2520using%2520a%2520two-enzyme%2520system%2520to%2520evaluate%2520agents%2520targeting%2520hypoxic%2520tumor%2520cells%26jtitle%3DRadiat.%2520Res.%26date%3D2008%26volume%3D170%26spage%3D651%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Baumann, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1553</span><span class="NLM_x">â</span> <span class="NLM_lpage">1561</span><div class="note"><p class="first last">. PMCID: PMC2885764</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1553-1561&author=R.+P.+Baumannauthor=P.+G.+Penkethauthor=K.+Ishiguroauthor=K.+Shyamauthor=Y.+L.+Zhuauthor=A.+C.+Sartorelli&title=Reductive+activation+of+the+prodrug+1%2C2-bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2-%5B%5B1-%284-nitrophenyl%29ethoxy%5Dcarbonyl%5Dhydrazine+%28KS119%29+selectively+occurs+in+oxygen-deficient+cells+and+overcomes+O6-alkylguanine-DNA+alkyltransferase+mediated+KS119+tumor+cell+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DY.%2BL.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DReductive%2520activation%2520of%2520the%2520prodrug%25201%252C2-bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2-%255B%255B1-%25284-nitrophenyl%2529ethoxy%255Dcarbonyl%255Dhydrazine%2520%2528KS119%2529%2520selectively%2520occurs%2520in%2520oxygen-deficient%2520cells%2520and%2520overcomes%2520O6-alkylguanine-DNA%2520alkyltransferase%2520mediated%2520KS119%2520tumor%2520cell%2520resistance%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1553%26epage%3D1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Rockwell, S.</span><span> </span><span class="NLM_article-title">In vivoâin vitro tumor systems: new models for studying the response of tumors to therapy</span> <span class="citation_source-journal">Lab. Animal Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">â</span> <span class="NLM_lpage">851</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=338981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A280%3ADyaE1c%252FmvF2rsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1977&pages=831-851&author=S.+Rockwell&title=In+vivo%E2%80%93in+vitro+tumor+systems%3A+new+models+for+studying+the+response+of+tumors+to+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo-in vitro tumor systems: new models for studing the response of tumours to therapy</span></div><div class="casAuthors">Rockwell S</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory animal science</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5 Pt 2</span>),
    <span class="NLM_cas:pages">831-51</span>
        ISSN:<span class="NLM_cas:issn">0023-6764</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRp27gpjoZYdLFU0A1HOshhfW6udTcc2eaD8zFWxwzvxbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1c%252FmvF2rsg%253D%253D&md5=177b36151b9b11f5f88b80835944ebf4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRockwell%26aufirst%3DS.%26atitle%3DIn%2520vivo%25E2%2580%2593in%2520vitro%2520tumor%2520systems%253A%2520new%2520models%2520for%2520studying%2520the%2520response%2520of%2520tumors%2520to%2520therapy%26jtitle%3DLab.%2520Animal%2520Sci.%26date%3D1977%26volume%3D27%26spage%3D831%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Belcourt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodnick, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">The intracellular location of NADH:cytochrome b5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">8875</span><span class="NLM_x">â</span> <span class="NLM_lpage">8881</span><div class="note"><p class="first last">. PMCID: PMC40257</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=8875-8881&author=M.+F.+Belcourtauthor=W.+F.+Hodnickauthor=S.+Rockwellauthor=A.+C.+Sartorelli&title=The+intracellular+location+of+NADH%3Acytochrome+b5+reductase+modulates+the+cytotoxicity+of+the+mitomycins+to+Chinese+hamster+ovary+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelcourt%26aufirst%3DM.%2BF.%26aulast%3DHodnick%26aufirst%3DW.%2BF.%26aulast%3DRockwell%26aufirst%3DS.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DThe%2520intracellular%2520location%2520of%2520NADH%253Acytochrome%2520b5%2520reductase%2520modulates%2520the%2520cytotoxicity%2520of%2520the%2520mitomycins%2520to%2520Chinese%2520hamster%2520ovary%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D8875%26epage%3D8881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hisao Saneyoshi, Kodai Nakamura, Kazuma Terasawa, <span class="NLM_string-name hlFld-ContribAuthor">Akira Ono</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Bioreduction Labile Protecting Groups for the 2â²-Hydroxyl Group of RNA. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (15)
                                     , 6006-6009. <a href="https://doi.org/10.1021/acs.orglett.0c02086" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02086%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDevelopment%252Bof%252BBioreduction%252BLabile%252BProtecting%252BGroups%252Bfor%252Bthe%252B2%2525E2%252580%2525B2-Hydroxyl%252BGroup%252Bof%252BRNA%26aulast%3DSaneyoshi%26aufirst%3DHisao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24062020%26date%3D14072020%26volume%3D22%26issue%3D15%26spage%3D6006%26epage%3D6009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kunal Nepali, Hsueh-Yun Lee, <span class="NLM_string-name hlFld-ContribAuthor">Jing-Ping Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Nitro-Group-Containing Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (6)
                                     , 2851-2893. <a href="https://doi.org/10.1021/acs.jmedchem.8b00147" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00147%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNitro-Group-Containing%252BDrugs%26aulast%3DNepali%26aufirst%3DKunal%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D29012018%26date%3D01112018%26date%3D08102018%26volume%3D62%26issue%3D6%26spage%3D2851%26epage%3D2893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishnamurthy  Shyam</span>, <span class="hlFld-ContribAuthor ">Philip G.  Penketh</span>, <span class="hlFld-ContribAuthor ">Raymond P.  Baumann</span>, <span class="hlFld-ContribAuthor ">Rick A.  Finch</span>, <span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Yong-Lian  Zhu</span>, and <span class="hlFld-ContribAuthor ">Alan C.  Sartorelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Antitumor Sulfonylhydrazines: Design, StructureâActivity Relationships, Resistance Mechanisms, and Strategies for Improving Therapeutic Utility. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (9)
                                     , 3639-3671. <a href="https://doi.org/10.1021/jm501459c" title="DOI URL">https://doi.org/10.1021/jm501459c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501459c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501459c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntitumor%252BSulfonylhydrazines%25253A%252BDesign%25252C%252BStructure%2525E2%252580%252593Activity%252BRelationships%25252C%252BResistance%252BMechanisms%25252C%252Band%252BStrategies%252Bfor%252BImproving%252BTherapeutic%252BUtility%26aulast%3DShyam%26aufirst%3DKrishnamurthy%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D22092014%26date%3D09022015%26date%3D14052015%26date%3D22012015%26volume%3D58%26issue%3D9%26spage%3D3639%26epage%3D3671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cindy  Cazares-KÃ¶rner</span>, <span class="hlFld-ContribAuthor ">Isabel M.  Pires</span>, <span class="hlFld-ContribAuthor ">I. Diane  Swallow</span>, <span class="hlFld-ContribAuthor ">Samuel C.  Grayer</span>, <span class="hlFld-ContribAuthor ">Liam J.  OâConnor</span>, <span class="hlFld-ContribAuthor ">Monica M.  Olcina</span>, <span class="hlFld-ContribAuthor ">Martin  Christlieb</span>, <span class="hlFld-ContribAuthor ">Stuart J.  Conway</span>, and <span class="hlFld-ContribAuthor ">Ester M.  Hammond</span>  . </span><span class="cited-content_cbyCitation_article-title">CH-01 is a Hypoxia-Activated Prodrug That Sensitizes Cells to Hypoxia/Reoxygenation Through Inhibition of Chk1 and Aurora A. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (7)
                                     , 1451-1459. <a href="https://doi.org/10.1021/cb4001537" title="DOI URL">https://doi.org/10.1021/cb4001537</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb4001537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb4001537%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DCH-01%252Bis%252Ba%252BHypoxia-Activated%252BProdrug%252BThat%252BSensitizes%252BCells%252Bto%252BHypoxia%25252FReoxygenation%252BThrough%252BInhibition%252Bof%252BChk1%252Band%252BAurora%252BA%26aulast%3DCazares-K%25C3%25B6rner%26aufirst%3DCindy%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D03092012%26date%3D18042013%26date%3D10052013%26date%3D19072013%26date%3D18042013%26volume%3D8%26issue%3D7%26spage%3D1451%26epage%3D1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Raymond P.  Baumann</span>, <span class="hlFld-ContribAuthor ">Philip G.  Penketh</span>, <span class="hlFld-ContribAuthor ">Krishnamurthy  Shyam</span>, and <span class="hlFld-ContribAuthor ">Alan C.  Sartorelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Hypoxia-Selective O6-Alkylguanine-DNA Alkyltransferase Inhibitors: Design, Synthesis, and Evaluation of 6-(Benzyloxy)-2-(aryldiazenyl)-9H-purines as Prodrugs of O6-Benzylguanine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (3)
                                     , 1355-1359. <a href="https://doi.org/10.1021/jm301804p" title="DOI URL">https://doi.org/10.1021/jm301804p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301804p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301804p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHypoxia-Selective%252BO6-Alkylguanine-DNA%252BAlkyltransferase%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252B6-%252528Benzyloxy%252529-2-%252528aryldiazenyl%252529-9H-purines%252Bas%252BProdrugs%252Bof%252BO6-Benzylguanine%26aulast%3DZhu%26aufirst%3DRui%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D07122012%26date%3D23012013%26date%3D14022013%26date%3D11012013%26volume%3D56%26issue%3D3%26spage%3D1355%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yufei  Xue</span>, <span class="hlFld-ContribAuthor ">Hua  Bai</span>, <span class="hlFld-ContribAuthor ">Bo  Peng</span>, <span class="hlFld-ContribAuthor ">Bin  Fang</span>, <span class="hlFld-ContribAuthor ">Jonathan  Baell</span>, <span class="hlFld-ContribAuthor ">Lin  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Nicolas Hans  Voelcker</span>. </span><span class="cited-content_cbyCitation_article-title">Stimulus-cleavable chemistry in the field of controlled drug delivery. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (8)
                                     , 4872-4931. <a href="https://doi.org/10.1039/D0CS01061H" title="DOI URL">https://doi.org/10.1039/D0CS01061H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS01061H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS01061H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DStimulus-cleavable%252Bchemistry%252Bin%252Bthe%252Bfield%252Bof%252Bcontrolled%252Bdrug%252Bdelivery%26aulast%3DXue%26aufirst%3DYufei%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D8%26spage%3D4872%26epage%3D4931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiankun  Cao</span>, <span class="hlFld-ContribAuthor ">Zongjian  Liu</span>, <span class="hlFld-ContribAuthor ">Congxiao  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Pan</span>, <span class="hlFld-ContribAuthor ">Shuyan  Qie</span>. </span><span class="cited-content_cbyCitation_article-title">Cell Models for Birth Defects Caused by Chloroethyl Nitrosourea-Induced DNA Lesions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Craniofacial Surgery</span><span> <strong>2021,</strong> <em>32 </em>
                                    (2)
                                     , 778-782. <a href="https://doi.org/10.1097/SCS.0000000000006850" title="DOI URL">https://doi.org/10.1097/SCS.0000000000006850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/SCS.0000000000006850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FSCS.0000000000006850%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Craniofacial%2520Surgery%26atitle%3DCell%252BModels%252Bfor%252BBirth%252BDefects%252BCaused%252Bby%252BChloroethyl%252BNitrosourea-Induced%252BDNA%252BLesions%26aulast%3DCao%26aufirst%3DJiankun%26date%3D2021%26date%3D2020%26volume%3D32%26issue%3D2%26spage%3D778%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip G.  Penketh</span>, <span class="hlFld-ContribAuthor ">Hugh S  Williamson</span>, <span class="hlFld-ContribAuthor ">Raymond P.  Baumann</span>, <span class="hlFld-ContribAuthor ">Krishnamurthy  Shyam</span>. </span><span class="cited-content_cbyCitation_article-title">Design Strategy for the EPR Tumor-Targeting of 1,2-Bis(sulfonyl)-1-alkylhydrazines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (2)
                                     , 259. <a href="https://doi.org/10.3390/molecules26020259" title="DOI URL">https://doi.org/10.3390/molecules26020259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26020259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26020259%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%252BStrategy%252Bfor%252Bthe%252BEPR%252BTumor-Targeting%252Bof%252B1%25252C2-Bis%252528sulfonyl%252529-1-alkylhydrazines%26aulast%3DPenketh%26aufirst%3DPhilip%2BG.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D2%26spage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Saqib</span>, <span class="hlFld-ContribAuthor ">Eugene  Arthur-Baidoo</span>, <span class="hlFld-ContribAuthor ">Milan  OnÄÃ¡k</span>, <span class="hlFld-ContribAuthor ">Stephan  Denifl</span>. </span><span class="cited-content_cbyCitation_article-title">Electron Attachment Studies with the Potential Radiosensitizer 2-Nitrofuran. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 8906. <a href="https://doi.org/10.3390/ijms21238906" title="DOI URL">https://doi.org/10.3390/ijms21238906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21238906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21238906%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DElectron%252BAttachment%252BStudies%252Bwith%252Bthe%252BPotential%252BRadiosensitizer%252B2-Nitrofuran%26aulast%3DSaqib%26aufirst%3DMuhammad%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D8906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip  Penketh</span>, <span class="hlFld-ContribAuthor ">Hugh  Williamson</span>, <span class="hlFld-ContribAuthor ">Krishnamurthy  Shyam</span>. </span><span class="cited-content_cbyCitation_article-title">Physicochemical Considerations of Tumor Selective Drug Delivery and Activity Confinement with Particular Reference to 1,2-Bis(Sulfonyl)-1- Alkylhydrazines Delivery. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Delivery</span><span> <strong>2020,</strong> <em>17 </em>
                                    (5)
                                     , 362-374. <a href="https://doi.org/10.2174/1567201817666200427215044" title="DOI URL">https://doi.org/10.2174/1567201817666200427215044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1567201817666200427215044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1567201817666200427215044%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Delivery%26atitle%3DPhysicochemical%252BConsiderations%252Bof%252BTumor%252BSelective%252BDrug%252BDelivery%252Band%252BActivity%252BConfinement%252Bwith%252BParticular%252BReference%252Bto%252B1%25252C2-Bis%252528Sulfonyl%252529-1-%252BAlkylhydrazines%252BDelivery%26aulast%3DPenketh%26aufirst%3DPhilip%26date%3D2020%26volume%3D17%26issue%3D5%26spage%3D362%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Sun</span>, <span class="hlFld-ContribAuthor ">Guohui  Sun</span>, <span class="hlFld-ContribAuthor ">Yaxin  Huang</span>, <span class="hlFld-ContribAuthor ">Yuxing  Hao</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Tang</span>, <span class="hlFld-ContribAuthor ">Na  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijiao  Zhao</span>, <span class="hlFld-ContribAuthor ">Rugang  Zhong</span>, <span class="hlFld-ContribAuthor ">Yongzhen  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>, 113988. <a href="https://doi.org/10.1016/j.bcp.2020.113988" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.113988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.113988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.113988%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3D3-Bromopyruvate%252Bregulates%252Bthe%252Bstatus%252Bof%252Bglycolysis%252Band%252BBCNU%252Bsensitivity%252Bin%252Bhuman%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DSun%26aufirst%3DXiaodong%26date%3D2020%26volume%3D177%26spage%3D113988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandana  Mannem</span>, <span class="hlFld-ContribAuthor ">Yan  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">An LCâMS/MS method for determination of O
              6
              âbenzylguanine and its metabolite O
              6
              âbenzylâ8âoxoguanine in human plasma. </span><span class="cited-content_cbyCitation_journal-name">Biomedical Chromatography</span><span> <strong>2020,</strong> <em>34 </em>
                                    (2)
                                     <a href="https://doi.org/10.1002/bmc.4750" title="DOI URL">https://doi.org/10.1002/bmc.4750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bmc.4750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbmc.4750%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520Chromatography%26atitle%3DAn%252BLC%2525E2%252580%252593MS%25252FMS%252Bmethod%252Bfor%252Bdetermination%252Bof%252BO%252B6%252B%2525E2%252580%252590benzylguanine%252Band%252Bits%252Bmetabolite%252BO%252B6%252B%2525E2%252580%252590benzyl%2525E2%252580%2525908%2525E2%252580%252590oxoguanine%252Bin%252Bhuman%252Bplasma%26aulast%3DMannem%26aufirst%3DChandana%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weinan  Xiao</span>, <span class="hlFld-ContribAuthor ">Guohui  Sun</span>, <span class="hlFld-ContribAuthor ">Tengjiao  Fan</span>, <span class="hlFld-ContribAuthor ">Junjun  Liu</span>, <span class="hlFld-ContribAuthor ">Na  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijiao  Zhao</span>, <span class="hlFld-ContribAuthor ">Rugang  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Reductive Activity and Mechanism of Hypoxia- Targeted AGT Inhibitors: An Experimental and Theoretical Investigation. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (24)
                                     , 6308. <a href="https://doi.org/10.3390/ijms20246308" title="DOI URL">https://doi.org/10.3390/ijms20246308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20246308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20246308%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DReductive%252BActivity%252Band%252BMechanism%252Bof%252BHypoxia-%252BTargeted%252BAGT%252BInhibitors%25253A%252BAn%252BExperimental%252Band%252BTheoretical%252BInvestigation%26aulast%3DXiao%26aufirst%3DWeinan%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D24%26spage%3D6308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lydia P.  Liew</span>, <span class="hlFld-ContribAuthor ">Dean C.  Singleton</span>, <span class="hlFld-ContribAuthor ">Way W.  Wong</span>, <span class="hlFld-ContribAuthor ">Gary J.  Cheng</span>, <span class="hlFld-ContribAuthor ">Stephen M. F.  Jamieson</span>, <span class="hlFld-ContribAuthor ">Michael P.  Hay</span>. </span><span class="cited-content_cbyCitation_article-title">HypoxiaâActivated Prodrugs of PERK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry â An Asian Journal</span><span> <strong>2019,</strong> <em>14 </em>
                                    (8)
                                     , 1238-1248. <a href="https://doi.org/10.1002/asia.201801826" title="DOI URL">https://doi.org/10.1002/asia.201801826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201801826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201801826%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DHypoxia%2525E2%252580%252590Activated%252BProdrugs%252Bof%252BPERK%252BInhibitors%26aulast%3DLiew%26aufirst%3DLydia%2BP.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D8%26spage%3D1238%26epage%3D1248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit  Sharma</span>, <span class="hlFld-ContribAuthor ">Jonathan F.  Arambula</span>, <span class="hlFld-ContribAuthor ">Seyoung  Koo</span>, <span class="hlFld-ContribAuthor ">Rajesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Hardev  Singh</span>, <span class="hlFld-ContribAuthor ">Jonathan L.  Sessler</span>, <span class="hlFld-ContribAuthor ">Jong Seung  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-targeted drug delivery. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2019,</strong> <em>48 </em>
                                    (3)
                                     , 771-813. <a href="https://doi.org/10.1039/C8CS00304A" title="DOI URL">https://doi.org/10.1039/C8CS00304A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CS00304A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CS00304A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DHypoxia-targeted%252Bdrug%252Bdelivery%26aulast%3DSharma%26aufirst%3DAmit%26date%3D2019%26date%3D2019%26volume%3D48%26issue%3D3%26spage%3D771%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yao  Ge</span>, <span class="hlFld-ContribAuthor ">Xinxin  Lai</span>, <span class="hlFld-ContribAuthor ">Jintao  Li</span>, <span class="hlFld-ContribAuthor ">Ran  Yu</span>, <span class="hlFld-ContribAuthor ">Zhuochen  Zhuang</span>, <span class="hlFld-ContribAuthor ">Guohui  Sun</span>, <span class="hlFld-ContribAuthor ">Xin  Cui</span>, <span class="hlFld-ContribAuthor ">Na  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijiao  Zhao</span>, <span class="hlFld-ContribAuthor ">Pramod  Upadhyaya</span>, <span class="hlFld-ContribAuthor ">Rugang  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">NBGNU: a hypoxia-activated tripartite combi-nitrosourea prodrug overcoming AGT-mediated chemoresistance. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (4)
                                     , 269-284. <a href="https://doi.org/10.4155/fmc-2018-0511" title="DOI URL">https://doi.org/10.4155/fmc-2018-0511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0511%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNBGNU%25253A%252Ba%252Bhypoxia-activated%252Btripartite%252Bcombi-nitrosourea%252Bprodrug%252Bovercoming%252BAGT-mediated%252Bchemoresistance%26aulast%3DGe%26aufirst%3DYao%26date%3D2019%26volume%3D11%26issue%3D4%26spage%3D269%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guohui  Sun</span>, <span class="hlFld-ContribAuthor ">Lijiao  Zhao</span>, <span class="hlFld-ContribAuthor ">Rugang  Zhong</span>, <span class="hlFld-ContribAuthor ">Yongzhen  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">The specific role of O
              6
              -methylguanine-DNA methyltransferase inhibitors in cancer chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (16)
                                     , 1971-1996. <a href="https://doi.org/10.4155/fmc-2018-0069" title="DOI URL">https://doi.org/10.4155/fmc-2018-0069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0069%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bspecific%252Brole%252Bof%252BO%252B6%252B-methylguanine-DNA%252Bmethyltransferase%252Binhibitors%252Bin%252Bcancer%252Bchemotherapy%26aulast%3DSun%26aufirst%3DGuohui%26date%3D2018%26volume%3D10%26issue%3D16%26spage%3D1971%26epage%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lakshmanan  Sandhiya</span>, <span class="hlFld-ContribAuthor ">Kittusamy  Senthilkumar</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the mechanisms for the radical induced damage of 6-thioguanine. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Quantum Chemistry</span><span> <strong>2018,</strong> <em>118 </em>
                                    (11)
                                     , e25544. <a href="https://doi.org/10.1002/qua.25544" title="DOI URL">https://doi.org/10.1002/qua.25544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/qua.25544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fqua.25544%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Quantum%2520Chemistry%26atitle%3DExploring%252Bthe%252Bmechanisms%252Bfor%252Bthe%252Bradical%252Binduced%252Bdamage%252Bof%252B6-thioguanine%26aulast%3DSandhiya%26aufirst%3DLakshmanan%26date%3D2018%26date%3D2017%26volume%3D118%26issue%3D11%26spage%3De25544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Baran</span>, <span class="hlFld-ContribAuthor ">Marina  Konopleva</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2017,</strong> <em>23 </em>
                                    (10)
                                     , 2382-2390. <a href="https://doi.org/10.1158/1078-0432.CCR-16-0895" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-16-0895</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-16-0895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-16-0895%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DMolecular%252BPathways%25253A%252BHypoxia-Activated%252BProdrugs%252Bin%252BCancer%252BTherapy%26aulast%3DBaran%26aufirst%3DNatalia%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D10%26spage%3D2382%26epage%3D2390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshio  Hamada</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in prodrug design strategies based on generally applicable modifications. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (8)
                                     , 1627-1632. <a href="https://doi.org/10.1016/j.bmcl.2017.02.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Bprogress%252Bin%252Bprodrug%252Bdesign%252Bstrategies%252Bbased%252Bon%252Bgenerally%252Bapplicable%252Bmodifications%26aulast%3DHamada%26aufirst%3DYoshio%26date%3D2017%26volume%3D27%26issue%3D8%26spage%3D1627%26epage%3D1632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weipei  Feng</span>, <span class="hlFld-ContribAuthor ">Yuechai  Wang</span>, <span class="hlFld-ContribAuthor ">Shizhu  Chen</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Shuxiang  Wang</span>, <span class="hlFld-ContribAuthor ">Shenghui  Li</span>, <span class="hlFld-ContribAuthor ">Hongyan  Li</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Jinchao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">4-Nitroimidazole-3-hydroxyflavone conjugate as a fluorescent probe for hypoxic cells. </span><span class="cited-content_cbyCitation_journal-name">Dyes and Pigments</span><span> <strong>2016,</strong> <em>131 </em>, 145-153. <a href="https://doi.org/10.1016/j.dyepig.2016.03.019" title="DOI URL">https://doi.org/10.1016/j.dyepig.2016.03.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dyepig.2016.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dyepig.2016.03.019%26sid%3Dliteratum%253Aachs%26jtitle%3DDyes%2520and%2520Pigments%26atitle%3D4-Nitroimidazole-3-hydroxyflavone%252Bconjugate%252Bas%252Ba%252Bfluorescent%252Bprobe%252Bfor%252Bhypoxic%252Bcells%26aulast%3DFeng%26aufirst%3DWeipei%26date%3D2016%26volume%3D131%26spage%3D145%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Song</span>, <span class="hlFld-ContribAuthor ">Xin  Yao</span>, <span class="hlFld-ContribAuthor ">Ting  Zhong</span>, <span class="hlFld-ContribAuthor ">Shuang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Guo</span>, <span class="hlFld-ContribAuthor ">Wei  Ren</span>, <span class="hlFld-ContribAuthor ">Dan  Huang</span>, <span class="hlFld-ContribAuthor ">Xiao-Chuan  Duan</span>, <span class="hlFld-ContribAuthor ">Yi-Fan  Yin</span>, <span class="hlFld-ContribAuthor ">Shu-Shi  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (30)
                                     , 48467-48480. <a href="https://doi.org/10.18632/oncotarget.10310" title="DOI URL">https://doi.org/10.18632/oncotarget.10310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.10310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.10310%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DThe%252Banti-tumor%252Befficacy%252Bof%252B3-%2525282-Nitrophenyl%252529%252Bpropionic%252Bacid-paclitaxel%252B%252528NPPA-PTX%252529%25253A%252Ba%252Bnovel%252Bpaclitaxel%252Bbioreductive%252Bprodrug%26aulast%3DSong%26aufirst%3DPing%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D30%26spage%3D48467%26epage%3D48480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liam J  O'Connor</span>, <span class="hlFld-ContribAuthor ">Cindy  Cazares-KÃ¶rner</span>, <span class="hlFld-ContribAuthor ">Jaideep  Saha</span>, <span class="hlFld-ContribAuthor ">Charles N G  Evans</span>, <span class="hlFld-ContribAuthor ">Michael R L  Stratford</span>, <span class="hlFld-ContribAuthor ">Ester M  Hammond</span>, <span class="hlFld-ContribAuthor ">Stuart J  Conway</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Nature Protocols</span><span> <strong>2016,</strong> <em>11 </em>
                                    (4)
                                     , 781-794. <a href="https://doi.org/10.1038/nprot.2016.034" title="DOI URL">https://doi.org/10.1038/nprot.2016.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nprot.2016.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnprot.2016.034%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Protocols%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bmolecularly%252Btargeted%252Bhypoxia-activated%252Bprodrugs%26aulast%3DO%2527Connor%26aufirst%3DLiam%2BJ%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D4%26spage%3D781%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhengxing  Zhang</span>, <span class="hlFld-ContribAuthor ">Joseph  Lau</span>, <span class="hlFld-ContribAuthor ">Hsiou-Ting  Kuo</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Navjit  Hundal-Jabal</span>, <span class="hlFld-ContribAuthor ">Nadine  Colpo</span>, <span class="hlFld-ContribAuthor ">FranÃ§ois  BÃ©nard</span>, <span class="hlFld-ContribAuthor ">Kuo-Shyan  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 18 F-labeled 4-nitrobenzyl derivatives for imaging tumor hypoxia with positron emission tomography: Comparison of 2-[ 18 F]fluoroethyl carbonate and 2-[ 18 F]fluoroethyl carbamate. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (2)
                                     , 584-588. <a href="https://doi.org/10.1016/j.bmcl.2015.11.066" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.11.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.11.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.11.066%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B18%252BF-labeled%252B4-nitrobenzyl%252Bderivatives%252Bfor%252Bimaging%252Btumor%252Bhypoxia%252Bwith%252Bpositron%252Bemission%252Btomography%25253A%252BComparison%252Bof%252B2-%25255B%252B18%252BF%25255Dfluoroethyl%252Bcarbonate%252Band%252B2-%25255B%252B18%252BF%25255Dfluoroethyl%252Bcarbamate%26aulast%3DZhang%26aufirst%3DZhengxing%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D584%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hisao  Saneyoshi</span>, <span class="hlFld-ContribAuthor ">Yuki  Hiyoshi</span>, <span class="hlFld-ContribAuthor ">Koichi  Iketani</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Kondo</span>, <span class="hlFld-ContribAuthor ">Akira  Ono</span>. </span><span class="cited-content_cbyCitation_article-title">Bioreductive deprotection of 4-nitrobenzyl group on thymine base in oligonucleotides for the activation of duplex formation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (23)
                                     , 5632-5635. <a href="https://doi.org/10.1016/j.bmcl.2015.10.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.10.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.10.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBioreductive%252Bdeprotection%252Bof%252B4-nitrobenzyl%252Bgroup%252Bon%252Bthymine%252Bbase%252Bin%252Boligonucleotides%252Bfor%252Bthe%252Bactivation%252Bof%252Bduplex%252Bformation%26aulast%3DSaneyoshi%26aufirst%3DHisao%26date%3D2015%26volume%3D25%26issue%3D23%26spage%3D5632%26epage%3D5635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lili  Li</span>, <span class="hlFld-ContribAuthor ">Sisi  Li</span>, <span class="hlFld-ContribAuthor ">Guohui  Sun</span>, <span class="hlFld-ContribAuthor ">Ruizeng  Peng</span>, <span class="hlFld-ContribAuthor ">Lijiao  Zhao</span>, <span class="hlFld-ContribAuthor ">Rugang  Zhong</span>, . </span><span class="cited-content_cbyCitation_article-title">Influence of the Expression Level of O6-Alkylguanine-DNA Alkyltransferase on the Formation of DNA Interstrand Crosslinks Induced by Chloroethylnitrosoureas in Cells: A Quantitation Using High-Performance Liquid Chromatography-Mass Spectrometry. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (3)
                                     , e0121225. <a href="https://doi.org/10.1371/journal.pone.0121225" title="DOI URL">https://doi.org/10.1371/journal.pone.0121225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0121225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0121225%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DInfluence%252Bof%252Bthe%252BExpression%252BLevel%252Bof%252BO6-Alkylguanine-DNA%252BAlkyltransferase%252Bon%252Bthe%252BFormation%252Bof%252BDNA%252BInterstrand%252BCrosslinks%252BInduced%252Bby%252BChloroethylnitrosoureas%252Bin%252BCells%25253A%252BA%252BQuantitation%252BUsing%252BHigh-Performance%252BLiquid%252BChromatography-Mass%252BSpectrometry%26aulast%3DLi%26aufirst%3DLili%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D3%26spage%3De0121225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William R.  Wilson</span>, <span class="hlFld-ContribAuthor ">Kevin O.  Hicks</span>, <span class="hlFld-ContribAuthor ">Jingli  Wang</span>, <span class="hlFld-ContribAuthor ">Frederik B.  Pruijn</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrug Strategies for Targeting Tumour Hypoxia. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 283-328. <a href="https://doi.org/10.1007/978-1-4614-9167-5_13" title="DOI URL">https://doi.org/10.1007/978-1-4614-9167-5_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-9167-5_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-9167-5_13%26sid%3Dliteratum%253Aachs%26atitle%3DProdrug%252BStrategies%252Bfor%252BTargeting%252BTumour%252BHypoxia%26aulast%3DWilson%26aufirst%3DWilliam%2BR.%26date%3D2014%26date%3D2013%26spage%3D283%26epage%3D328%26pub%3DSpringer%2520New%2520York%26atitle%3DHypoxia%252Band%252BCancer%26aulast%3DMelillo%26aufirst%3DGiovanni%26date%3D2014%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiechuang  Su</span>, <span class="hlFld-ContribAuthor ">ChristopherÂ P.  Guise</span>, <span class="hlFld-ContribAuthor ">WilliamÂ R.  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">FSL-61 is a 6-nitroquinolone fluorogenic probe for one-electron reductases in hypoxic cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2013,</strong> <em>452 </em>
                                    (1)
                                     , 79-86. <a href="https://doi.org/10.1042/BJ20121695" title="DOI URL">https://doi.org/10.1042/BJ20121695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BJ20121695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBJ20121695%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DFSL-61%252Bis%252Ba%252B6-nitroquinolone%252Bfluorogenic%252Bprobe%252Bfor%252Bone-electron%252Breductases%252Bin%252Bhypoxic%252Bcells%26aulast%3DSu%26aufirst%3DJiechuang%26date%3D2013%26date%3D2013%26volume%3D452%26issue%3D1%26spage%3D79%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Raymond P.  Baumann</span>, <span class="hlFld-ContribAuthor ">Eric  Patridge</span>, <span class="hlFld-ContribAuthor ">Philip G.  Penketh</span>, <span class="hlFld-ContribAuthor ">Krishnamurthy  Shyam</span>, <span class="hlFld-ContribAuthor ">Kimiko  Ishiguro</span>, <span class="hlFld-ContribAuthor ">Alan C.  Sartorelli</span>. </span><span class="cited-content_cbyCitation_article-title">Chloroethylating and methylating dual function antineoplastic agents display superior cytotoxicity against repair proficient tumor cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (6)
                                     , 1853-1859. <a href="https://doi.org/10.1016/j.bmcl.2013.01.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DChloroethylating%252Band%252Bmethylating%252Bdual%252Bfunction%252Bantineoplastic%252Bagents%252Bdisplay%252Bsuperior%252Bcytotoxicity%252Bagainst%252Brepair%252Bproficient%252Btumor%252Bcells%26aulast%3DZhu%26aufirst%3DRui%26date%3D2013%26volume%3D23%26issue%3D6%26spage%3D1853%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Helen A.  Seow</span>, <span class="hlFld-ContribAuthor ">Raymond P.  Baumann</span>, <span class="hlFld-ContribAuthor ">Kimiko  Ishiguro</span>, <span class="hlFld-ContribAuthor ">Philip G.  Penketh</span>, <span class="hlFld-ContribAuthor ">Krishnamurthy  Shyam</span>, <span class="hlFld-ContribAuthor ">Alan C.  Sartorelli</span>. </span><span class="cited-content_cbyCitation_article-title">Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (19)
                                     , 6242-6247. <a href="https://doi.org/10.1016/j.bmcl.2012.08.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.08.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.08.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Bof%252Ba%252Bhypoxia-activated%252Bprodrug%252Binhibitor%252Bof%252BO6-alkylguanine-DNA%252Balkyltransferase%26aulast%3DZhu%26aufirst%3DRui%26date%3D2012%26volume%3D22%26issue%3D19%26spage%3D6242%26epage%3D6247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip G.  Penketh</span>, <span class="hlFld-ContribAuthor ">Krishnamurthy  Shyam</span>, <span class="hlFld-ContribAuthor ">Raymond P.  Baumann</span>, <span class="hlFld-ContribAuthor ">Kimiko  Ishiguro</span>, <span class="hlFld-ContribAuthor ">Eric V.  Patridge</span>, <span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Alan C.  Sartorelli</span>. </span><span class="cited-content_cbyCitation_article-title">A Strategy for Selective O6-Alkylguanine-DNA Alkyltransferase Depletion Under Hypoxic Conditions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2012,</strong> <em>80 </em>
                                    (2)
                                     , 279-290. <a href="https://doi.org/10.1111/j.1747-0285.2012.01401.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2012.01401.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2012.01401.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2012.01401.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DA%252BStrategy%252Bfor%252BSelective%252BO6-Alkylguanine-DNA%252BAlkyltransferase%252BDepletion%252BUnder%252BHypoxic%252BConditions%26aulast%3DPenketh%26aufirst%3DPhilip%2BG.%26date%3D2012%26date%3D2012%26volume%3D80%26issue%3D2%26spage%3D279%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Influence of oxygen concentration on nitro reduction. Shown is the chemical mechanism underlying the inverse oxygen concentration dependency of net prodrug reduction that leads to molecular fragmentation and the release of the AGT inhibitor <i>O</i><sup>6</sup>-BG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="schI" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0002.jpeg" id="rightTab-_i2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=schI"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="schII" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0001.jpeg" id="rightTab-_i4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=schII"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) phosgene CH<sub>2</sub>Cl<sub>2</sub>/pyridine, 0 Â°C to room temperature, 20 h; (ii) room temperature, 2â40 h; (iii) EtOH/1 M NaOH (6:1), 0 Â°C, 30 min, followed by neutralization with 10% acetic acid, or 0.1â1 M NH<sub>3</sub> in CH<sub>3</sub>OH, 20â40 h.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Loss of parental prodrugs (<b>1</b>, upper row; <b>2</b>, middle row; <b>3</b>, lower row) and the subsequent generation of <i>O</i><sup>6</sup>-BG over a 3 h 37 Â°C incubation period in medium in the presence of either 10<sup>7</sup>/mL DU145 cells (left-hand column) or 10<sup>7</sup>/mL EMT6 cells (right-hand column). In all panels, â  represents the concentration of parental prodrug under normoxic conditions, â¼ represents the concentration of parental prodrug under oxygen deficient conditions, â² represents the concentration of generated <i>O</i><sup>6</sup>-BG under normoxic conditions, and â represents the concentration of generated <i>O</i><sup>6</sup>-BG under oxygen deficient conditions. The plotted values represent the mean of three separate experiments Â± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/medium/jm-2011-01115f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Sensitization of DU145 human prostate carcinoma cells to laromustine by <b>3</b> induced inhibition of AGT in clonogenic experiments. DU145 AGT containing cells in confluent monolayers were exposed to 40 Î¼M <b>3</b> for 6 h and then treated with graded concentrations of laromustine for a total of 24 h under conditions of normoxia (â ) or oxygen deficiency (â²). The cytotoxicity of laromustine alone under conditions of normoxia (â¼) or oxygen deficiency (â) is also displayed. After treatment, cells were detached by trypsinization and survival was quantified using clonogenicity. The <i>Y</i> axis indicates the percent survival and the <i>X</i> axis the concentration of laromustine employed. Oxygen was removed from test samples enzymatically in the presence of 2 units/mL glucose oxidase, 120 units/mL catalase, and 25 mM glucose during incubation and plating of cells to measure cloning efficiency. All points are the result of at least three independent experimental determinations Â± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201115f/production/images/large/jm-2011-01115f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201115f&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47104" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47104" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loomis, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">796</span><span class="NLM_x">â</span> <span class="NLM_lpage">801</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9505021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=796-801&author=K.+Shyamauthor=P.+G.+Penkethauthor=R.+H.+Loomisauthor=W.+C.+Roseauthor=A.+C.+Sartorelli&title=Antitumor+2-%28aminocarbonyl%29-1%2C2-bis%28methylsulfonyl%29-1-%282-chloroethyl%29hydrazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm9505021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9505021%26sid%3Dliteratum%253Aachs%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DLoomis%26aufirst%3DR.%2BH.%26aulast%3DRose%26aufirst%3DW.%2BC.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DAntitumor%25202-%2528aminocarbonyl%2529-1%252C2-bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529hydrazines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D796%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Finch, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3033</span><span class="NLM_x">â</span> <span class="NLM_lpage">3038</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=3033-3038&author=R.+A.+Finchauthor=K.+Shyamauthor=P.+G.+Penkethauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2-%28methylamino%29carbonylhydrazine+%28101M%29%3A+a+novel+sulfonylhydrazine+prodrug+with+broad-spectrum+antineoplastic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinch%26aufirst%3DR.%2BA.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2-%2528methylamino%2529carbonylhydrazine%2520%2528101M%2529%253A%2520a%2520novel%2520sulfonylhydrazine%2520prodrug%2520with%2520broad-spectrum%2520antineoplastic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D3033%26epage%3D3038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Baumann, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seow, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">The antineoplastic efficacy of the prodrug cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation</span> <span class="citation_source-journal">Oncol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">â</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=16408696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGns73L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=313-325&author=R.+P.+Baumannauthor=H.+A.+Seowauthor=K.+Shyamauthor=P.+G.+Penkethauthor=A.+C.+Sartorelli&title=The+antineoplastic+efficacy+of+the+prodrug+cloretazine+is+produced+by+the+synergistic+interaction+of+carbamoylating+and+alkylating+products+of+its+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation</span></div><div class="casAuthors">Baumann, Raymond P.; Seow, Helen A.; Shyam, Krishnamurthy; Penketh, Philip G.; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">313-325</span>CODEN:
                <span class="NLM_cas:coden">ONREE8</span>;
        ISSN:<span class="NLM_cas:issn">0965-0407</span>.
    
            (<span class="NLM_cas:orgname">Cognizant Communication Corp.</span>)
        </div><div class="casAbstract">Cloretazine {1,2-bis(methylsulfonyl)-1-[(2-chloroethyl)-2-(methylamino)carbonyl]hydrazine; VNP40101M; 101M} is a sulfonylhydrazine prodrug that possesses broad spectrum antitumor efficacy against transplanted murine and human tumor models and has shown activity in clin. trials against relapsed or refractory acute myeloid leukemia.  Base catalyzed activation of this prodrug generates two different reactive intermediates: chloroethylating species that covalently interact with DNA at the O6-position of guanine residues that progress to a G-C interstrand cross-link, and a carbamoylating agent, Me isocyanate.  Previous findings from this lab. have provided initial evidence that Me isocyanate can contribute to the efficacy of Cloretazine by enhancing the cytotoxicity of the generated chloroethylating species.  This action may be due in part to inhibition of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT); however, activity in cells devoid of AGT indicates that other actions are involved in the synergistic cytotoxicity.  Herein we demonstrate that O6-benzylguanine can also produce synergistic cell kill with the alkylating component of Cloretazine but differs from Me isocyanate in that the enhancement occurs in AGT-contg. cells, but not in cells devoid of AGT.  Me isocyanate generated by the decompn. of 1,2-bis(methylsulfonyl)-1-[methylaminocarbonyl]hydrazine also acts to enhance the activity of a variety of DNA crosslinking agents, while only producing additive cytotoxicity with methylating agents.  How cytometric studies using annexin as a marker for apoptosis indicate that in Chinese hamster ovary cells and in human leukemia cells Cloretazine-induced apoptosis is primarily caused by the generated Me isocyanate.  Comet assays designed to detect DNA cross-links in intact cells indicate that the chloroethylating species generated by the activation of Cloretazine produce DNA cross-links, with the co-generated Me isocyanate increasing the degree of crosslinking produced by the reactive chloroethylating species.  These findings provide further evidence that the Me isocyanate produced by the activation of Cloretazine can be a major contributor to the cytotoxicity produced by this antineoplastic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKSXgyHd6hYLVg90H21EOLACvtfcHk0lhVGz1gttu6Xg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGns73L&md5=1906d7583ae64a43c7fc393f6dcbce4f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DSeow%26aufirst%3DH.%2BA.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DThe%2520antineoplastic%2520efficacy%2520of%2520the%2520prodrug%2520cloretazine%2520is%2520produced%2520by%2520the%2520synergistic%2520interaction%2520of%2520carbamoylating%2520and%2520alkylating%2520products%2520of%2520its%2520activation%26jtitle%3DOncol.%2520Res.%26date%3D2005%26volume%3D15%26spage%3D313%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Role of <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">â</span> <span class="NLM_lpage">1763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1158%2F1535-7163.MCT-05-0169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=16275997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyrtLjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=1755-1763&author=K.+Ishiguroauthor=K.+Shyamauthor=P.+G.+Penkethauthor=A.+C.+Sartorelli&title=Role+of+O6-alkylguanine-DNA+alkyltransferase+in+the+cytotoxic+activity+of+cloretazine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine</span></div><div class="casAuthors">Ishiguro, Kimiko; Shyam, Krishnamurthy; Penketh, Philip G.; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1755-1763</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cloretazine (VNP40101M; 101M; 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine) is a sulfonylhydrazine prodrug that generates both chloroethylating and carbamoylating species on activation.  To explore the mol. mechanisms underlying the broad anticancer activity obsd. in preclin. studies, cloretazine and chloroethylating-only [i.e., 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine] and carbamoylating-only (i.e., 1,2-bis(methylsulfonyl)-1-[(methylamino)carbonyl]hydrazine) analogs were evaluated in five murine hematopoietic cell lines.  These cell lines were separable into two groups by virtue of their sensitivity to 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine; the sensitive group included L1210, P388, and F-MEL leukemias (IC50s, 6-8 Î¼mol/L) and the resistant group consisted of Ba/F3 bone marrow and WEHI-3B leukemia cells (IC50s, 50-70 Î¼mol/L).  Resistant cells expressed O6-alkylguanine-DNA alkyltransferase (AGT), whereas sensitive cells did not.  A correlation existed between AGT expression and the functional status of p53; AGT- cells possessed defective p53, whereas AGT+ cells contained wild-type p53.  Based on recent findings on regulation of AGT gene expression by others, we suspect that silencing of the AGT gene by promoter hypermethylation frequently occurs during tumor progression involving p53 inactivation.  O6-Chloroethylguanine is the initial DNA lesion that progresses to lethal interstrand DNA cross-links.  Cloretazine exhibited a much higher preference toward the O6-chloroethylation of guanine, as measured by the difference in IC50s to wild-type and AGT-transfected L1210 cells, than 1,3-bis(2-chloroethyl)-1-nitrosourea, which targets the same site in DNA.  Preferential toxicity of cloretazine against AGT- tumor cells coupled with decreased toxicity to AGT+ cells in host tissues constitute the therapeutic basis for cloretazine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Gm7rc8wLOLVg90H21EOLACvtfcHk0lgsCxn_5HbbJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyrtLjI&md5=2b12a94dfcd41eb622cea51e1301c6dd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0169%26sid%3Dliteratum%253Aachs%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DRole%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%2520in%2520the%2520cytotoxic%2520activity%2520of%2520cloretazine%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D1755%26epage%3D1763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seow, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Mode of action of the chloroethylating and carbamoylating moiety of the prodrug cloretazine</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">â</span> <span class="NLM_lpage">976</span><div class="note"><p class="first last">. PMCID: PMC2680221</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1158%2F1535-7163.MCT-05-0532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=16648568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=969-976&author=K.+Ishiguroauthor=H.+A.+Seowauthor=P.+G.+Penkethauthor=A.+C.+Sartorelli&title=Mode+of+action+of+the+chloroethylating+and+carbamoylating+moiety+of+the+prodrug+cloretazine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mode of action of the chloroethylating and carbamoylating moieties of the prodrug cloretazine</span></div><div class="casAuthors">Ishiguro, Kimiko; Seow, Helen A.; Penketh, Philip G.; Shyam, Krishnamurthy; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">969-976</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cloretazine is an antitumor sulfonylhydrazine prodrug that generates both chloroethylating and carbamoylating species.  The cytotoxic potency of these species was analyzed in L1210 leukemia cells using analogs with chloroethylating or carbamoylating function only.  Clonogenic assays showed that the chloroethylating-only agent 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine (90CE) produced marked differential cytotoxicity against wild-type and O6-alkylguanine-DNA alkyltransferase-transfected L1210 cells (LC10, 1.4 vs. 31 Î¼mol/L), indicating that a large portion of the cytotoxicity was due to alkylation of DNA at the O-6 position of guanine.  Consistent with the concept that O-6 chloroethylation of DNA guanine progresses to interstrand cross-links, the comet assay, in which DNA cross-links were measured by a redn. in DNA migration induced by strand breaks, showed that cloretazine and 90CE, but not the carbamoylating-only agent 1,2-bis(methylsulfonyl)-1-[(methylamino)carbonyl]hydrazine (101MDCE), produced DNA cross-links and that cloretazine caused more DNA cross-links than 90CE at equimolar concns.  Cell cycle analyses showed that 90CE and 101MDCE at concns. of 5 and 80 Î¼mol/L, resp., produced similar degrees of G2-M arrest.  90CE produced selective inhibition of DNA synthesis after overnight incubation, whereas 101MDCE caused rapid and nonselective inhibition of RNA, DNA, and protein syntheses.  Both 90CE and 101MDCE induced phosphorylation of histone H2AX, albeit with distinct kinetics.  These results indicate that (a) differential expression of O6-alkylguanine-DNA alkyltransferase in tumor and host cells seems to be responsible for tumor selectivity exerted by cloretazine; (b) 101MDCE enhances DNA crosslinking activity; and (c) 90CE induces cell death at concns. lower than those causing alterations in the cell cycle and macromol. syntheses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk7NojajtpXLVg90H21EOLACvtfcHk0lgsCxn_5HbbJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7w%253D&md5=6961c6c4bb345a016c66494fb6d1250b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0532%26sid%3Dliteratum%253Aachs%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DSeow%26aufirst%3DH.%2BA.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DMode%2520of%2520action%2520of%2520the%2520chloroethylating%2520and%2520carbamoylating%2520moiety%2520of%2520the%2520prodrug%2520cloretazine%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D969%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seow, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Lethality to leukemia cell lines of DNA interstrand cross-links generated by cloretazine derived alkylating species</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1546</span><span class="NLM_x">â</span> <span class="NLM_lpage">1553</span><div class="note"><p class="first last">. PMCID: PMC2888535</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1016%2Fj.leukres.2008.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=18479747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntlGgs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=1546-1553&author=P.+G.+Penkethauthor=R.+P.+Baumannauthor=K.+Ishiguroauthor=K.+Shyamauthor=H.+A.+Seowauthor=A.+C.+Sartorelli&title=Lethality+to+leukemia+cell+lines+of+DNA+interstrand+cross-links+generated+by+cloretazine+derived+alkylating+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating species</span></div><div class="casAuthors">Penketh, Philip G.; Baumann, Raymond P.; Ishiguro, Kimiko; Shyam, Krishnamurthy; Seow, Helen A.; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1546-1553</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cloretazine [1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine; VNP40101M; 101 M] is a relatively new prodrug with activity in elderly acute myelogenous leukemia (AML) patients.  Its therapeutic action is due largely to the prodn. of 1-(3-cytosinyl),2-(1-guanyl)ethane cross-links (G-C ethane cross-links) in DNA.  The nos. of cross-links produced in three exptl. leukemia lines (L1210, U937 and HL-60) were fewer than 10 per genome at their resp. LC50 concns.  Only 1 in approx. 20,000 90CE mols. produces a cross-link in the AGT (O 6-alkylguanine-DNA alkyltransferase) neg. L1210 and U937 cell lines and 1 in 400,000 in the AGT pos. HL-60 cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZlmxuj5gTfrVg90H21EOLACvtfcHk0lgsCxn_5HbbJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntlGgs74%253D&md5=34e2216f8d6963bdad1bdaa747dcac69</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2008.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2008.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DSeow%26aufirst%3DH.%2BA.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DLethality%2520to%2520leukemia%2520cell%2520lines%2520of%2520DNA%2520interstrand%2520cross-links%2520generated%2520by%2520cloretazine%2520derived%2520alkylating%2520species%26jtitle%3DLeuk.%2520Res.%26date%3D2008%26volume%3D32%26spage%3D1546%26epage%3D1553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belcourt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loomis, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Hypoxia-selective nitrobenzyloxycarbonyl derivatives of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">â</span> <span class="NLM_lpage">946</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9805891" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=941-946&author=K.+Shyamauthor=P.+G.+Penkethauthor=M.+Shapiroauthor=M.+F.+Belcourtauthor=R.+H.+Loomisauthor=S.+Rockwellauthor=A.+C.+Sartorelli&title=Hypoxia-selective+nitrobenzyloxycarbonyl+derivatives+of+1%2C2-bis%28methylsulfonyl%29-1-%282-chloroethyl%29hydrazine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm9805891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9805891%26sid%3Dliteratum%253Aachs%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DBelcourt%26aufirst%3DM.%2BF.%26aulast%3DLoomis%26aufirst%3DR.%2BH.%26aulast%3DRockwell%26aufirst%3DS.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DHypoxia-selective%2520nitrobenzyloxycarbonyl%2520derivatives%2520of%25201%252C2-bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529hydrazine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D941%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Seow, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): an anticancer agents targeting hypoxic cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">9282</span><span class="NLM_x">â</span> <span class="NLM_lpage">9287</span><div class="note"><p class="first last">. PMCID: PMC1166587</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=9282-9287&author=H.+A.+Seowauthor=P.+G.+Penkethauthor=K.+Shyamauthor=S.+Rockwellauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2%5B%5B1-%284-nitrophenyl%29ethoxy%5Dcarbonyl%5Dhydrazine+%28KS119%29%3A+an+anticancer+agents+targeting+hypoxic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeow%26aufirst%3DH.%2BA.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DRockwell%26aufirst%3DS.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2%255B%255B1-%25284-nitrophenyl%2529ethoxy%255Dcarbonyl%255Dhydrazine%2520%2528KS119%2529%253A%2520an%2520anticancer%2520agents%2520targeting%2520hypoxic%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D9282%26epage%3D9287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pegg, A. E.</span><span> </span><span class="NLM_article-title">Mammalian <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6119</span><span class="NLM_x">â</span> <span class="NLM_lpage">6129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=6119-6129&author=A.+E.+Pegg&title=Mammalian+O6-alkylguanine-DNA+alkyltransferase%3A+regulation+and+importance+in+response+to+alkylating+carcinogenic+and+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPegg%26aufirst%3DA.%2BE.%26atitle%3DMammalian%2520O6-alkylguanine-DNA%2520alkyltransferase%253A%2520regulation%2520and%2520importance%2520in%2520response%2520to%2520alkylating%2520carcinogenic%2520and%2520therapeutic%2520agents%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D6119%26epage%3D6129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Brent, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remack, J. S.</span><span> </span><span class="NLM_article-title">Formation of covalent complexes between human <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase and BCNU-treated defined length oligodeoxynucleotides</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6779</span><span class="NLM_x">â</span> <span class="NLM_lpage">6788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1988&pages=6779-6788&author=T.+P.+Brentauthor=J.+S.+Remack&title=Formation+of+covalent+complexes+between+human+O6-alkylguanine-DNA+alkyltransferase+and+BCNU-treated+defined+length+oligodeoxynucleotides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrent%26aufirst%3DT.%2BP.%26aulast%3DRemack%26aufirst%3DJ.%2BS.%26atitle%3DFormation%2520of%2520covalent%2520complexes%2520between%2520human%2520O6-alkylguanine-DNA%2520alkyltransferase%2520and%2520BCNU-treated%2520defined%2520length%2520oligodeoxynucleotides%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1988%26volume%3D16%26spage%3D6779%26epage%3D6788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Baumann, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brent, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2mac_hyphen;[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of <i>O</i><sup>6</sup>-alkylguanine DNA alkyltransferase in cytotoxicity</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">â</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1007%2Fs00280-003-0739-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=14685775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVWgsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=288-295&author=R.+P.+Baumannauthor=K.+Shyamauthor=P.+G.+Penkethauthor=J.+Remackauthor=T.+P.+Brentauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2mac_hyphen%3B%5B%28methylamino%29carbonyl%5Dhydrazine+%28VNP40101M%29%3A+II.+Role+of+O6-alkylguanine+DNA+alkyltransferase+in+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity</span></div><div class="casAuthors">Baumann, R. P.; Shyam, K.; Penketh, P. G.; Remack, J. S.; Brent, T. P.; Sartorelli, A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">288-295</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">VNP40101M (1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine) is a sulfonylhydrazine prodrug that possesses broad spectrum antitumor efficacy in murine models.  VNP40101M activation generates chloroethylating species that alkylate DNA at the O6-position of guanine, and a carbamoylating agent, Me isocyanate, which inhibits O6-alkylguanine-DNA alkyltransferase (AGT) in model systems.  We detd. whether expression of AGT in Chinese hamster ovary (CHO) cells decreased sensitivity to VNP40101M and explored the mechanism of VNP40101M cytotoxicity by employing analogs of VNP40101M that generate reactive intermediates with either carbamoylating or chloroethylating activity.  AGT was overexpressed in CHO cells by transfection with an expression vector contg. the human AGT gene.  Cell lines expressing AGT were employed in clonogenic assays to det. the cytotoxicity of VNP40101M and its analogs.  VNP40101M was more active against AGT-expressing CHO cells than 90CE (1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine), a chloroethylating generator devoid of carbamoylating activity.  Furthermore, the greater the degree of AGT expression the more resistance to VNP40101M cytotoxicity.  Combination chemotherapy expts. support the conclusions that Me isocyanate and the chloroethylating species generated from the activation of VNP40101M function synergistically to kill cells.  The findings support the concept that alkylation of the O6-position of guanine residues in DNA is the predominant lesion created by VNP40101M, and that Me isocyanate resulting from the base-catalyzed activation of VNP40101M inhibits AGT and presumably other enzymes involved in DNA repair, thereby enhancing the yield of the DNA G-C interstrand crosslinks responsible for the antitumor activity of this agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhaLV7N-CdBbVg90H21EOLACvtfcHk0ljPrjc44yk3Vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVWgsrg%253D&md5=f977fb4530185d2e1c098e051c78531f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00280-003-0739-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-003-0739-0%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DRemack%26aufirst%3DJ.%26aulast%3DBrent%26aufirst%3DT.%2BP.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2mac_hyphen%253B%255B%2528methylamino%2529carbonyl%255Dhydrazine%2520%2528VNP40101M%2529%253A%2520II.%2520Role%2520of%2520O6-alkylguanine%2520DNA%2520alkyltransferase%2520in%2520cytotoxicity%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2004%26volume%3D53%26spage%3D288%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Gerson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K.</span><span> </span><span class="NLM_article-title"><i>O</i><sup>6</sup>-Alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance</span> <span class="citation_source-journal">Hematol. Oncol. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">â</span> <span class="NLM_lpage">450</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=7642472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A280%3ADyaK2MzntVWjtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=431-450&author=S.+L.+Gersonauthor=J.+K.+Willson&title=O6-Alkylguanine-DNA+alkyltransferase.+A+target+for+the+modulation+of+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance</span></div><div class="casAuthors">Gerson S L; Willson J K</div><div class="citationInfo"><span class="NLM_cas:title">Hematology/oncology clinics of North America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">431-50</span>
        ISSN:<span class="NLM_cas:issn">0889-8588</span>.
    </div><div class="casAbstract">The DNA repair protein, O6-alkylguanine DNA alkyltransferase, is a major contributor to the resistance to the nitrosourea, triazine, and tetrazine class of alkylating agents.  Many tumor cells and primary tumor samples contain high levels of this protein, although a great deal of heterogeneity exists between and within tumors.  Inhibition of the alkyl-transferase by O6-benzylguanine results in significant potentiation of the cytotoxic effects of these chemotherapeutic agents, generating responses in human tumor xenografts that are completely resistant to nitrosoureas alone.  These studies may rekindle the interest in the nitrosourea class of alkylating agents and stimulate the search for inhibitors of other mechanisms of chemotherapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGEsUYPoRYj7ZpSb_XWfMrfW6udTcc2eatD9uXe6Hp77ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2MzntVWjtA%253D%253D&md5=441b5a9977ab012a6f9913aa06f7e5cb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerson%26aufirst%3DS.%2BL.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%26atitle%3DO6-Alkylguanine-DNA%2520alkyltransferase.%2520A%2520target%2520for%2520the%2520modulation%2520of%2520drug%2520resistance%26jtitle%3DHematol.%2520Oncol.%2520Clin.%2520North%2520Am.%26date%3D1995%26volume%3D9%26spage%3D431%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Schold, S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brent, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Hofe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenberg, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleihues, P.</span><span> </span><span class="NLM_article-title"><i>O</i><sup>6</sup>-Alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts</span> <span class="citation_source-journal">J. Neurosurg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">â</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.3171%2Fjns.1989.70.4.0573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=2926498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A280%3ADyaL1M7nslGisA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1989&pages=573-577&author=S.+Scholdauthor=T.+P.+Brentauthor=E.+von+Hofeauthor=H.+S.+Friedmanauthor=S.+Mitraauthor=D.+D.+Bignerauthor=J.+A.+Swenbergauthor=P.+Kleihues&title=O6-Alkylguanine-DNA+alkyltransferase+and+sensitivity+to+procarbazine+in+human+brain-tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts</span></div><div class="casAuthors">Schold S C Jr; Brent T P; von Hofe E; Friedman H S; Mitra S; Bigner D D; Swenberg J A; Kleihues P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurosurgery</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">573-7</span>
        ISSN:<span class="NLM_cas:issn">0022-3085</span>.
    </div><div class="casAbstract">The level of O6-alkylguanine-deoxyribonucleic acid (DNA) alkyltransferase (AT) was determined in 15 human brain-tumor xenografts in athymic mice.  This enzyme is a primary intracellular repair mechanism for lesions produced at the O6 position of guanine by a wide range of alkylating agents, including nitrosoureas and procarbazine.  Its activity ranged from undetectable in five tumor lines to 2338 fmol/mg protein in N-1941, a human glioblastoma xenograft.  The sensitivity of 10 of these xenografts to procarbazine was determined and it was found that four of the five tumor lines with AT levels of more than 100 fmol/mg protein had growth delays after procarbazine treatment of less than 20 days, whereas all five lines with undetectable AT levels had growth delays of over 30 days.  The primary cytotoxic DNA adduct produced by procarbazine (namely, O6-methylguanine) was found to be significantly higher in two sensitive lines with low AT levels than in a highly resistant line with a high AT level.  These data suggest that the AT levels of individual brain tumors can be used as predictive indicators of their susceptibility to drugs that exert their antineoplastic effect primarily by O6-alkylation of guanine in nuclear DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAZRWUuW1YBsAKB7Fa-xrUfW6udTcc2eZbaH0q86-6uLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7nslGisA%253D%253D&md5=ec237fc7488007e7d7fb8a03a94eb459</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3171%2Fjns.1989.70.4.0573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3171%252Fjns.1989.70.4.0573%26sid%3Dliteratum%253Aachs%26aulast%3DSchold%26aufirst%3DS.%26aulast%3DBrent%26aufirst%3DT.%2BP.%26aulast%3Dvon%2BHofe%26aufirst%3DE.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DSwenberg%26aufirst%3DJ.%2BA.%26aulast%3DKleihues%26aufirst%3DP.%26atitle%3DO6-Alkylguanine-DNA%2520alkyltransferase%2520and%2520sensitivity%2520to%2520procarbazine%2520in%2520human%2520brain-tumor%2520xenografts%26jtitle%3DJ.%2520Neurosurg.%26date%3D1989%26volume%3D70%26spage%3D573%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span> </span><span class="NLM_article-title">Depletion of mammalian <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase activity by <i>O</i><sup>6</sup>-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">5368</span><span class="NLM_x">â</span> <span class="NLM_lpage">5372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=5368-5372&author=M.+E.+Dolanauthor=R.+C.+Moschelauthor=A.+E.+Pegg&title=Depletion+of+mammalian+O6-alkylguanine-DNA+alkyltransferase+activity+by+O6-benzylguanine+provides+a+means+to+evaluate+the+role+of+this+protein+in+protection+against+carcinogenic+and+therapeutic+alkylating+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26atitle%3DDepletion%2520of%2520mammalian%2520O6-alkylguanine-DNA%2520alkyltransferase%2520activity%2520by%2520O6-benzylguanine%2520provides%2520a%2520means%2520to%2520evaluate%2520the%2520role%2520of%2520this%2520protein%2520in%2520protection%2520against%2520carcinogenic%2520and%2520therapeutic%2520alkylating%2520agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1990%26volume%3D87%26spage%3D5368%26epage%3D5372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mummert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span> </span><span class="NLM_article-title">Effect of <i>O</i><sup>6</sup>-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3367</span><span class="NLM_x">â</span> <span class="NLM_lpage">3372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=3367-3372&author=M.+E.+Dolanauthor=R.+B.+Mitchellauthor=C.+Mummertauthor=R.+C.+Moschelauthor=A.+E.+Pegg&title=Effect+of+O6-benzylguanine+analogues+on+sensitivity+of+human+tumor+cells+to+the+cytotoxic+effects+of+alkylating+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DMitchell%26aufirst%3DR.%2BB.%26aulast%3DMummert%26aufirst%3DC.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26atitle%3DEffect%2520of%2520O6-benzylguanine%2520analogues%2520on%2520sensitivity%2520of%2520human%2520tumor%2520cells%2520to%2520the%2520cytotoxic%2520effects%2520of%2520alkylating%2520agents%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D3367%26epage%3D3372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Baer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlands, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafferty, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margison, G. P.</span><span> </span><span class="NLM_article-title">Depletion of <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumor cells</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1299</span><span class="NLM_x">â</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1038%2Fbjc.1993.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=8512814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFGht7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1993&pages=1299-1302&author=J.+C.+Baerauthor=A.+A.+Freemanauthor=E.+S.+Newlandsauthor=A.+J.+Watsonauthor=J.+A.+Raffertyauthor=G.+P.+Margison&title=Depletion+of+O6-alkylguanine-DNA+alkyltransferase+correlates+with+potentiation+of+temozolomide+and+CCNU+toxicity+in+human+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumor cells</span></div><div class="casAuthors">Baer, J. C.; Freeman, A. A.; Newlands, E. S.; Watson, A. J.; Rafferty, J. A.; Margison, G. P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1299-302</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Temozolomide (8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-triazin-4(3H)-one) has shown promising activity in Phase I trials against some brain (glioma) and skin (Melanoma, mycosis fungoides) cancers.  Temozolomide and lomustine (CCNU) showed parallel toxicity in seven human tumor cell lines and this generally correlated (correlation coeffs. 0.87 and 0.92 resp.) with the level of expression of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (ATase, EC 2.1.1.63).  Pretreating cells with the ATase inhibitor, O6-benzylguanine (BG), potentiated cytotoxicity to a similar degree with both drugs, but did not sensitize a cell line (ZR-75-1) expressing very low levels of this protein.  When BG pretreatment was combined with repeat doses of temozolomide a dramatic potentiation (300 fold) was seen in MAWI cells, which express high levels of ATase, but not in a cell line (U373) expressing lower levels of ATase.  [14C]-labeled temozolomide uptake was similar in sensitive and resistant lines.  Human ATase-cDNA transfected Xeroderma pigmentosum (XP) fibroblasts were more resistant than XP control cells to temozolomide and the related chloroethylating agent mitozolomide and although BG completely suppressed ATase activity in these cells, resistance was still greater than in control cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsxAlV44XaBbVg90H21EOLACvtfcHk0lhr_l089OYGdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFGht7g%253D&md5=0b2862b808fe4d4ed2c92961bbc9067f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1993.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1993.241%26sid%3Dliteratum%253Aachs%26aulast%3DBaer%26aufirst%3DJ.%2BC.%26aulast%3DFreeman%26aufirst%3DA.%2BA.%26aulast%3DNewlands%26aufirst%3DE.%2BS.%26aulast%3DWatson%26aufirst%3DA.%2BJ.%26aulast%3DRafferty%26aufirst%3DJ.%2BA.%26aulast%3DMargison%26aufirst%3DG.%2BP.%26atitle%3DDepletion%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%2520correlates%2520with%2520potentiation%2520of%2520temozolomide%2520and%2520CCNU%2520toxicity%2520in%2520human%2520tumor%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1993%26volume%3D67%26spage%3D1299%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Magull-Seltenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeller, W. J.</span><span> </span><span class="NLM_article-title">Sensitization of human colon tumor cell lines to carmustine by depletion of <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase</span> <span class="citation_source-journal">J. Cancer Res. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">â</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1995&pages=225-229&author=A.+Magull-Seltenreichauthor=W.+J.+Zeller&title=Sensitization+of+human+colon+tumor+cell+lines+to+carmustine+by+depletion+of+O6-alkylguanine-DNA+alkyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMagull-Seltenreich%26aufirst%3DA.%26aulast%3DZeller%26aufirst%3DW.%2BJ.%26atitle%3DSensitization%2520of%2520human%2520colon%2520tumor%2520cell%2520lines%2520to%2520carmustine%2520by%2520depletion%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D1995%26volume%3D121%26spage%3D225%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Quinn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colvin, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haglund, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClendon, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Provenzale, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guruangan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourt-Uhlig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J. E.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidman, H. S.</span><span> </span><span class="NLM_article-title">Phase II trial of carmustine plus <i>O</i><sup>6</sup>-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2277</span><span class="NLM_x">â</span> <span class="NLM_lpage">2283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1200%2FJCO.2002.09.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=11980998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVKrs78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=2277-2283&author=J.+A.+Quinnauthor=J.+Pludaauthor=M.+E.+Dolanauthor=S.+Delaneyauthor=R.+Kaplanauthor=J.+N.+Richauthor=A.+H.+Friedmanauthor=D.+A.+Reardonauthor=J.+H.+Sampsonauthor=O.+M.+Colvinauthor=M.+M.+Haglundauthor=A.+E.+Peggauthor=R.+C.+Moschelauthor=R.+E.+McClendonauthor=J.+M.+Provenzaleauthor=S.+Guruanganauthor=S.+Tourt-Uhligauthor=J.+E.+Herndonauthor=D.+D.+Bignerauthor=H.+S.+Freidman&title=Phase+II+trial+of+carmustine+plus+O6-benzylguanine+for+patients+with+nitrosourea-resistant+recurrent+or+progressive+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of carmustine plus O6-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma</span></div><div class="casAuthors">Quinn, Jennifer A.; Pluda, James; Dolan, M. Eileen; Delaney, Shannon; Kaplan, Richard; Rich, Jeremy N.; Friedman, Allan H.; Reardon, David A.; Sampson, John H.; Colvin, O. Michael; Haglund, Michael M.; Pegg, Anthony E.; Moschel, Robert C.; McLendon, Roger E.; Provenzale, James M.; Gururangan, Sridharan; Tourt-Uhlig, Sandra; Herndon, James E., II; Bigner, Darell D.; Friedman, Henry S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2277-2283</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose: the authors conducted a phase II trial of carmustine (BCNU) plus the O6-alkylguanine-DNA alkyltransferase inhibitor O6-benzylguanine (O6-BG) to define the activity and toxicity of this regimen in the treatment of adults with progressive or recurrent malignant glioma resistant to nitrosoureas.  Patients and Methods: Patients were treated with O6-BG at an i.v. dose of 120 mg/M2 followed 1 h later by 40 mg/M2 of BCNU, with cycles repeated at 6-wk intervals.  Results: Eighteen patients were treated (15 with glioblastoma multiforme, two with anaplastic astrocytoma, and one with malignant glioma).  None of the 18 patients demonstrated a partial or complete response.  Two patients exhibited stable disease for 12 wk before their tumors progressed.  Three patients demonstrated stable disease for 6, 12, and 18 wk before discontinuing therapy because of hematopoietic toxicity.  Twelve patients experienced reversible â¥ grade 3 hematopoietic toxicity.  There was no difference in half-lives (0.56Â±0.21 h v 0.54Â±0.20 h) or area under the curve values (4.8Â±1.7 Î¼g/mL/h v 5.0Â±1.3 Î¼g/mL/h) of O6-BG for patients receiving phenytoin and those not treated with this drug.  Conclusion: These results indicate that O6-BG plus BCNU at the dose schedule used in this trial is unsuccessful in producing tumor regression in patients with nitrosourea-resistant malignant glioma, although stable disease was seen in five patients for 6, 12, 12, 12, and 18 wk.  Future use of this approach will require strategies to minimize dose-limiting toxicity of BCNU such as regional delivery or hematopoietic stem-cell protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCxLQ0k9A7ErVg90H21EOLACvtfcHk0lhaMvGmDesyHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVKrs78%253D&md5=60e1702ff9920f775d83e1f2ea08f60b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1200%2FJCO.2002.09.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2002.09.084%26sid%3Dliteratum%253Aachs%26aulast%3DQuinn%26aufirst%3DJ.%2BA.%26aulast%3DPluda%26aufirst%3DJ.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DDelaney%26aufirst%3DS.%26aulast%3DKaplan%26aufirst%3DR.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26aulast%3DFriedman%26aufirst%3DA.%2BH.%26aulast%3DReardon%26aufirst%3DD.%2BA.%26aulast%3DSampson%26aufirst%3DJ.%2BH.%26aulast%3DColvin%26aufirst%3DO.%2BM.%26aulast%3DHaglund%26aufirst%3DM.%2BM.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26aulast%3DMcClendon%26aufirst%3DR.%2BE.%26aulast%3DProvenzale%26aufirst%3DJ.%2BM.%26aulast%3DGuruangan%26aufirst%3DS.%26aulast%3DTourt-Uhlig%26aufirst%3DS.%26aulast%3DHerndon%26aufirst%3DJ.%2BE.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFreidman%26aufirst%3DH.%2BS.%26atitle%3DPhase%2520II%2520trial%2520of%2520carmustine%2520plus%2520O6-benzylguanine%2520for%2520patients%2520with%2520nitrosourea-resistant%2520recurrent%2520or%2520progressive%2520malignant%2520glioma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2002%26volume%3D20%26spage%3D2277%26epage%3D2283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Schilsky, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewesuedo, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelzang, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratain, M. J.</span><span> </span><span class="NLM_article-title">Phase I clinical and pharmacological study of <i>O</i><sup>6</sup>-benzylguanine followed by carmustine in patients with advanced cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3025</span><span class="NLM_x">â</span> <span class="NLM_lpage">3031</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=10955780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVOmsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=3025-3031&author=R.+L.+Schilskyauthor=M.+E.+Dolanauthor=D.+Bertucciauthor=R.+B.+Ewesuedoauthor=N.+J.+Vogelzangauthor=S.+Maniauthor=L.+R.+Wilsonauthor=M.+J.+Ratain&title=Phase+I+clinical+and+pharmacological+study+of+O6-benzylguanine+followed+by+carmustine+in+patients+with+advanced+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer</span></div><div class="casAuthors">Schilsky, Richard L.; Dolan, M. Eileen; Bertucci, Donna; Ewesuedo, Reginald B.; Vogelzang, Nicholas J.; Mani, Sridhar; Wilson, Lynette R.; Ratain, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3025-3031</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">O6-benzylguanine (BG) is a potent inactivator of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT) that enhances sensitivity to nitrosoureas in tumor cell lines and tumor-bearing animals.  The major objectives of this study were to define the optimal modulatory dose and assocd. toxicities of benzylguanine administered alone and in combination with carmustine; to define the maximally tolerated dose and assocd. toxicities of carmustine administered with benzylguanine and to describe the pharmacokinetics of BG in humans and its effects on AGT depletion and recovery in peripheral blood mononuclear cells.  Patients with histol. confirmed advanced solid tumors or lymphoma that had failed to respond to std. therapy or for which no std. therapy was available were eligible to participate in this study.  Patients initially received BG as a 1-h i.v. infusion without carmustine.  After a 14-day washout (i.e., without therapy) period, patients received BG as a 1-h i.v. infusion followed, 1 h later, by a 15-min i.v. infusion of carmustine.  Cycles of chemotherapy were repeated every 6 wk.  Cohorts of patients received BG doses ranging from 10 to 120 mg/m2 and carmustine doses ranging from 13 to 50 mg/m2.  Plasma and urine samples were collected and analyzed for BG, and O6-benzyl-8-oxoguanine concns. and AGT activity was detd. in peripheral blood mononuclear cells.  There was no toxicity attributable to BG alone at any dose tested.  Bone marrow suppression was the primary and dose-limiting toxicity of BG combined with carmustine and was cumulative in some patients.  The neutrophil nadir occurred at a median of day 27, with complete recovery in most patients by day 43.  Nonhematol. toxicity included fatigue, anorexia, increased bilirubin, and transaminase elevation.  Recommended doses for Phase II testing are 120 mg/m2 BG given with carmustine at 40 mg/m2.  BG rapidly disappeared from plasma and was converted to a major metabolite, O6-benzyl-8-oxoguanine, which has a 2.4-fold higher maximal concn. and 20-fold higher area under the concn. vs. time curve than BG.  AGT activity in peripheral blood mononuclear cells was rapidly and completely suppressed at all of the BG doses.  The rate of AGT regeneration was more rapid for patients treated with the lowest dose of BG but was similar for BG doses ranging from 20-120 mg/m2.  In conclusion, coadministration of BG and carmustine is feasible in cancer patients, but the maximal dose of carmustine that can be safely administered with BG is approx. one-third of the std. clin. dose.  Bone marrow suppression, which may be cumulative, is the dose-limiting toxicity of the combination.  Prolonged AGT suppression is likely attributable primarily to the effect of O6-benzyl-8-oxoguanine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcXhq5tQNd4rVg90H21EOLACvtfcHk0lhaMvGmDesyHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVOmsb8%253D&md5=0a9215fd136d362e082a31551eecb927</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchilsky%26aufirst%3DR.%2BL.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DBertucci%26aufirst%3DD.%26aulast%3DEwesuedo%26aufirst%3DR.%2BB.%26aulast%3DVogelzang%26aufirst%3DN.%2BJ.%26aulast%3DMani%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DL.%2BR.%26aulast%3DRatain%26aufirst%3DM.%2BJ.%26atitle%3DPhase%2520I%2520clinical%2520and%2520pharmacological%2520study%2520of%2520O6-benzylguanine%2520followed%2520by%2520carmustine%2520in%2520patients%2520with%2520advanced%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D3025%26epage%3D3031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kennedy, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teicher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">The hypoxic tumor cell: a target for selective cancer chemotherapy</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1980&pages=1-8&author=K.+A.+Kennedyauthor=B.+A.+Teicherauthor=S.+Rockwellauthor=A.+C.+Sartorelli&title=The+hypoxic+tumor+cell%3A+a+target+for+selective+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DK.%2BA.%26aulast%3DTeicher%26aufirst%3DB.%2BA.%26aulast%3DRockwell%26aufirst%3DS.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DThe%2520hypoxic%2520tumor%2520cell%253A%2520a%2520target%2520for%2520selective%2520cancer%2520chemotherapy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1980%26volume%3D29%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Therapeutic attack of hypoxic cells of solid tumors: presidential address</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">â</span> <span class="NLM_lpage">778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1988&pages=775-778&author=A.+C.+Sartorelli&title=Therapeutic+attack+of+hypoxic+cells+of+solid+tumors%3A+presidential+address"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DTherapeutic%2520attack%2520of%2520hypoxic%2520cells%2520of%2520solid%2520tumors%253A%2520presidential%2520address%26jtitle%3DCancer%2520Res.%26date%3D1988%26volume%3D48%26spage%3D775%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Chae, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDougall, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span> </span><span class="NLM_article-title">Substituted <i>O</i><sup>6</sup>-benzylguanine derivatives and their inactivation of human <i>O</i><sup>6</sup>-alkylguanine DNA alkyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">â</span> <span class="NLM_lpage">347</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00029a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=342-347&author=M.-Y.+Chaeauthor=M.+G.+McDougallauthor=M.+E.+Dolanauthor=K.+Swennauthor=A.+E.+Peggauthor=R.+C.+Moschel&title=Substituted+O6-benzylguanine+derivatives+and+their+inactivation+of+human+O6-alkylguanine+DNA+alkyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm00029a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00029a005%26sid%3Dliteratum%253Aachs%26aulast%3DChae%26aufirst%3DM.-Y.%26aulast%3DMcDougall%26aufirst%3DM.%2BG.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DSwenn%26aufirst%3DK.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26atitle%3DSubstituted%2520O6-benzylguanine%2520derivatives%2520and%2520their%2520inactivation%2520of%2520human%2520O6-alkylguanine%2520DNA%2520alkyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D342%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Chae, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanugula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span> </span><span class="NLM_article-title">8-Substituted <i>O</i><sup>6</sup>-benzylguanine, substituted 6(4)-(benzyloxy)pyrimidine derivatives, and related compounds as inhibitors of human <i>O</i><sup>6</sup>-alkylguanine DNA alkyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">â</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00002a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=359-365&author=M.-Y.+Chaeauthor=K.+Swennauthor=S.+Kanugulaauthor=M.+E.+Dolanauthor=A.+E.+Peggauthor=R.+C.+Moschel&title=8-Substituted+O6-benzylguanine%2C+substituted+6%284%29-%28benzyloxy%29pyrimidine+derivatives%2C+and+related+compounds+as+inhibitors+of+human+O6-alkylguanine+DNA+alkyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm00002a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00002a018%26sid%3Dliteratum%253Aachs%26aulast%3DChae%26aufirst%3DM.-Y.%26aulast%3DSwenn%26aufirst%3DK.%26aulast%3DKanugula%26aufirst%3DS.%26aulast%3DDolan%26aufirst%3DM.%2BE.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26atitle%3D8-Substituted%2520O6-benzylguanine%252C%2520substituted%25206%25284%2529-%2528benzyloxy%2529pyrimidine%2520derivatives%252C%2520and%2520related%2520compounds%2520as%2520inhibitors%2520of%2520human%2520O6-alkylguanine%2520DNA%2520alkyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D359%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loktionova, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschel, R. C.</span><span> </span><span class="NLM_article-title">Î²-Glucuronidase-cleavable prodrugs of <i>O</i><sup>6</sup>-benzylguanine and <i>O</i><sup>6</sup>-benzyl-2â²-deoxyguanine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">â</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493865" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=256-261&author=G.+Weiauthor=N.+A.+Loktionovaauthor=A.+E.+Peggauthor=R.+C.+Moschel&title=%CE%B2-Glucuronidase-cleavable+prodrugs+of+O6-benzylguanine+and+O6-benzyl-2%E2%80%B2-deoxyguanine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm0493865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493865%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DG.%26aulast%3DLoktionova%26aufirst%3DN.%2BA.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26aulast%3DMoschel%26aufirst%3DR.%2BC.%26atitle%3D%25CE%25B2-Glucuronidase-cleavable%2520prodrugs%2520of%2520O6-benzylguanine%2520and%2520O6-benzyl-2%25E2%2580%25B2-deoxyguanine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D256%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Penketh, P. G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, R. P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remack, J. S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brent, T. P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">â</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1007%2Fs00280-003-0740-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=14704831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVWgs7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=279-287&author=P.+G+Penkethauthor=K+Shyamauthor=R.+P+Baumannauthor=J.+S+Remackauthor=T.+P+Brentauthor=A.+C.+Sartorelli&title=1%2C2-Bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2-%5B%28methylamino%29carbonyl%5Dhydrazine+%28VNP40101M%29%3A+I.+Direct+inhibition+of+O6-alkylguanine-DNA+alkyltransferase+%28AGT%29+by+electrophilic+species+generated+by+decomposition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition</span></div><div class="casAuthors">Penketh, P. G.; Shyam, K.; Baumann, R. P.; Remack, J. S.; Brent, T. P.; Sartorelli, A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-287</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">To investigate the interaction of the electrophilic species generated by the decompn. of the antineoplastic prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M) on the ability of O6-alkylguanine-DNA alkyltransferase (AGT) to repair alkylated O6-chloroethylguanine and/or N1,O6-ethanoguanine DNA lesions.  The contributions of inhibitory electrophilic species generated from VNP40101M towards AGT was assessed using analogs that selectively generated either the chloroethylating or the carbamoylating components of VNP40101M.  The activity of AGT was detd. from the inhibition of crosslink formation from O6-chloroethylguanine and/or N1,O6-ethanoguanine lesions.  The half-lives of sulfonylhydrazine derivs. and isocyanates were measured using an acidification assay which gives a change in absorbance proportional to the release or consumption of small quantities of protons.  Both of the reactive components produced by VNP40101M directly inactivated cloned human AGT; the carbamoylating moiety (IC50 about 13 Î¼M) was approx. seven- to eight-fold more potent than the alkylating component(s) (IC50 about 100 Î¼M).  These inhibitory actions were moderated by the addn. of naked T5 bacteriophage DNA.  Thus, AGT bound to DNA was markedly more resistant than free AGT to these electrophilic species.  DNA also blocked the spontaneous loss of AGT activity which occurred upon incubation of this protein under mild conditions.  The reaction of AGT with the Me isocyanate generated from the decompn. of VNP40101M increased the net no. of crosslinks generated by VNP40101M compared to a sulfonylhydrazine prodrug that formed the equiv. alkylating species in the absence of the cogeneration of Me isocyanate.  These actions may be of significance to the antineoplastic activity of VNP40101M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbeymFLugB-7Vg90H21EOLACvtfcHk0liL9Yzqw_NIDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVWgs7o%253D&md5=432784614b47bc46aec031bc0c2e7a72</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00280-003-0740-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-003-0740-7%26sid%3Dliteratum%253Aachs%26aulast%3DPenketh%26aufirst%3DP.%2BG%26aulast%3DShyam%26aufirst%3DK%26aulast%3DBaumann%26aufirst%3DR.%2BP%26aulast%3DRemack%26aufirst%3DJ.%2BS%26aulast%3DBrent%26aufirst%3DT.%2BP%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3D1%252C2-Bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2-%255B%2528methylamino%2529carbonyl%255Dhydrazine%2520%2528VNP40101M%2529%253A%2520I.%2520Direct%2520inhibition%2520of%2520O6-alkylguanine-DNA%2520alkyltransferase%2520%2528AGT%2529%2520by%2520electrophilic%2520species%2520generated%2520by%2520decomposition%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2004%26volume%3D53%26spage%3D279%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Thomson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, M. R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P. D.</span><span> </span><span class="NLM_article-title">Hypoxia-driven elimination of thiopurines from their nitrobenzyl prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4320</span><span class="NLM_x">â</span> <span class="NLM_lpage">4322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4320-4322&author=P.+Thomsonauthor=M.+A.+Naylorauthor=M.+R.+L.+Stratfordauthor=G.+Lewisauthor=S.+Hillauthor=K.+B.+Patelauthor=P.+Wardmanauthor=P.+D.+Davis&title=Hypoxia-driven+elimination+of+thiopurines+from+their+nitrobenzyl+prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DP.%26aulast%3DNaylor%26aufirst%3DM.%2BA.%26aulast%3DStratford%26aufirst%3DM.%2BR.%2BL.%26aulast%3DLewis%26aufirst%3DG.%26aulast%3DHill%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DK.%2BB.%26aulast%3DWardman%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DP.%2BD.%26atitle%3DHypoxia-driven%2520elimination%2520of%2520thiopurines%2520from%2520their%2520nitrobenzyl%2520prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4320%26epage%3D4322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bianco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haladjian, J.</span><span> </span><span class="NLM_article-title">Study of two forms of ferredoxin from <i>Desulfovibrio gigas</i> by differential pulse polarography</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">â</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1977&pages=323-327&author=P.+Biancoauthor=J.+Haladjian&title=Study+of+two+forms+of+ferredoxin+from+Desulfovibrio+gigas+by+differential+pulse+polarography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBianco%26aufirst%3DP.%26aulast%3DHaladjian%26aufirst%3DJ.%26atitle%3DStudy%2520of%2520two%2520forms%2520of%2520ferredoxin%2520from%2520Desulfovibrio%2520gigas%2520by%2520differential%2520pulse%2520polarography%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1977%26volume%3D78%26spage%3D323%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Baumann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A.</span><span> </span><span class="NLM_article-title">Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cells</span> <span class="citation_source-journal">Radiat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">â</span> <span class="NLM_lpage">660</span><div class="note"><p class="first last">. PMCID: PMC2667281</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm201115f&amp;key=10.1667%2FRR1431.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=18959466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlCnt73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=651-660&author=R.+Baumannauthor=P.+Penkethauthor=H.+Seowauthor=K.+Shyamauthor=A.+Sartorelli&title=Generation+of+oxygen+deficiency+in+cell+culture+using+a+two-enzyme+system+to+evaluate+agents+targeting+hypoxic+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cells</span></div><div class="casAuthors">Baumann, Raymond P.; Penketh, Philip G.; Seow, Helen A.; Shyam, Krishnamurthy; Sartorelli, Alan C.</div><div class="citationInfo"><span class="NLM_cas:title">Radiation Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">651-660</span>CODEN:
                <span class="NLM_cas:coden">RAREAE</span>;
        ISSN:<span class="NLM_cas:issn">0033-7587</span>.
    
            (<span class="NLM_cas:orgname">Radiation Research Society</span>)
        </div><div class="casAbstract">The poor and aberrant vascularization of solid tumors makes them susceptible to localized areas of oxygen deficiency that can be considered sites of tumor vulnerability to prodrugs that are preferentially activated to cytotoxic species under conditions of low oxygenation.  To readily facilitate the selection of agents targeted to oxygen-deficient cells in solid tumors, we have developed a simple and convenient two-enzyme system to generate oxygen deficiency in cell cultures.  Glucose oxidase is employed to deplete oxygen from the medium by selectively oxidizing glucose and reducing mol. oxygen to hydrogen peroxide; an excess of catalase is also used to scavenge the peroxide mols.  Rapid and sustained depletion of oxygen occurs in medium or buffer, even in the presence of oxygen at the liq./air interface.  Studies using CHO/AA8 Chinese hamster cells, EMT6 murine mammary carcinoma cells, and U251 human glioma cells indicate that this system generates an oxygen deficiency that produces activation of the hypoxia-targeted prodrug KS 119.  This method of generating oxygen deficiency in cell culture is inexpensive, does not require cumbersome equipment, permits longer incubation times to be used without the loss of sample vol., and should be adaptable for high-throughput screening in 96-well plates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQFARvu3M87Vg90H21EOLACvtfcHk0ljLv7-sHDSiZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlCnt73M&md5=60e0e75caa5cf7e0257d4f30df2a4d2d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1667%2FRR1431.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1667%252FRR1431.1%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DR.%26aulast%3DPenketh%26aufirst%3DP.%26aulast%3DSeow%26aufirst%3DH.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DSartorelli%26aufirst%3DA.%26atitle%3DGeneration%2520of%2520oxygen%2520deficiency%2520in%2520cell%2520culture%2520using%2520a%2520two-enzyme%2520system%2520to%2520evaluate%2520agents%2520targeting%2520hypoxic%2520tumor%2520cells%26jtitle%3DRadiat.%2520Res.%26date%3D2008%26volume%3D170%26spage%3D651%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Baumann, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penketh, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1553</span><span class="NLM_x">â</span> <span class="NLM_lpage">1561</span><div class="note"><p class="first last">. PMCID: PMC2885764</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1553-1561&author=R.+P.+Baumannauthor=P.+G.+Penkethauthor=K.+Ishiguroauthor=K.+Shyamauthor=Y.+L.+Zhuauthor=A.+C.+Sartorelli&title=Reductive+activation+of+the+prodrug+1%2C2-bis%28methylsulfonyl%29-1-%282-chloroethyl%29-2-%5B%5B1-%284-nitrophenyl%29ethoxy%5Dcarbonyl%5Dhydrazine+%28KS119%29+selectively+occurs+in+oxygen-deficient+cells+and+overcomes+O6-alkylguanine-DNA+alkyltransferase+mediated+KS119+tumor+cell+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaumann%26aufirst%3DR.%2BP.%26aulast%3DPenketh%26aufirst%3DP.%2BG.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DShyam%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DY.%2BL.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DReductive%2520activation%2520of%2520the%2520prodrug%25201%252C2-bis%2528methylsulfonyl%2529-1-%25282-chloroethyl%2529-2-%255B%255B1-%25284-nitrophenyl%2529ethoxy%255Dcarbonyl%255Dhydrazine%2520%2528KS119%2529%2520selectively%2520occurs%2520in%2520oxygen-deficient%2520cells%2520and%2520overcomes%2520O6-alkylguanine-DNA%2520alkyltransferase%2520mediated%2520KS119%2520tumor%2520cell%2520resistance%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1553%26epage%3D1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Rockwell, S.</span><span> </span><span class="NLM_article-title">In vivoâin vitro tumor systems: new models for studying the response of tumors to therapy</span> <span class="citation_source-journal">Lab. Animal Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">â</span> <span class="NLM_lpage">851</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm201115f&amp;key=338981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201115f&amp;key=1%3ACAS%3A280%3ADyaE1c%252FmvF2rsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1977&pages=831-851&author=S.+Rockwell&title=In+vivo%E2%80%93in+vitro+tumor+systems%3A+new+models+for+studying+the+response+of+tumors+to+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo-in vitro tumor systems: new models for studing the response of tumours to therapy</span></div><div class="casAuthors">Rockwell S</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory animal science</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5 Pt 2</span>),
    <span class="NLM_cas:pages">831-51</span>
        ISSN:<span class="NLM_cas:issn">0023-6764</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRp27gpjoZYdLFU0A1HOshhfW6udTcc2ea2UyDsgr7S2rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1c%252FmvF2rsg%253D%253D&md5=177b36151b9b11f5f88b80835944ebf4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRockwell%26aufirst%3DS.%26atitle%3DIn%2520vivo%25E2%2580%2593in%2520vitro%2520tumor%2520systems%253A%2520new%2520models%2520for%2520studying%2520the%2520response%2520of%2520tumors%2520to%2520therapy%26jtitle%3DLab.%2520Animal%2520Sci.%26date%3D1977%26volume%3D27%26spage%3D831%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Belcourt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodnick, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartorelli, A. C.</span><span> </span><span class="NLM_article-title">The intracellular location of NADH:cytochrome b5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">8875</span><span class="NLM_x">â</span> <span class="NLM_lpage">8881</span><div class="note"><p class="first last">. PMCID: PMC40257</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=8875-8881&author=M.+F.+Belcourtauthor=W.+F.+Hodnickauthor=S.+Rockwellauthor=A.+C.+Sartorelli&title=The+intracellular+location+of+NADH%3Acytochrome+b5+reductase+modulates+the+cytotoxicity+of+the+mitomycins+to+Chinese+hamster+ovary+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelcourt%26aufirst%3DM.%2BF.%26aulast%3DHodnick%26aufirst%3DW.%2BF.%26aulast%3DRockwell%26aufirst%3DS.%26aulast%3DSartorelli%26aufirst%3DA.%2BC.%26atitle%3DThe%2520intracellular%2520location%2520of%2520NADH%253Acytochrome%2520b5%2520reductase%2520modulates%2520the%2520cytotoxicity%2520of%2520the%2520mitomycins%2520to%2520Chinese%2520hamster%2520ovary%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D8875%26epage%3D8881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201115f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-21%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm201115f%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201115f" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998546ca083bf2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
